
<html lang="en"     class="pb-page"  data-request-id="ce0f2051-8860-4d4d-9734-63988ed3b3b6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm401695d;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-6;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Structure–Activity Relationship of a Novel Series of GluN2C-Selective Potentiators" /></meta><meta name="dc.Creator" content="Sommer S.  Zimmerman" /></meta><meta name="dc.Creator" content="Alpa  Khatri" /></meta><meta name="dc.Creator" content="Ethel C.  Garnier-Amblard" /></meta><meta name="dc.Creator" content="Praseeda  Mullasseril" /></meta><meta name="dc.Creator" content="Natalie L.  Kurtkaya" /></meta><meta name="dc.Creator" content="Stefka  Gyoneva" /></meta><meta name="dc.Creator" content="Kasper B.  Hansen" /></meta><meta name="dc.Creator" content="Stephen F.  Traynelis" /></meta><meta name="dc.Creator" content="Dennis C.  Liotta" /></meta><meta name="dc.Description" content="NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A–D subunits that mediate a slow Ca2+-permeable component of excitatory synaptic transmission. NMDA receptors have been implicated..." /></meta><meta name="Description" content="NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A–D subunits that mediate a slow Ca2+-permeable component of excitatory synaptic transmission. NMDA receptors have been implicated..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 25, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401695d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401695d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401695d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401695d" /></link>
        
    
    

<title>Design, Synthesis, and Structure–Activity Relationship of a Novel Series of GluN2C-Selective Potentiators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401695d" /></meta><meta property="og:title" content="Design, Synthesis, and Structure–Activity Relationship of a Novel Series of GluN2C-Selective Potentiators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0025.jpeg" /></meta><meta property="og:description" content="NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A–D subunits that mediate a slow Ca2+-permeable component of excitatory synaptic transmission. NMDA receptors have been implicated in a wide range of neurological diseases and thus represent an important therapeutic target. We herein describe a novel series of pyrrolidinones that selectively potentiate only NMDA receptors that contain the GluN2C subunit. The most active analogues tested were over 100-fold selective for recombinant GluN2C-containing receptors over GluN2A/B/D-containing NMDA receptors as well as AMPA and kainate receptors. This series represents the first class of allosteric potentiators that are selective for diheteromeric GluN2C-containing NMDA receptors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401695d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401695d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401695d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401695d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401695d&amp;href=/doi/10.1021/jm401695d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2334-2356</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401609a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401705g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.5b00199"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Structure–Activity Relationship of a Novel Series of GluN2C-Selective Potentiators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sommer+S.++Zimmerman">Sommer S. Zimmerman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alpa++Khatri">Alpa Khatri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ethel+C.++Garnier-Amblard">Ethel C. Garnier-Amblard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Praseeda++Mullasseril">Praseeda Mullasseril</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natalie+L.++Kurtkaya">Natalie L. Kurtkaya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefka++Gyoneva">Stefka Gyoneva</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kasper+B.++Hansen">Kasper B. Hansen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+F.++Traynelis">Stephen F. Traynelis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+C.++Liotta">Dennis C. Liotta</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span></div><div class="corresp-info"><strong>*</strong>S.F.T. (for biology): phone, 404-727-0357; fax, 404 727 0365; e-mail, <a href="/cdn-cgi/l/email-protection#17646365766e797257727a78656e39727362"><span class="__cf_email__" data-cfemail="99eaedebf8e0f7fcd9fcf4f6ebe0b7fcfdec">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>D.C.L. (for chemistry): phone, 404-727-6602; fax, 404 412 8649; e-mail, <a href="/cdn-cgi/l/email-protection#eb8f8782849f9f8aab8e86849992c58e8f9e"><span class="__cf_email__" data-cfemail="c9ada5a0a6bdbda889aca4a6bbb0e7acadbc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401695d&amp;href=/doi/10.1021%2Fjm401695d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2334–2356</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 10, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 November 2013</li><li><span class="item_label"><b>Published</b> online</span>25 February 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401695d" title="DOI URL">https://doi.org/10.1021/jm401695d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401695d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3205</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401695d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Structure–Activity Relationship of a Novel Series of GluN2C-Selective Potentiators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sommer&quot;,&quot;last_name&quot;:&quot;S. Zimmerman&quot;},{&quot;first_name&quot;:&quot;Alpa&quot;,&quot;last_name&quot;:&quot;Khatri&quot;},{&quot;first_name&quot;:&quot;Ethel&quot;,&quot;last_name&quot;:&quot;C. Garnier-Amblard&quot;},{&quot;first_name&quot;:&quot;Praseeda&quot;,&quot;last_name&quot;:&quot;Mullasseril&quot;},{&quot;first_name&quot;:&quot;Natalie&quot;,&quot;last_name&quot;:&quot;L. Kurtkaya&quot;},{&quot;first_name&quot;:&quot;Stefka&quot;,&quot;last_name&quot;:&quot;Gyoneva&quot;},{&quot;first_name&quot;:&quot;Kasper&quot;,&quot;last_name&quot;:&quot;B. Hansen&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;F. Traynelis&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;C. Liotta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;2334-2356&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401695d&quot;},&quot;abstract&quot;:&quot;NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A–D subunits that mediate a slow Ca2+-permeable component of excitatory synaptic transmission. NMDA receptors have been implicated in a wide range of neurological diseases and thus represent an important therapeutic target. We herein describe a novel series of pyrrolidinones that selectively potentiate only NMDA receptors that contain the GluN2C subunit. The most active analogues tested were over 100-fold selective for recombinant GluN2C-containing receptors over GluN2A/B/D-containing NMDA receptors as well as AMPA and kainate receptors. This series represents the first class of allosteric potentiators that are selective for diheteromeric GluN2C-containing NMDA receptors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401695d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401695d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401695d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401695d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401695d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401695d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401695d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401695d&amp;href=/doi/10.1021/jm401695d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401695d" /></input><a href="/doi/pdf/10.1021/jm401695d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401695d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401695d%26sid%3Dliteratum%253Aachs%26pmid%3D24512267%26genre%3Darticle%26aulast%3DZimmerman%26date%3D2014%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2Ba%2BNovel%2BSeries%2Bof%2BGluN2C-Selective%2BPotentiators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D6%26spage%3D2334%26epage%3D2356%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jmcmar.2014.57.issue-6/production/jmcmar.2014.57.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">NMDA receptors are tetrameric complexes composed of GluN1 and GluN2A–D subunits that mediate a slow Ca<sup>2+</sup><b>-</b>permeable component of excitatory synaptic transmission. NMDA receptors have been implicated in a wide range of neurological diseases and thus represent an important therapeutic target. We herein describe a novel series of pyrrolidinones that selectively potentiate only NMDA receptors that contain the GluN2C subunit. The most active analogues tested were over 100-fold selective for recombinant GluN2C-containing receptors over GluN2A/B/D-containing NMDA receptors as well as AMPA and kainate receptors. This series represents the first class of allosteric potentiators that are selective for diheteromeric GluN2C-containing NMDA receptors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptors are members of the family of ionotropic glutamate receptors that mediate excitatory neurotransmission. NMDA receptors are tetrameric assemblies of two GluN1 subunits, which bind the coagonist glycine, and two GluN2 subunits, which bind glutamate.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Both GluN1 and GluN2 subunits share a similar architecture, comprised of an extracellular amino-terminal domain (ATD), an extracellular ligand-binding domain (LBD), a transmembrane domain (TMD), and an intracellular carboxyl-terminal domain (CTD).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The GluN2 subunit is encoded by four distinct gene products (GluN2A-D), which have temporally and spatially distinct expression patterns in the brain.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The GluN2 subunit controls pharmacological characteristics such as agonist sensitivity, deactivation time course, mean open time, and open probability.<a onclick="showRef(event, 'ref2 cit3b ref4'); return false;" href="javascript:void(0);" class="ref ref2 cit3b ref4">(2, 3b, 4)</a></div><div class="NLM_p">The distinct anatomical locations of the GluN2 subunits could allow subunit-selective modulators (either potentiators or inhibitors) to target specific brain regions for therapeutic gain. NMDA receptors are thought to play a role in neuronal development, learning, and memory formation,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> as well as being implicated in ischemia,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> dementia,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> schizophrenia,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> treatment resistant depression,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and Parkinson’s disease.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Recently discovered modulators have demonstrated selectivity for GluN2A, 3-chloro-4-fluoro-<i>N</i>-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulfonamide (TCN201); GluN2A/GluN2B, 9-cyclopropylphenanthrene-3-carboxylic acid (UBP710); and GluN2C/GluN2D, (3-chlorophenyl) [3,4-dihydro-6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-2(1<i>H</i>)-isoquinolinyl]methanone (CIQ), 4-[6-methoxy-2-[(1<i>E</i>)-2-(3-nitrophen yl)ethenyl]-4-oxo-3(4<i>H</i>)quinazolinyl]benzoic acid (QNZ46), 5-(4-bromophenyl)-3-(1,2-dihydro-6- methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-g-oxo-1<i>H</i>-pyrazole-1-butanoic acid (DQP1105), and (2<i>R</i>,3<i>S</i>)-1-(phenanthrenyl-3-carbonyl)piperazine-2,3-dicarboxylic acid (UBP141).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Here, we describe the development of the first class of positive allosteric modulators that are selective for GluN2C-containing NMDA receptors over GluN2A-, GluN2B-, and GluN2D-containing receptors.</div><div class="NLM_p">To identify this class of ligands, a GluN1/GluN2C cell line and multiwell fluorescence-based assay were developed to enable screening of compound libraries for NMDA receptor modulators. We screened two commercial diversity libraries to identify several compounds that modulate GluN2C-containing NMDA receptors. One of these screening hits established a novel class of subunit-selective potentiators for recombinant GluN1/GluN2C NMDA receptors, exemplified by compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Optimization of the initial lead pyrrolidinone scaffold involved the development of a structure–activity relationship, which led to the identification of a novel series of compounds with potency in the low micromolar range and high selectivity for recombinant GluN2C-containing receptors over GluN2A/B/D-containing NMDA receptors. In addition, no detectable potentiation was observed at recombinant AMPA, kainate, GABA, glycine, serotonin, nicotinic, or purinergic receptors (data not shown). These analogues represent a novel class of NMDA receptor modulators that are highly selective for diheteromeric GluN1/GluN2C receptor subtypes and provide a useful tool with which to evaluate the physiological role of GluN2C in normal and neuropathological conditions.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of screening hit. Chemical structure of methyl 4-(1-(2-(1<i>H</i>-indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (compound <b>1</b>) that was identified as a positive modulator using a fluorescence-based screen of compound libraries in a cell line expressing diheteromeric GluN1/GluN2C NMDA receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">We used bioinformatic searches and medicinal chemistry to obtain analogues for our initial screening hit, compound <b>1</b> (see below). Both commercially available analogues and compounds synthesized via a mi-component Biginelli-like reaction (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) were assessed at 30 μM. We determined the EC<sub>50</sub> and maximal potentiation from concentration–effect curves for compounds that showed potentiation of more than 120% of control at 30 μM. No compounds in this class potentiated GluN2A-, GluN2B-, or GluN2D-containing receptors, suggesting remarkable selectivity for this class (see below). Modifications were made at either R<sup>1</sup>, the A-ring, or the B-ring using alternative methodologies to access the appropriate precursor.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1<i>H</i>-Pyrrol-2(5<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: PPTS, rt, 1–24 h, 2% to >99% (procedure I). Final compounds <b>161</b>–<b>180</b>, in which either the A or B ring is replaced, were also prepared using these conditions.</p></p></figure><div class="NLM_p">Addition of diethyl oxalate and sodium ethoxide to a methyl ketone generated a series of pyruvate analogues (<b>3</b>–<b>20</b>) containing modifications at R<sup>1</sup> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Only when R<sup>1</sup> was a phenol was it necessary to first protect the hydroxyl group with triisopropyl chloride (TIPSCl) before the addition of diethyl oxalate. Standard deprotection afforded the target pyruvate (<b>21</b>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route for the Synthesis of Pyruvate Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) diethyl oxalate, NaOEt, EtOH, 0 °C to rt, 4 h, 15% to >99% (procedure II); (b) TIPSCl, imidazole, rt, 6 h, >99%; (c) diethyl oxalate, NaOEt, EtOH, 0 °C to rt, 4 h, 28% (procedure II); (d) TBAF, 0 °C to rt, 1 h, 43%.</p></p></figure><div class="NLM_p">Analogues containing disubstituted A-rings were synthesized using several procedures based on the commercially available precursors (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Benzaldehydes <b>32</b>–<b>41</b> were prepared from methyl esters <b>145</b>–<b>154</b>. Dibromination and hydrolysis afforded analogues <b>32</b> and <b>33</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Suzuki coupling between dibutyl vinylboronate and the appropriately substituted methyl 4-iodobenzoate, followed by ozonolysis, gave phenols <b>34</b> and <b>35</b>. Alternatively, addition of a Grignard reagent and <i>N</i>,<i>N</i>-dimethylformamide (DMF) led to isolation of benzaldehyde <b>36</b>. A palladium-catalyzed formylation was used to access benzaldehydes <b>37</b>–<b>40</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Finally, anisole <b>41</b> was prepared via a dialkylation of both the hydroxyl and carboxylic acid functional groups.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes to Access Substituted Benzaldehydes <b>32</b>–<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 2.0 equiv NBS, (PhCOO)<sub>2</sub>, reflux, 4 h, then AgNO<sub>3</sub>, rt, 3 h, 38–63%; (b) dibutyl vinylboronate, 5 mol % (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, NaCO<sub>3</sub>, reflux, 2 h, 68–80%; (c) O<sub>3</sub>; then (CH<sub>3</sub>)<sub>2</sub>S, −78 °C to rt, 12 h, 60–87%; (d) <i>i</i>-PrMgCl, DMF, −15 °C to rt, 3 h, 70%; (e) CO<sub>(g)</sub>, (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, NaCO<sub>3</sub>, 110 °C, 8–24% (procedure IV); (f) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, rt, 3 h, 58%.</p></p></figure><div class="NLM_p">Benzaldehydes containing a <i>para</i>-amide (<b>42</b>–<b>44</b>) or <i>para</i>-ester (<b>45</b>–<b>47</b>) substituent were synthesized as illustrated in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Primary amide <b>42</b> was synthesized from carboxylic acid <b>155</b> by generating the acid chloride in situ. Standard amide coupling conditions were employed for the preparation of amides <b>43</b> and <b>44</b>. Alkylation of carboxylic acid <b>155</b> with the appropriate alkyl iodide afforded esters <b>45</b> and <b>46</b>, while <i>t</i>-butyl ester <b>47</b> was prepared using a method previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Routes for the Synthesis of Amides <b>42</b>–<b>44</b> and Esters <b>45</b>–<b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) Vilsmeier reagent, aq NH<sub>3</sub>, 0 °C, 16 h, 30%; (b) R<sup>2a</sup>R<sup>2b</sup>N where R<sup>2a</sup> = H and R<sup>2b</sup> = Me or where R<sup>2a</sup> = R<sup>2b</sup> = Me, DMAP, EDCI, 0 °C to rt, 24 h, 14–51%; (c) R<sup>2</sup>I where R<sup>2</sup> = Et or R<sup>2</sup> = <i>i</i>-Pr, K<sub>2</sub>CO<sub>3</sub>, rt, 4 h, 24–87%; (d) (CH<sub>3</sub>)<sub>2</sub>NCH(O<i>t</i>-Bu)<sub>2</sub>, reflux, 1<sup>1</sup>/<sub>2</sub> h, 81%.</p></p></figure><div class="NLM_p">An alternative strategy was used to synthesize analogues containing a modification at R<sup>11</sup> starting from pyrrolidinones <b>1</b> and <b>106</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Protection of analogue <b>1</b> with trimethylsilyl diazomethane afforded methoxy <b>156</b>. Amine <b>157</b> was generated by reaction with ammonium formate. Esterification of <b>1</b> with acetic anhydride gave acetate <b>158</b>. Alternatively, esters <b>159</b> and <b>160</b> were synthesized from enol <b>106</b> using the appropriate acyl chloride and triethylamine.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Route to Modifications at R<sup>11</sup><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) TMSCH<sub>2</sub>N<sub>2</sub>, rt, 5 h, 46%; (b) NH<sub>4</sub>HCO<sub>2</sub>, reflux, 3 h, 14%; (c) Ac<sub>2</sub>O, pyridine, rt, 6<sup>1</sup>/<sub>2</sub> h, 7%; (d) R<sup>11</sup>C(O)Cl where R<sup>11</sup> = CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> or R<sup>11</sup> = CH═CH<sub>2</sub>, TEA, −30 °C, 2 h, 20–35%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pyrrolidinones Selectively Potentiate GluN2C-Containing Receptors</h3><div class="NLM_p">A fluorescence-based screen of 57504 compounds obtained from Asinex and ChemDiv libraries was performed in BHK cells with inducible expression of GluN1/GluN2C receptors. Hits were defined as compounds that produced changes that were 2.5 standard deviations away from the average response to maximally effective agonist (i.e., glutamate and glycine) application. In this primary screen, 1% of the compounds met these criteria. Compounds that showed potentiation were further evaluated for their ability to produce responses in cells with no NMDA receptor expression (in uninduced cells) in order to identify false positive hits. False positive results can occur when the compounds directly release Ca<sup>2+</sup> from intracellular stores, enhance Ca<sup>2+</sup> channel function, possess fluorescent properties in the excitation/emission range of Fluo-4, or otherwise produce an increase in intracellular Ca<sup>2+</sup> signal independent of NMDA receptor activation. Compounds that showed potentiation of glutamate responses in induced cells and did not produce responses in uninduced cells were subsequently studied by two-electrode voltage-clamp recording of NMDA receptor responses.</div><div class="NLM_p">A single compound was found to selectively potentiate the GluN1/GluN2C receptors and did not show any activity at GluN2A/B/D-containing NMDA receptors expressed in <i>Xenopus laevis</i> oocytes (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Compound <b>1</b>, which contains a pyrrolidinone core motif, potentiated GluN1/GluN2C responses to 238 ± 8.2% of control at 100 μM with an EC<sub>50</sub> of 24 ± 2.4 μM (<i>n</i> = 12) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). Compound <b>1</b> had no agonist activity on its own in that it did not induce current responses in oocytes expressing GluN1/GluN2C in the absence of glutamate and glycine (<i>n</i> = 4). In addition, 30 μM of compound <b>1</b> did not potentiate homomeric recombinant GluA1 AMPA receptor responses (97 ± 1.1% control, <i>n</i> = 16). In addition, 120 μM of compound <b>1</b> did not potentiate homomeric GluK2 recombinant kainate receptors (95 ± 2.3% of control, <i>n</i> = 5).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> selectively potentiates the GluN1/GluN2C response. (A) Current traces for <b>1</b> at the GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, and the GluN1/GluN2D receptors. (B) Compound <b>1</b> selectively potentiates the GluN1/GluN2C receptor to a fitted maximum of 275 ± 10% with an EC<sub>50</sub> of 24 ± 2.4, <i>n</i> = 12. (C) The EC<sub>50</sub> for glycine in the absence and presence of <b>1</b> is 0.20 ± 0.01 μM (<i>n</i> = 6) and 0.16 ± 0.02 μM (<i>n</i> = 4), respectively. The EC<sub>50</sub> for glutamate in the absence and presence of <b>1</b> is 0.8 ± 0.07 μM (<i>n</i> = 8) and 1.2 ± 0.04 μM (<i>n</i> = 6), respectively. The presence of <b>1</b> did not shift the glycine or glutamate EC<sub>50</sub> values significantly. (D) The reversal potential is −5.1 ± 0.8 mV when activated by coagonists (100 μM glutamate and 30 μM glycine) and is −5.0 ± 1.2 mV (<i>n</i> = 6) when the GluN1/GluN2C receptor is potentiated by <b>1</b>. The reversal potential was not significantly shifted in the presence of <b>1</b>, suggesting that potentiation is independent of membrane potential.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>1</b> (68 μM) did not detectably alter the EC<sub>50</sub> of glycine or glutamate (<i>n</i> = 4–6; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). Additionally, the reversal potential of glutamate and glycine induced current responses was unchanged in the presence (−5.0 + 1.2 mV, <i>n</i> = 6) or absence (−5.1 + 0.8 mV, <i>n</i> = 6) of compound <b>1</b>. Potentiation was not significantly different at −40 mV (202 ± 11%) compared to +30 mV (180 ± 12%; <i>p</i> = 0.2679; paired <i>t</i> test), indicating that potentiation of GluN2C-containing receptors by compound <b>1</b> at 20 μM was voltage-independent (<i>n</i> = 6; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Effect of Modifications to R<sup>1</sup> on Potency at GluN2C-Containing Receptors</h3><div class="NLM_p">We subsequently evaluated the response to 30 μM of all pyrrolidinone analogues at GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, and GluN1/GluN2D and proceeded to determine the concentration–effect curve when potentiation exceeded 120% of control. Exploration of the effects of keto-linked R<sup>1</sup> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>; see <a class="ref internalNav" href="#sec2_1" aria-label="Chemistry">Chemistry</a> section) substitutions on potentiation of GluN2C-containing receptors in oocytes revealed that additional steric bulk was tolerated, with only minimal improvements in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <b>62</b>–<b>65</b>). For example, replacement of R<sup>1</sup> with a phenyl group, as in <b>65</b>, produced a small increase in potency (EC<sub>50</sub> = 17 ± 2.3) accompanied by a modest decrease in maximal potentiation compared to compound <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Analogues containing <i>m</i>-substituted phenyl rings (<b>66</b>–<b>70</b>) offered variable potentiation, while analogues with <i>o</i>- and <i>p</i>-substituted phenyl rings were inactive (data not shown). Notably, <b>66</b>, with a <i>meta</i>-hydroxyl group, displayed a considerably higher potency at GluN2C-containing receptors (7.0 ± 0.9 μM) but caused significant inhibition of GluN2A-, GluN2B-, and GluN2D-containing receptors at 100 μM (responses were 76 ± 2.0%, 42 ± 1.6%, and 48 ± 2.4% of control, respectively, normalized to agonist activated current). Such mixed-action modulators that potentiate one subunit while inhibiting another are intriguing but of little utility as pharmacological probes. Two compounds containing a pyridine ring at R<sup>1</sup> potentiated responses up to ∼200% with EC<sub>50</sub> values of 12 ± 1.9 μM (<b>72</b>) and 8.9 ± 1.3 μM (<b>73</b>). Interestingly, <b>71</b>, which contains a 2-substituted pyridine ring, was inactive at all receptor subunits. These initial experiments confirmed the ability of derivatives within this class to selectively potentiate GluN2C-containing receptors compared to other NMDA receptor subtypes.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Optimization of Potency through Evaluation of Keto-Linked Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant figures when potentiation at 30 μM of the test compound exceeded 120% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response. Hill slopes varied between 1.2 and 2.0. Data for active compounds at GluN1/GluN2C are from between 6 and 12 oocytes from 2–3 frogs for each compound. When no effect was found (<i>n</i> = 3–15 oocytes), the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 3 oocytes all compounds). For all tables, GluN2 subunits were coexpressed with GluN1 in <i>Xenopus</i> oocytes and evaluated using two-electrode voltage-clamp recordings.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">The response to 100 μM of test compound was greater than 140% of control.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Effect of A-Ring Modifications</h3><div class="NLM_p">Next, we evaluated the effects of various A-ring substituents (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) utilizing R<sup>1</sup> substitutions shown to offer the desired activity. Positional isomer analogues <b>81</b> and <b>82</b> were inactive at GluN1/GluN2C. One compound, <b>84</b>, which contains an ethyl ester at ring position R<sup>2</sup>, displayed comparable potency compared to screening hit <b>1</b>. Analogues containing bulkier ester substituents (e.g., <b>85</b> with an <i>iso</i>-propyl ester and <b>86</b> with a <i>tert</i>-butyl ester) led to inactivity. A series of compounds containing ester isosteres including a nitrile (<b>87</b>), nitro (<b>88</b>), amide (<b>89</b>–<b>91</b>), and sulfonamide (<b>92</b> and <b>93</b>) were also evaluated for their ability to potentiate GluN2C-containing NMDA receptors. Unfortunately, none of these analogues exhibited any activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of A-Ring Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant figures when potentiation at 30 μM of the test compound exceeded 120% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response. Hill slopes varied between 1.3 and 1.7. Data for active compounds at GluN1/GluN2C are from between 8 and 12 oocytes from 2–3 frogs for each compound. When no effect was found (<i>n</i> = 3–11 oocytes), the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 3 oocytes all compounds).</p></div></div><div></div></div><div class="NLM_p">A variety of substituents at A-ring positions R<sup>3</sup> and R<sup>4</sup> were systematically tested while holding the <i>para</i>-methyl ester constant at R<sup>2</sup> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Substitution at the <i>meta</i> position (R<sup>3</sup>) revealed either a reduction in potency (<b>95</b>) or complete inactivity (<b>96</b>–<b>99</b>). Evaluation of a series of <i>ortho</i> (R<sup>4</sup>) ring substituents demonstrated a preference for electron donating groups. For example, analogues containing an <i>ortho</i>-hydroxyl (<b>100</b>) exhibited potentiation with a modest increase in potency, whereas <i>ortho</i>-chloro (<b>103</b>) or -fluoro (<b>104</b>) substituents were slightly less active.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Evaluation of Combinations of A-Ring Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0014.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">I<sub>30 μM</sub>/I<sub>control</sub> (mean ± SEM %)</th><th class="rowsep1 colsep0" align="center" char="±">EC<sub>50</sub> (max) μM (%)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>#</b></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char="±">GluN2A</th><th class="colsep0 rowsep0" align="center" char="±">GluN2B</th><th class="colsep0 rowsep0" align="center" char="±">GluN2C</th><th class="colsep0 rowsep0" align="center" char="±">GluN2D</th><th class="colsep0 rowsep0" align="center" char="±">GluN2C</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>95</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">81 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">79 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">123 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">90 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">29 ± 2.8 (151)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>96</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">98 ± 3.3</td><td class="colsep0 rowsep0" align="char" char="±">80 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">86 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">108 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">91 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">86 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 4.3</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 5.1</td><td class="colsep0 rowsep0" align="char" char="±">113 ± 4.2</td><td class="colsep0 rowsep0" align="char" char="±">83 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 4.1</td><td class="colsep0 rowsep0" align="char" char="±">83 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">114 ± 3.3</td><td class="colsep0 rowsep0" align="char" char="±">93 ± 5.3</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>100</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char="±">107 ± 3.9</td><td class="colsep0 rowsep0" align="char" char="±">86 ± 3.8</td><td class="colsep0 rowsep0" align="char" char="±">173 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">15 ± 0.6 (202)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 6.1</td><td class="colsep0 rowsep0" align="char" char="±">83 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">132 ± 3.3</td><td class="colsep0 rowsep0" align="char" char="±">100 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">46 ± 19 (183)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char="±">101 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">95 ± 4.2</td><td class="colsep0 rowsep0" align="char" char="±">129 ± 3.6</td><td class="colsep0 rowsep0" align="char" char="±">85 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">35 ± 1.4 (165)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>103</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">103 ± 3.9</td><td class="colsep0 rowsep0" align="char" char="±">87 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">139 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">90 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">36 ± 3.0 (191)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>104</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">93 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">96 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">123 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">91 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">37 ± 2.6 (155)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant digits when potentiation at 30 μM of the test compound exceeded 120% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response; Hill slopes ranged between 1.3 and 1.8. Data for active compounds at GluN1/GluN2C are from between 3 and 12 oocytes from 2–3 frogs for each compound. When no effect was found (<i>n</i> = 3–15 oocytes), the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 5 oocytes for all compounds).</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effect of B-Ring Modifications</h3><div class="NLM_p">Replacement of the B-ring with an assortment of acyclic, cyclic, and heterocyclic systems generated a series of compounds that were evaluated for potency and subunit selectivity while retaining optimal R<sup>1</sup> and A-ring substitutions (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Interestingly, substitution with a napthyl derivative, as in <b>162</b>, led to strong inhibition at all four subunits. Replacement of the indole NH with an oxygen atom led only to weak activity (<b>163</b>), suggesting the presence of a hydrogen bond in the binding pocket. In all other instances, removal of the indole led to complete inactivity (i.e., <b>164</b> and <b>165</b>). These data suggest that the indole functionality is preferred for activity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effect of Replacing the B-Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0015.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0016.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant digits when potentiation at 30 μM of the test compound exceeded 120% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response. All data are from 3–14 oocytes from 2–3 frogs. When no effect was found, the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 3 oocytes for all compounds).</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Inhibited at GluN1/GluN2A with an IC<sub>50</sub> of 18 μM, at GluN1/GluN2B with an IC<sub>50</sub> of 7.2 μM, at GluN1/GluN2C with an IC<sub>50</sub> of 11 μM, and GluN1/GluN2D with an IC<sub>50</sub> of 5.7 μM.</p></div></div><div></div></div><div class="NLM_p">This led us to examine B-ring substituents as an alternative strategy to access increased potency. The data describing these compounds is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Methylation of the indole nitrogen led to inactivity (<b>105</b>), further suggesting the importance of a hydrogen atom at this position in the binding pocket. The best potency was obtained for analogues with substitutions at B-ring position R<sup>9</sup>. Compound <b>111</b> demonstrated an ability to selectively potentiate GluN2C-containing NMDA receptors up to 218% with an EC<sub>50</sub> value of 4.3 ± 0.3 μM. It is unclear whether the increase in potency observed for <b>111</b> can be ascribed to a steric effect or, alternatively, to a mildly electropositive effect. Consistent with a steric effect, analogues which contain larger R<sup>9</sup> substituents such as R<sup>9</sup> = OMe (<b>112</b>) revealed a loss of potency compared to <b>111</b>. Analogues containing strongly electron withdrawing R<sup>9</sup> substituents such as R<sup>9</sup> = F (<b>109</b>) also decreased the observed activity.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of B-Ring Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0017.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0018.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant digits when potentiation at 30 μM of the test compound exceeded 120% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response. Hill slopes were between 1.3 and 1.9. Data for active compounds at GluN1/GluN2C are from between 6 and 27 oocytes from 2–3 frogs for each compound. When no effect was found (<i>n</i> = 4–11 oocytes), the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 4 oocytes for all compounds).</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Effect of Combinatorial Modifications on Potency at GluN2C-Containing Receptors</h3><div class="NLM_p">We subsequently evaluated the effect of combining modifications at R<sup>1</sup>, the A-ring and the B-ring that had previously demonstrated an improvement in potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Substitution with either a <i>meta</i>- or <i>para</i>-substituted pyridine ring at R<sup>1</sup> and a <i>para</i>-ethyl ester at R<sup>2</sup> revealed potentiation of GluN1/GluN2C responses with EC<sub>50</sub> values of 8.2 ± 0.9 μM (<b>116</b>) and 9.7 ± 0.6 μM (<b>117</b>), respectively. Modification of the B-ring and either R<sup>1</sup> (R<sup>1</sup> = <i>m</i>-pyridine) or R<sup>2</sup> (R<sup>2</sup> = <i>p</i>-CO<sub>2</sub>Et) exhibited a similar increase in on-target potency. For example, substitution with a methyl group at R<sup>6</sup> and a <i>para</i>-ethyl ester at R<sup>2</sup>, as in analogue <b>119</b>, resulted in a 2-fold potency enhancement.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Optimization of Potency though Additional Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0019.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0020.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant digits when potentiation at 30 μM of the test compound exceeded 120% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response. Data for active compounds at GluN1/GluN2C are from between 8 and 14 oocytes from 2 frogs for each compound; the Hill slope varied between 1.2 and 1.5. When no effect was found at 30 μM (<i>n</i> = 3–6 oocytes), the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 7 oocytes for all compounds).</p></div></div><div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Effect of Linker Modifications on Potency of 1616-Series</h3><div class="NLM_p">The original screening hit, <b>1</b>, contains a two carbon region linking the B-ring with the core pyrrolidinone. The linker modifications explored are illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. Both shortening (<b>121</b>) and extending (<b>122</b>) the linker eliminated all activity, suggesting that the potency of pyrrolidinone analogues is highly dependent on the length of the carbon linkage.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Optimization of Potency though Linker Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0021.gif" alt="" id="fx12" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0022.gif" alt="" id="fx13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant digits when potentiation at 30 μM of the test compound exceeded 120%; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response. Data for active compounds at GluN1/GluN2C are from between 7 and 8 oocytes from 2 frogs for each compound tested; the Hill slope varied between 1.3 and 1.4. When no effect was found at 30 μM (<i>n</i> = 3–11 oocytes), the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 4 oocytes for all compounds).</p></div></div><div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Effect of Modifications to R<sup>11</sup> on Potency at GluN2C-Containing Receptors</h3><div class="NLM_p">Several modifications were made at R<sup>11</sup> to determine the significance of the enol in controlling potency and selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Replacement with an amine, as in <b>157</b>, led to a complete loss of potentiation at concentrations up to 100 μM. In most instances, compounds containing a protected alcohol led to less potent analogues. For example, a 2-fold decrease in potency was observed for acetate <b>158</b>. In contrast, propyl ester <b>159</b> maintained activity comparable to lead analogue <b>1</b>, with an EC<sub>50</sub> of 17 ± 1.8 μM. These data suggest that enhancements in potency cannot be gained though modifications of the enol.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Optimization of Potency though Evaluation of Vinyl Substituents</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0023.gif" alt="" id="fx14" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0024.gif" alt="" id="fx15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>Table a</sup><p class="last">Fitted EC<sub>50</sub> values are shown for GluN1/GluN2C to two significant digits when potentiation at 30 μM of the test compound exceeded 120% of control; values in parentheses are the fitted maximum response as a percentage of the initial glutamate (100 μM) and glycine (30 μM) response. Data for active compounds at GluN1/GluN2C are from between 5 and 9 oocytes from 2–3 frogs for each compound. The Hill slope varied between 1.2 and 1.8 and was fixed to be 1.5 for less potent analogues (<b>157</b>, <b>159</b>). When no effect was found (<i>n</i> = 3–9 oocytes), the lack of effect was confirmed by testing at 100 μM (data not shown, <i>n</i> ≥ 4 oocytes for all compounds).</p></div></div><div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Effect of Absolute Configuration on Potency at GluN2C-Containing Receptors</h3><div class="NLM_p">To enable evaluation of potential stereoselectivity for pyrrolidinone analogues at GluN1/GluN2C, we separated the enantiomers of <b>106</b> using a semipreparatory OD-RH chiral HPLC column (see <a class="ref internalNav" href="#sec4_2" aria-label="Chemistry Experimentals">Chemistry Experimentals</a>). Each enantiomer was subjected to two-electrode voltage clamp analysis in <i>Xenopus laevis</i> oocytes. The results, illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, indicate that only one enantiomer (<b>106a</b>) is active and may account for the activity of <b>106</b>. Compound <b>106a</b> potentiated GluN2C response by 259 ± 7.8% with an estimated EC<sub>50</sub> value of 18 ± 0.6 μM (<i>n</i> = 6). In contrast, no activity was observed for the other enantiomer (<b>106b</b>) (<i>n</i> = 6). The active analogue demonstrated weak inhibition at GluN2D-containing receptors and had no effect at GluN2A- or GluN2B-containing receptors. Compound <b>106b</b> was inactive at all other subunits. These data suggest that the activity of pyrrolidinone analogues may rely on a single enantiomer and that the binding pocket can distinguish between the enantiomers.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Composite concentration–effect curves for <b>106</b> enantiomers. Concentration–effect curves for the enantiomers of <b>106</b> demonstrate that only one enantiomer, <b>106a</b>, is active, potentiating the GluN1/GluN2C receptor to a fitted maximum of 259 ± 8% of control with an EC<sub>50</sub> of 18 ± 0.6 μM (<i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The incorporation of a methyl group at the C-7 position of the indole of initial screening hit <b>1</b> afforded <b>111</b>, which selectively potentiates GluN2C-containing NMDA receptors with a potency of 4.3 ± 0.3 μM. In addition, the activity of this series appears to originate from one enantiomer. These compounds represent the first class of allosteric potentiators selective for diheteromeric GluN1/GluN2C receptors over receptors containing GluN2A-, GluN2B-, and GluN2D subunits. Future studies will address the activity of this series of modulators on triheteromeric GluN2C-containing NMDA receptors containing two different GluN2 subunits (e.g., GluN1/GluN2A/GluN2C). This series of molecules may serve as a pharmacological tool to evaluate the role of the GluN2C subunit in normal and neuropathological function.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Biology Experimentals</h3><div class="NLM_p">All protocols involving <i>Xenopus laevis</i> were approved by the Emory University Institutional Animal Care and Use Committee. Two-electrode voltage-clamp recordings were made from <i>Xenopus laevis</i> oocytes expressing recombinant GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, GluN1/GluN2D, GluA1, or GluK2 receptors following injection of cRNA. cDNAs for rat GluN1–1a (GenBank accession numbers <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=U11418">U11418</a> and <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=U08261">U08261</a>; hereafter GluN1), GluN2A (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=D13211">D13211</a>), GluN2B (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=U11419">U11419</a>), GluN2C (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=M91563">M91563</a>), GluN2D (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=L31611">L31611</a>), GluA1 (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=X17184">X17184</a>), and GluK2 (<a href="https://www.ncbi.nlm.nih.gov/gquery?Term=Z11548">Z11548</a>) were provided by Drs. S. Heinemann (Salk Institute), S. Nakanishi (Kyoto University), and P. Seeburg (University of Heidelberg). Oocyte isolation, cRNA synthesis, and cRNA injection have been previously described;<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> some experiments were performed with oocytes obtained from Ecocyte (Austin, TX). Voltage-clamp recordings from oocytes were made during perfusion with recording solution containing 90 mM NaCl, 1.0 mM KCl, 0.5 mM BaCl<sub>2</sub>, 0.005 mM EDTA, and 10 mM HEPES at pH 7.4 (23 °C). Glass microelectrodes had resistances of 0.3–1.0 MΩ and were filled with 0.3–3.0 M KCl; the membrane potential was held at −40 mV for all recordings. Compounds were made as 20 mM stock solutions in DMSO and diluted to the final concentration in recording solution; final DMSO content was 0.05–0.5% (v/v). Oocytes expressing GluK2 receptors were pretreated with 10 μM concanavalin A for 10 min. NMDA receptors were activated by 100 μM glutamate plus 30 μM glycine; GluA1 and GluK2 receptors were activated by 100 μM glutamate. To prevent a gradual increase in current response over the course of the experiment of GluN1/GluN2A receptor responses in oocytes, some oocytes expressing GluN1/GluN2A were injected with 20–50 nL of 2 mM K-BAPTA (potassium 1,2-bis(<i>o</i>-aminophenoxy)ethane-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid). When the response to agonist in the presence of 30 μM of a test compound exceeded 120% of control, the response to glutamate and glycine in the absence and presence of 5–7 concentrations of active analogues were recorded in multiple oocytes obtained from two or more different frogs for all experiments. The EC<sub>50</sub> (half-maximally effective concentration of potentiator) was determined by fitting the equation<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/jm-2013-01695d_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>to the concentration–response data normalized to the current in the absence of potentiator (100%) for each oocyte, and the mean (±SEM) presented. <i>N</i> is the Hill slope, which ranged between 1 and 2 and is not reported; <i>maximum</i> is the fitted maximal response expressed as a percent of control to a saturating concentration of potentiator. When responses were inhibited by test compound at 30 μM to less than 60% of control, the IC<sub>50</sub> value was determined by fitting the equation<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/jm-2013-01695d_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>to the concentration–response data normalized to the current. For some compounds, visual detection of precipitation led to inclusion of 1–10 mM 2-hydroxypropyl-β-cyclodextrin in the recording solution to enhance solubility and enable generation of the full concentration–response data.</div><div class="NLM_p last">To generate a cell line with inducible NMDA receptor expression, we used a previously described Tet-On (tetracycline-inducible promoter; Clontech, Mountain View, CA) baby hamster kidney (BHK-21, ATCC CCL-10) cell line.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The BHK-21 Tet-On cell line was maintained at 37 °C, 5% CO<sub>2</sub>, and 95% relative humidity in culture medium composed of Dulbecco’s Modified Eagle Medium (DMEM) containing GlutaMAX-I, 4500 mg/L glucose, and 110 mg/L sodium pyruvate (Invitrogen, Carlsbad, CA) supplemented with penicillin (100 units/mL), streptomycin (100 μg/mL), (Invitrogen, Carlsbad, CA), 10% dialyzed fetal bovine serum (Invitrogen, Carlsbad, CA), and 1 mg/mL G418 (Invitrogen, Carlsbad, CA). The selection marker G418 was always included to provide continuous selection of Tet-On-compatible BHK-21 cells. The cells were cotransfected with rat GluN1-1a (GenBank accession no. <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=U11418">U11418</a>) in the inducible pTRE2 vector and rat GluN2C (GenBank accession no. <a href="https://www.ncbi.nlm.nih.gov/gquery?Term=D13212">D13212</a>) in the pCI-IRES-bla vector (see ref  <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a> for details on this vector) using Fugene 6 transfection reagent (Promega, Madison, WI). The ratio of GluN1 and GluN2C DNA used for transfection was 10:1. The NMDA receptor antagonists <span class="smallcaps smallerCapital">dl</span>-2-amino-5-phosphonopentanoate (AP5) (200 μM; Abcam, Cambridge, MA) and 7-chloro-kynurenate (7-CKA) (200 μM; Abcam, Cambridge, MA) were added to the culture medium to prevent NMDA receptor-mediated cell death. The following day, the cells were diluted 1:1000 and 1:10,000 and seeded in 144 mm dishes. The next day (e.g., two days after transfection), 10 μg/mL blasticidin S (Invivogen, San Diego, CA) was added to the culture medium to select for transfected cells. Unless otherwise stated, the culture medium for the cell lines always contained 1 mg/mL G418 and 10 μg/mL blasticidin S for selection as well as 200 μM AP5 and 200 μM DCKA to prevent NMDA receptor-mediated cell death. The media was changed every 2–3 days, and blasticidin S-resistant clones were isolated 10–20 days after transfection and evaluated for their response properties. Fluorescence-based assays were conducted as previously described,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and test compounds were screened at 10 μM.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Chemistry Experimentals</h3><div class="NLM_p">Compounds for which synthesis is not described were purchased from commercial vendors. Purity of purchased compounds was greater than 90%, as determined by the suppliers, via HPLC or NMR.</div><div class="NLM_p">All dry solvents were obtained from a Glass Contour System. Reagents used were acquired from commercial suppliers and utilized without additional purification. Precoated glass plates (silica gel 60 F254, 0.25 mm) were used to monitor the progress of reactions by thin layer chromatography (TLC). Purification by flash column chromatography was performed on a Teledyne ISCO Combiflash Companion using prepackaged Teledyne RediSep disposable normal phase silica columns. Melting temperatures were determined on a Mel-Temp apparatus and are uncorrected. <sup>1</sup>H and <sup>13</sup>C NMR experiments were each carried out on an INOVA-400 (400 MHz), VNMR 400 (400 MHz), INOVA-600 (600 MHz), Unity-600 (600 MHz), or Mercury 300 Vx (300 MHz). All chemical shifts are reported in parts per million and referenced to the residual solvent peak. All coupling constants are reported in hertz (Hz). The IR spectra were acquired with a Nicolet Avatar 370 DTGS. Mass spectra were performed by the Emory University Mass Spectrometry Center on a VG 70-S Nier Johnson or JEOL instrument. Purity of all final compounds was found to be ≥95% by LC/MS analysis unless otherwise noted.</div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Separation of Enantiomers</h4><div class="NLM_p last">The separation of the enantiomers of <b>106</b> was obtained using a ChiralPak OD-RH 30 mm × 250 mm, 5 μm column with the following conditions: flow rate 10 mL/min, injection volume 1–2 mL (5 mg/mL), 44% ACN/66% water with 0.1% formic acid; <b>106a</b><i>t</i><sub>R</sub> = 121.3 min; <b>106b</b><i>t</i><sub>R</sub> = 129.3 min. Enantiomeric excess (<i>ee</i>) of both enantiomers <b>106a</b> and <b>106b</b> was determined using a ChiralPak OD-RH 4.6 mm × 150 mm, 5 μm column with the following conditions: flow rate 0.5 mL/min, injection volume 10 μL, 44% ACN/66% water with 0.1% formic acid; <b>106a</b> [α]<sub class="stack"><i>D</i></sub><sup class="stack">20</sup> −18 (<i>c</i> = 0.10, methanol), <i>t</i><sub>R</sub> = 26.1 min, 98% <i>ee</i>; <b>106b</b> [α]<sub class="stack"><i>D</i></sub><sup class="stack">20</sup> + 9 (<i>c</i> = 0.10, methanol), <i>t</i><sub>R</sub> = 29.1 min, 96% <i>ee</i>. A Perkin-Elmer 314 instrument was used to obtain optical rotation data.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure for Synthesis of Pyrrolidinone Compounds (Procedure I: <b>1</b>, <b>62</b>–<b>82</b>, <b>84</b>–<b>122</b>, <b>161</b>–<b>180</b>)</h4><div class="NLM_p last">To a stirred solution of aldehyde (1.0 mmol) in dioxane (1.0 M) was added tryptamine (1.0 equiv) and 10 mol % pyridinium 4-methylbenzenesulfonate. Upon the formation of a slurry, methyl acetopyruvate (1.0 equiv) was added. The resulting mixture was allowed to stir at rt for up to 12 h. In most instances, a precipitate was visible, which was collected via filtration and washed with Et<sub>2</sub>O. The solid was dissolved in an appropriate solvent and washed with saturated ammonium chloride and brine before being dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. If a precipitate did not form, the mixture was concentrated in vacuo before being subjected to the workup as described above. Purification was achieved via flash column chromatography on SiO<sub>2</sub> (MeOH/DCM) to afford the desired pyrrolidinone. Additional purification was obtained by HPLC (85% ACN/15% water with 0.1% formic acid) as needed.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Preparation of Pyruvate Compounds (Procedure II: <b>3</b>–<b>20</b>, <b>144</b>)</h4><div class="NLM_p last">To a solution of sodium ethanolate (1.0 equiv) in EtOH (0.72 M) at 0 °C was added a mixture of diethyl oxalate (1.0 equiv) and ethanone (1.0 mmol) over 20 min. The mixture was allowed to stir at rt for 4 h. In most instances, a precipitate had formed which was collected via filtration and washed with absolute EtOH. If no precipitate was evident, a minimal amount of water was added and the mixture was concentrated in vacuo. The residue was dissolved in water, neutralized with acetic acid, and extracted with Et<sub>2</sub>O (3×). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification was achieved as needed via flash column chromatography on SiO<sub>2</sub> (hexanes/EtOAc: 4/1) to obtain the product.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Preparation of Methyl Benzoate Compounds (Procedure III: <b>184</b>–<b>186</b>)</h4><div class="NLM_p last">To a solution of 4-bromobenzoic acid (1.0 mmol) in THF:MeOH (4:1, 0.3 M) at 0 °C was added (diazomethyl)trimethylsilane (2.4 equiv). The reaction was allowed to warm to rt over the period of 1 h. At this time, the mixture was concentrated in vacuo and 1.0 M HCl was added. The mixture was extracted with EtOAc (2×), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford the product.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Preparation of Methyl 4-Formylbenzoate Compounds (Procedure IV: <b>37</b>–<b>40</b>)</h4><div class="NLM_p last">To a solution of methyl 4-bromobenzoate (1.0 mmol) in DMF (0.6 M) was added 17 mol % bis(triphenylphosphine)palladium(II) dichloride and sodium formate (1.5 equiv). The reaction mixture was stirred at 110 °C under a steady stream of CO<sub>(g)</sub> for 2 h. At this time, the mixture was cooled to rt, diluted with saturated sodium carbonate, and extracted with EtOAc (2×). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification was achieved via flash column chromatography on SiO<sub>2</sub> (hexanes/EtOAc: 3/1) to yield the desired product, which was taken on without further purification.</div></div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>1</b>)</h4><div class="NLM_p last">Compound <b>1</b> was prepared via procedure I from methyl 4-formylbenzoate (3.0 g, 18 mmol), tryptamine (2.9 g, 18 mmol), and methyl acetopyruvate (2.6 g, 18 mmol) to yield a cream-colored solid (5.5 g, 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 2H), 7.33–7.24 (m, 4H), 7.12–7.03 (m, 2H), 6.91 (t, <i>J</i> = 7.6 Hz, 1H), 5.17 (s, 1H), 3.83 (s, 3H), 3.83–3.77 (m, 1H), 3.00–2.90 (m, 1H), 2.87–2.80 (m, 1H), 2.74–2.67 (m, 1H), 2.27 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.6, 165.1, 142.5, 136.3, 129.3, 128.1, 126.9, 125.5, 122.9, 121.2, 121.1, 118.4, 118.3, 118.1, 111.6, 111.5, 110.8, 66.4, 59.8, 52.2, 40.8, 23.6; mp 99–105 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub> 419.1607; found 419.1606 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-5-oxo-3-propionyl-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>62</b>)</h4><div class="NLM_p last">Compound <b>62</b> was prepared via procedure I from methyl 4-formylbenzoate (0.095 g, 0.58 mmol), tryptamine (0.93 g, 0.58 mmol), and <b>3</b> (0.10 g, 0.58 mmol) to yield a cream-colored solid (0.16 g, 64%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (s, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 2H), 7.33–7.23 (m, 4H), 7.09 (d, <i>J</i> = 2.4 Hz, 1H), 7.05 (t, <i>J</i> = 8.0 Hz, 1H), 6.91 (t, <i>J</i> = 6.8 Hz, 1H), 5.17 (s, 1H), 3.83–3.76 (m, 4H), 2.96–2.89 (m, 1H), 2.86–2.79 (m, 1H), 2.75–2.57 (m, 3H), 0.85 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.9, 165.1, 142.5, 136.2, 129.7, 129.3, 128.1, 126.9, 125.5, 122.9, 121.0, 118.2, 118.1, 111.5, 110.7, 59.8, 54.9, 52.2, 40.8, 40.0, 23.6 (note: carbons 1 and 2 are absent); mp 175–180 °C. HMS (APCI) calcd C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 433.1758; found 433.1756 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-isobutyryl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>63</b>)</h4><div class="NLM_p last">Compound <b>63</b> was prepared via procedure I from methyl 4-formylbenzoate (0.088 g, 0.54 mmol), tryptamine (0.086 g, 0.54 mmol), and <b>4</b> (0.10 g, 0.54 mmol) to yield a light-brown, amorphous solid (0.067 g, 28%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 70 °C) δ 10.65 (s, 1H), 7.84 (d, <i>J</i> = 7.8 Hz, 2H), 7.32 (d, <i>J</i> = 7.8 Hz, 2H), 7.28 (d, <i>J</i> = 7.8 Hz, 2H), 7.06–7.03 (m, 2H), 6.92 (t, <i>J</i> = 8.4 Hz, 1H), 5.18 (s, 1H), 3.83 (s, 3H), 3.79–3.75 (m, 1H), 3.40–3.20 (m, 2H), 2.98–2.93 (m, 1H), 2.91–2.86 (m, 1H), 2.72–2.67 (m, 1H), 0.86 (d, J = 4.8 Hz, 6H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 182.1, 166.0, 136.2, 129.2, 128.1, 128.0, 126.9, 125.5, 123.4, 122.8, 121.1, 121.0, 118.5, 118.2, 118.1, 111.6, 111.5, 110.9, 109.5, 60.0, 52.1, 40.9, 23.7, 23.2, 18.5, 17.7. HMS (APCI) calcd for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub> 447.1915; found 447.1916 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-5-oxo-3-pivaloyl-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>64</b>)</h4><div class="NLM_p last">Compound <b>64</b> was prepared via procedure I from methyl 4-formylbenzoate (0.082 g, 0.50 mmol), tryptamine (0.080 g, 0.50 mmol), and <b>5</b> (0.10 g, 0.50 mmol) to yield an orange oil (0.092 g, 40%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.17 (br s, 1H), 7.93 (d, <i>J</i> = 7.8 Hz, 2H), 7.40–7.35 (m, 2H), 7.20 (t, <i>J</i> = 7.2 Hz, 1H), 7.09 (t, <i>J</i> = 7.2 Hz, 1H), 7.04 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 7.8 Hz, 2H), 6.96 (s, 1H), 5.04 (s, 1H), 4.02–3.99 (m, 1H), 3.91 (s, 3H), 3.09–3.00 (m, 2H), 2.95–2.91 (m, 1H), 1.06 (s, 9H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 202.2, 181.2, 166.7, 141.2, 136.5, 130.6, 130.2, 128.0, 127.2, 122.5, 122.2, 119.8, 118.8, 118.7, 111.6, 111.4, 63.0, 52.4, 41.7, 27.7, 25.3, 24.5 (note: either carbon 1 or 2 is absent). HMS (APCI) calcd for C<sub>27</sub>H<sub>28</sub>N<sub>2</sub>O<sub>5</sub> 461.2071; found 461.2077 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-benzoyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>65</b>)</h4><div class="NLM_p last">Compound <b>65</b> was prepared via procedure I from <b>6</b> (0.15 g, 0.68 mmol), tryptamine (0.11 g, 0.68 mmol), and methyl 4-formylbenzoate (0.11 g, 0.68 mmol) to yield a cream-colored solid (0.031 g, 9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 7.79 (d, <i>J</i> = 7.2 Hz, 2H), 7.59–7.48 (m, 2H), 7.40–7.28 (m, 3H), 7.24–7.21 (m, 3H), 7.11–7.04 (m, 2H), 6.92 (t, <i>J</i> = 7.6 Hz, 1H), 6.74 (s, 1H), 5.25 (s, 1H), 3.80–3.74 (m, 4H), 3.00–2.90 (m, 1H), 2.82–2.67 (m, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.1, 188.9, 165.9, 165.4, 142.1, 138.2, 136.4, 132.4, 129.6, 129.5, 128.7, 128.3, 128.1, 127.0, 123.0, 121.1, 118.9, 118.4, 118.2, 111.6, 110.9, 60.8, 52.1, 41.2, 23.8; mp 200–205 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 481.1771; found 481.1765 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-(3-hydroxybenzoyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>66</b>)</h4><div class="NLM_p last">Compound <b>66</b> was prepared via procedure I from methyl 4-formylbenzoate (0.35 g, 2.1 mmol), tryptamine (0.34 g, 2.1 mmol), and <b>21</b> (0.50 g, 2.1 mmol) to yield a cream-colored solid (1.0 g, 96%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.77 (s, 1H), 7.83 (d, <i>J</i> = 7.8 Hz, 2H), 7.37–7.29 (m, 6H), 7.13–7.12 (m, 1H), 7.07–7.03 (m, 3H), 6.91 (t, <i>J</i> = 7.8 Hz, 1H), 5.36 (s, 1H), 3.87–3.81 (m, 4H), 3.00–2.93 (m, 2H), 2.78–2.73 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 198.0, 166.0, 157.1, 136.40, 136.3, 129.4, 128.4, 128.2, 125.6, 123.4, 122.9, 121.2, 121.1, 119.5, 118.6, 118.4, 118.25, 118.19, 115.2, 111.7, 111.6, 110.9, 109.7, 66.5, 52.2, 41.2, 23.8; mp 78–80 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub> 497.1707; found 497.1707 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-(3-methoxybenzoyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>67</b>)</h4><div class="NLM_p last">Compound <b>67</b> was prepared via procedure I from methyl 4-formylbenzoate (0.066 g, 0.40 mmol), tryptamine (0.064 g, 0.40 mmol), and <b>7</b> (0.10 g, 0.40 mmol) to yield a pale-yellow, amorphous solid (0.046 g, 23%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 80 °C) δ 10.64 (s, 1H), 7.89–7.82 (m, 3H), 7.35–7.22 (m, 6H), 7.07–7.05 (m, 2H), 6.98–6.91 (m, 2H), 5.34 (s, 1H), 4.26 (m, 1H), 3.82 (s, 3H), 3.74 (s, 3H), 3.01–2.90 (m, 2H), 2.78–2.75 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 188.6, 165.9, 165.1, 158.9, 141.9, 139.3, 136.3, 129.6, 129.4, 129.3, 128.3, 128.1, 126.9, 125.5, 122.9, 121.2, 121.1, 119.0, 118.3, 118.1, 113.5, 111.5, 110.8, 60.7, 55.3, 52.2, 41.1, 23.8. HMS (APCI) calcd for C<sub>30</sub>H<sub>26</sub>N<sub>2</sub>O<sub>6</sub> 511.1877; found 511.1871 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-(3-methylbenzoyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>68</b>)</h4><div class="NLM_p last">Compound <b>68</b> was prepared via procedure I from methyl 4-formylbenzoate (0.17 g, 1.0 mmol), tryptamine (0.17 g, 1.0 mmol), and <b>8</b> (0.24 g, 1.0 mmol) to yield a pale-yellow, amorphous solid (0.029 g, 6%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 80 °C) δ 10.67 (s, 1H), 7.72 (m, 2H), 7.36–7.33 (m, 2H), 7.28–7.21 (m, 2H), 7.11–7.04 (m, 6H), 6.93 (t, <i>J</i> = 7.2 Hz, 1H), 5.29 (s, 1H), 3.86–3.78 (m, 4H), 3.01–2.96 (m, 1H), 2.91–2.86 (m, 1H), 2.76–2.72 (m, 1H), 2.23 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.2, 190.0, 182.1, 182.0, 166.0, 145.4, 144.7, 136.2, 128.8, 127.9, 126.9, 122.9, 122.8, 121.0, 118.3, 118.1, 111.5, 111.1, 109.2, 52.0, 48.6, 41.1, 23.6, 20.9 (note: carbons 1, 2, 3, and 4 are absent). HMS (APCI) calcd for C<sub>30</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub> 493.1769; found 493.1768 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-(3-chlorobenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>69</b>)</h4><div class="NLM_p last">Compound <b>69</b> was prepared via procedure I from methyl 4-formylbenzoate (0.064 g, 0.39 mmol), tryptamine (0.063 g, 0.39 mmol), and <b>9</b> (0.10 g, 0.39 mmol) to yield a pale-yellow, amorphous solid (0.045 g, 22%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 80 °C) δ 10.69 (s, 1H), 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.69 (s, 1H), 7.58 (d, <i>J</i> = 6.0 Hz, 1H), 7.35–7.32 (m, 3H), 7.29–7.26 (m, 3H), 7.07–7.05 (m, 2H), 6.93 (t, <i>J</i> = 7.2 Hz, 1H), 5.28 (s, 1H), 3.82–3.79 (m, 4H), 2.98–2.94 (m, 1H), 2.88–2.84 (m, 1H), 2.74–2.68 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 182.1, 166.1, 145.4, 137.9, 136.4, 136.3, 129.2, 128.2, 127.0, 126.8, 125.5, 123.44, 123.43, 122.8, 121.2, 121.0, 118.5, 118.3, 118.1, 111.6, 111.5, 111.0, 109.5, 60.5, 52.1, 23.2, 20.8. HMS (APCI) calcd for C<sub>29</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>5</sub> 513.1223; found 513.1219 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-(3-fluorobenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>70</b>)</h4><div class="NLM_p last">Compound <b>70</b> was prepared via procedure I from methyl 4-formylbenzoate (0.069 g, 0.42 mmol), tryptamine (0.067 g, 0.42 mmol), and <b>10</b> (0.10 g, 0.42 mmol) to yield a yellow, amorphous solid (0.028 g, 14%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 80 °C) δ 10.66 (s, 1H), 7.79 (d, <i>J</i> = 8.4 Hz, 2H), 7.53–7.45 (m, 2H), 7.34 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 8.4 Hz, 2H), 7.29–7.26 (m, 1H), 7.22 (d, <i>J</i> = 7.8 Hz, 2H), 7.13–7.10 (m, 1H), 7.07–7.04 (m, 2H), 6.93 (t, <i>J</i> = 7.8 Hz, 1H), 5.32 (s, 1H), 3.84–3.79 (m, 4H), 3.01–2.96 (m, 1H), 2.92–2.88 (m, 1H), 2.76–2.71 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.7, 167.0, 161.5 (d, <i>J</i> = 241.7 Hz), 143.0, 137.6, 136.2, 129.3, 128.9, 128.6, 128.1, 127.9, 126.9, 125.5, 124.1, 122.8, 121.0, 118.3, 118.1, 116.6, 116.5, 111.5, 110.9, 61.0, 52.0, 41.2, 23.5 (note: carbon 3 is absent). HMS (APCI) calcd for C<sub>29</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>5</sub> 497.1510; found 497.1513 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-5-oxo-3-picolinoyl-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>71</b>)</h4><div class="NLM_p last">Compound <b>71</b> was prepared via procedure I from methyl 4-formylbenzoate (0.074 g, 0.45 mmol), tryptamine (0.072 g, 0.45 mmol), and <b>18</b> (0.10 g, 0.45 mmol) to yield a yellow, amorphous solid (0.037 g, 17%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.66 (d, <i>J</i> = 4.2 Hz, 1H), 8.21 (s, 1H), 8.14 (d, <i>J</i> = 7.8 Hz, 1H), 8.07 (dt, <i>J</i> = 1.2 Hz, <i>J</i> = 7.8 Hz, 1H), 7.94 (d, <i>J</i> = 8.4 Hz, 2H), 7.71 (dt, <i>J</i> = 0.6 Hz, <i>J</i> = 6.0 Hz, 1H), 7.39 (d, <i>J</i> = 7.2 Hz, 1H), 7.36 (d, <i>J</i> = 7.8 Hz, 1H), 7.21–7.17 (m, 3H), 7.07 (t, <i>J</i> = 8.4 Hz, 1H), 7.01 (d, <i>J</i> = 1.8 Hz, 1H), 5.14 (s, 1H), 4.15–4.10 (m, 1H), 3.89 (s, 3H), 3.11–2.95 (m, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 181.8, 173.2, 166.8, 165.7, 151.7, 145.3, 142.5, 140.6, 136.5, 130.3, 130.0, 128.3, 128.1, 127.3, 125.2, 122.3, 119.6, 118.7, 112.5, 111.5, 109.6, 61.6, 41.4, 29.9, 24.3 (note: carbon 3 is absent). HMS (APCI) calcd for C<sub>28</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> 482.1710; found 482.1708 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>72</b>)</h4><div class="NLM_p last">Compound <b>72</b> was prepared via procedure I from methyl 4-formylbenzoate (0.079 g, 0.48 mmol), tryptamine (0.077 g, 0.45 mmol), and <b>19</b> (0.10 g, 0.48 mmol) to yield a yellow solid (0.11 g, 49%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (s, 1H), 8.80 (s, 1H), 8.69 (d, <i>J</i> = 4.4 Hz, 1H), 8.00 (d, <i>J</i> = 7.6 Hz, 1H), 7.88 (d, <i>J</i> = 7.2 Hz, 2H), 7.43–7.42 (m, 2H), 7.34–7.29 (m, 2H), 7.14 (d, <i>J</i> = 8.0 Hz, 2H), 7.06 (t, <i>J</i> = 6.8 Hz, 1H), 6.92 (t, <i>J</i> = 7.2 Hz, 1H), 5.42 (s, 1H), 3.87–3.82 (m, 4H), 3.02–2.89 (m, 2H), 2.79–2.74 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.8, 165.9, 165.0, 152.1, 149.1, 142.1, 136.3, 133.9, 129.5, 129.4, 128.3, 128.1, 126.9, 125.5, 123.5, 122.9, 121.0, 118.3, 118.1, 111.5, 110.7, 109.5, 60.4, 52.2, 41.1, 23.7; mp 199–205 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> 482.1711; found 482.1707 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-isonicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>73</b>)</h4><div class="NLM_p last">Compound <b>73</b> was prepared via procedure I from methyl 4-formylbenzoate (0.15 g, 0.9 mmol), tryptamine (0.15 g, 0.9 mmol), and <b>20</b> (0.20 g, 0.9 mmol) to yield a yellow solid (0.13 g, 30%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 80 °C) δ 10.63 (s, 1H), 8.47 (d, <i>J</i> = 2.8 Hz, 1H), 7.76–6.92 (m, 12H), 5.27 (s, 1H), 3.82–3.78 (m, 4H), 3.00–2.95 (m, 1H), 2.91–2.86 (m, 1H), 2.74–2.72 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.3, 166.0, 149.5, 149.0, 146.6, 136.3, 128.9, 128.5, 128.0, 127.0, 122.8, 122.3, 121.1, 120.7, 118.3, 118.1, 111.5, 111.0, 52.0, 48.6, 41.1, 23.5 (note: carbons 1 and 2 are absent); mp >250 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> 480.1570; found 480.1568 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-(2-methoxybenzoyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>74</b>)</h4><div class="NLM_p last">Compound <b>74</b> was prepared via procedure I from methyl 4-formylbenzoate (0.13 g, 0.80 mmol), tryptamine (0.13 g, 0.80 mmol), and <b>11</b> (0.20 g, 0.80 mmol) to yield a pink, amorphous solid (0.028 g, 7%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 7.89 (s, 1H), 7.50 (d, <i>J</i> = 6.0 Hz, 1H), 7.34–7.18 (m, 5H), 7.09–7.04 (m, 3H), 6.96–6.88 (m, 3H), 5.27 (s, 1H), 3.83–3.74 (m, 6H), 2.99–2.87 (m, 2H), 2.73–2.65 (m, 2H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.1, 182.1, 166.2, 156.0, 146.1, 137.3, 132.7, 129.1, 128.8, 128.4, 128.1, 128.0, 127.7, 127.0, 125.6, 122.8, 121.0, 119.7, 118.2, 118.1, 111.5, 111.1, 111.0, 60.3, 56.1, 55.2, 52.1, 40.9, 23.6, 18.6. HMS (APCI) calcd for C<sub>30</sub>H<sub>26</sub>N<sub>2</sub>O<sub>6</sub> 509.1710; found 509.1711 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-(2-methylbenzoyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>75</b>)</h4><div class="NLM_p last">Compound <b>75</b> was prepared via procedure I from methyl 4-formylbenzoate (0.14 g, 0.85 mmol), tryptamine (0.14 g, 0.85 mmol), and <b>12</b> (0.20 g, 0.85 mmol) to yield a pale-yellow, amorphous solid (0.040 g, 9%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 70 °C) δ 10.71 (br s, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 2H), 7.37 (d, <i>J</i> = 9.0 Hz, 1H), 7.30 (d, <i>J</i> = 7.8 Hz, 1H), 7.13–6.99 (m, 4H), 6.94–6.91 (m, 2H), 6.84–6.74 (m, 3H), 4.96 (s, 1H), 3.82–3.76 (m, 4H), 2.97–2.92 (m, 1H), 2.82–2.71 (m, 2H), 1.78 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.1, 182.1, 182.03, 182.01, 165.9, 144.4, 139.4, 136.3, 134.2, 129.3, 128.8, 128.3, 127.9, 127.0, 124.7, 123.0, 122.7, 121.1, 118.3, 118.1, 111.6, 111.2, 108.9, 60.3, 52.0, 48.6, 41.1, 23.6. HMS (APCI) calcd for C<sub>30</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub> 493.1761; found 493.1763 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-(2-chlorobenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>76</b>)</h4><div class="NLM_p last">Compound <b>76</b> was prepared via procedure I from methyl 4-formylbenzoate (0.13 g, 0.79 mmol), tryptamine (0.13 g, 0.79 mmol), and <b>13</b> (0.20 g, 0.79 mmol) to yield a cream-colored solid (0.27 g, 66%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 80 °C) δ 10.64 (s,1H), 7.67 (m, 2H), 7.35 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (d, <i>J</i> = 7.8 Hz, 1H), 7.24–7.18 (m, 2H), 7.10–7.03 (m, 4H), 6.92 (t, <i>J</i> = 7.2 Hz, 2H), 6.78 (m, 1H), 5.04 (s, 1H), 3.86–3.75 (m, 4H), 2.97–2.92 (m, 1H), 2.85–2.83 (m, 1H), 2.73–2.68 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.2, 165.9, 144.1, 136.3, 130.0, 129.5, 129.1, 128.8, 128.7, 128.6, 128.1, 128.0, 126.9, 126.5, 123.0, 121.0, 118.3, 118.1, 111.5, 111.0, 67.1, 52.1, 40.0, 25.2 (note: carbons 1, 2, and 3 are absent); mp 248–253 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>5</sub> 513.1214; found 513.1215 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-(2-fluorobenzoyl)-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>77</b>)</h4><div class="NLM_p last">Compound <b>77</b> was prepared via procedure I from methyl 4-formylbenzoate (0.19 g, 0.84 mmol), tryptamine (0.14 g, 0.84 mmol), and <b>14</b> (0.20 g, 0.84 mmol) to yield a brown, amorphous solid (0.070 g, 17%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 70 °C) δ 10.68 (s, 1H), 7.80–7.54 (m, 2H), 7.35–7.30 (m, 4H), 7.11–6.78 (m, 7H), 5.07 (s, 1H), 3.81–3.74 (m, 4H), 2.97–2.92 (m, 1H), 2.87–2.82 (m, 1H), 2.72–2.67 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.6, 165.9, 161.2, 156.0, 155.1, 139.5, 136.3, 135.0, 130.0, 129.6, 128.6, 126.8, 126.7, 126.3, 125.3, 124.8, 123.1, 121.1, 119.3, 118.3, 118.0, 111.5, 110.6, 59.1, 52.3, 41.2, 23.8. HMS (APCI) calcd for C<sub>29</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>5</sub> 497.1510; found 497.1513 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-(furan-2-carbonyl)-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>78</b>)</h4><div class="NLM_p last">Compound <b>78</b> was prepared via procedure I from methyl 4-formylbenzoate (0.42 g, 2.6 mmol), tryptamine (0.41 g, 2.6 mmol), and <b>15</b> (0.50 g, 2.6 mmol) to yield an orange solid (0.079 g, 7%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.32 (s, 1H), 8.05 (s, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.43–7.41 (m, 2H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 2H), 7.16 (t, <i>J</i> = 7.2 Hz, 1H), 7.06 (t, <i>J</i> = 7.2 Hz, 1H), 6.94 (s, 1H), 6.39 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 3.6 Hz, 1H), 5.39 (s, 1H), 4.04–3.99 (m, 1H), 3.88 (s, 3H), 3.07–2.96 (m, 2H), 2.93–2.89 (m, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 173.9, 167.1, 153.1, 145.1, 136.5, 129.8, 129.7, 129.2, 128.4, 128.2, 127.4, 122.3, 122.2, 119.5, 118.9, 117.1, 114.2, 112.7, 111.7, 111.4, 111.3, 61.3, 52.2, 41.3, 24.3; mp 60–65 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>22</sub>N<sub>2</sub>O<sub>6</sub> 471.1551; found 471.1547 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-5-oxo-3-(thiophene-2-carbonyl)-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>79</b>)</h4><div class="NLM_p last">Compound <b>79</b> was prepared via procedure I from methyl 4-formylbenzoate (0.073 g, 0.44 mmol), tryptamine (0.071 g, 0.44 mmol), and <b>16</b> (0.10 g, 0.44 mmol) to yield a yellow, amorphous solid (0.043 g, 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.80 (s, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 2H), 7.55 (d, <i>J</i> = 4.0 Hz, 1H), 7.34–7.29 (m, 4H), 7.06–7.02 (m, 3H), 6.92 (t, <i>J</i> = 7.2 Hz, 1H), 5.80–5.70 (m, 1H), 5.28 (s, 1H), 3.86–3.74 (m, 4H), 3.00–2.89 (m, 1H), 2.85–2.78 (m, 1H), 2.73–2.67 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.8, 144.7, 136.2, 129.0, 128.2, 126.9, 126.8, 123.4, 122.9, 121.2, 121.0, 118.5, 118.3, 118.1, 111.6, 111.5, 111.1, 109.5, 52.0, 48.6, 40.0, 23.5 (note: carbons 1, 2, and 4 are absent); mp 190–195 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub>S 485.1177; found 485.1173 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-5-oxo-3-(thiophene-3-carbonyl)-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>80</b>)</h4><div class="NLM_p last">Compound <b>80</b> was prepared via procedure I from methyl 4-formylbenzoate (0.36 g, 2.2 mmol), tryptamine (0.35 g, 2.2 mmol), and <b>17</b> (0.50 g, 2.2 mmol) to yield a cream-colored solid (0.70 g, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.86 (s, 1H), 8.38 (d, <i>J</i> = 2.8 Hz, 1H), 7.85 (d, <i>J</i> = 7.6 Hz, 2H), 7.49 (t, <i>J</i> = 4.0 Hz, 1H), 7.37–7.31 (m, 4H), 7.13 (s, 1H), 7.07 (t, <i>J</i> = 7.6 Hz, 1H), 6.93 (t, <i>J</i> = 6.8 Hz, 1H), 5.76 (d, <i>J</i> = 1.2 Hz, 1H), 5.44 (s, 1H), 3.89–3.81 (m, 4H), 3.02–2.90 (m, 2H), 2.80–2.74 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 181.8, 165.9, 142.1, 141.6, 136.3, 134.2, 129.5, 129.4, 128.3, 128.1, 127.3, 126.9, 126.3, 125.5, 122.9, 121.1, 118.3, 118.1, 111.5, 110.8, 60.7, 52.1, 41.1, 23.8; mp 189–192 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub>S 487.1336; found 487.1335 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Methyl 3-(1–2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>81</b>)</h4><div class="NLM_p last">Compound <b>81</b> was prepared via procedure I from methyl 3-formylbenzoate (0.50 g, 3.1 mmol), tryptamine (0.49 g, 3.1 mmol), and methyl acetopyruvate (0.44 g, 3.1 mmol) to yield a pale-pink solid (0.77 g, 60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 7.87 (d, <i>J</i> = 7.6 Hz, 1H), 7.73 (s, 1H), 7.45 (t, <i>J</i> = 7.2 Hz, 1H), 7.39–7.26 (m, 3H), 7.10 (d, <i>J</i> = 2.0 Hz, 1H), 7.05 (t, <i>J</i> = 7.2 Hz, 1H), 6.89 (t, <i>J</i> = 8.0 Hz, 1H), 5.24 (s, 1H), 3.85–3.76 (m, 4H), 2.98–2.91 (m, 1H), 2.87–2.80 (m, 1H), 2.72–2.65 (m, 1H), 2.72 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 166.0, 165.1, 154.8, 137.8, 136.3, 132.5, 129.9, 129.1, 129.0, 128.4, 126.9, 122.9, 121.1, 119.8, 118.3, 118.1, 111.5, 110.8, 59.8, 52.3, 40.8, 29.8, 23.7; mp 218–220 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub> 419.1593; found 419.1596 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Methyl 2-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>82</b>)</h4><div class="NLM_p last">Compound <b>82</b> was prepared via procedure I from methyl 2-formylbenzoate (0.10 g, 0.61 mmol), tryptamine (0.098 g, 0.61 mmol), and methyl acetopyruvate (0.088 g, 0.61 mmol) to yield a white solid (0.18 g, 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 7.87 (d, <i>J</i> = 7.6 Hz, 1H), 7.72 (s, 1H), 7.46 (t, <i>J</i> = 7.6 Hz, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.32–7.25 (m, 2H), 7.10 (d, <i>J</i> = 1.6 Hz, 1H), 7.02 (t, <i>J</i> = 7.6 Hz, 1H), 6.89 (t, <i>J</i> = 7.6 Hz, 1H), 5.24 (s, 1H), 3.86 (s, 3H), 3.82–3.75 (m, 1H), 2.97–2.90 (m, 1H), 2.86–2.79 (m, 1H), 2.71–2.66 (m, 1H), 2.27 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.6, 166.0, 165.0, 154.5, 137.8, 136.2, 132.5, 129.8, 129.0, 128.9, 128.3, 126.8, 122.9, 121.0, 119.9, 118.2, 118.0, 111.4, 110.7, 59.7, 52.2, 40.8, 29.8, 23.6; mp 210–218 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub> 419.1602; found 419.1599 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoic Acid (<b>83</b>)</h4><div class="NLM_p last">To a suspension of <b>1</b> (0.10 g, 0.24 mmol) in EtOH (3.5 mL) was added a 2N aq sodium hydroxide solution (0.8 mL). The reaction was heated at reflux for 2 h. The solution was then cooled to 0 °C, and concentrated HCl was added carefully. The precipitate was filtered off, rinsed with cold water, and dried under vacuum for 12 h to afford a white powder (0.090 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (br s, 1H), 10.79 (br s, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 2H), 7.30–7.28 (m, 2H), 7.23 (d, <i>J</i> = 8.0 Hz, 2H), 7.03–7.01 (m, 2H), 6.90 (app t, <i>J</i> = 8.0 Hz, 1H), 5.56 (s, 1H), 3.77–3.74 (m, 1H), 2.89–2.71 (m, 1H), 2.71–2.61 (m, 2H), 2.10 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 196.5, 179.9, 169.3, 164.3, 146.9, 136.5, 130.1 (×2), 128.5, 127.8 (×2), 127.4, 123.0, 119.1, 121.7, 119.8, 118.8, 113.0, 111.1, 54.7, 49.1, 26.6, 24.3; mp >250 °C. HMS (ESI<sup>+</sup>) calcd For C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>NaO<sub>5</sub> 427.1270; found 427.1263 [M + Na]<sup>+</sup>.</div></div><div id="sec4_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Ethyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>84</b>)</h4><div class="NLM_p last">Compound <b>84</b> was prepared via procedure I from <b>45</b> (0.20 g, 1.1 mmol), tryptamine (0.18 g, 1.1 mmol), and methyl acetopyruvate (0.16 g, 1.1 mmol) to yield a pale-pink solid (0.20 g, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.48 (br s, 1H), 10.82 (s, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 2H), 7.33–7.24 (m, 4H), 7.09 (d, <i>J</i> = 2.4 Hz, 1H), 7.05 (t, <i>J</i> = 7.2 Hz, 1H), 6.91 (t, <i>J</i> = 7.6 Hz, 1H), 5.18 (s, 1H), 4.30 (q, <i>J</i> = 7.2 Hz, 2H), 3.83–3.76 (m, 1H), 2.97–2.89 (m, 1H), 2.87–2.80 (m, 1H), 2.74–2.67 (m, 1H), 2.26 (s, 3H), 1.30 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.6, 165.4, 165.1, 142.4, 136.2, 129.6, 129.3, 128.1, 126.9, 122.9, 121.0, 118.3, 118.1, 111.5, 110.7, 60.7, 59.8, 40.8, 39.9, 23.6, 14.2 (note: carbon 3 and either carbon 1 or 2 are absent); mp 180–183 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 433.1771; found 433.1765 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Isopropyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>85</b>)</h4><div class="NLM_p last">Compound <b>85</b> was prepared via procedure I from <b>46</b> (0.20 g, 1.0 mmol), tryptamine (0.17 g, 1.0 mmol), and methyl acetopyruvate (0.15 g, 1.0 mmol) to yield an orange, amorphous solid (0.028 g, 6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.70 (s, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 2H), 7.33–7.23 (m, 3H), 7.11–7.00 (m, 3H), 6.91 (t, <i>J</i> = 7.6 Hz, 1H), 5.16–5.11 (m, 2H), 3.82–3.77 (m, 1H), 3.02–2.85 (m, 2H), 2.76–2.71 (m, 1H), 2.26 (s, 3H), 1.32 (s, 3H), 1.31 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.0, 164.9, 136.2, 129.2, 128.1, 126.8, 125.5, 123.5, 122.8, 121.2, 121.0, 118.5, 118.3, 118.1, 111.5, 110.8, 68.1, 59.8, 40.9, 39.9, 23.6, 21.6 (note: carbons 1 and 2 are absent). HMS (APCI) calcd for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub> 447.1928; found 447.1922 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>tert</i>-Butyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2, 5-dihydro-1<i>H</i>-pyrrol-2-yl) benzoate (<b>86</b>)</h4><div class="NLM_p last">Compound <b>86</b> was prepared via procedure I from <b>47</b> (0.50 g, 2.4 mmol), tryptamine (0.39 g, 2.4 mmol), and methyl acetopyruvate (0.35 g, 2.4 mmol) to yield a pale-yellow solid (0.92 g, 83%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 2H), 7.33–7.22 (m, 4H), 7.10 (d, <i>J</i> = 2.0 Hz, 1H), 7.05 (t, <i>J</i> = 7.2 Hz, 1H), 6.91 (t, <i>J</i> = 7.6 Hz, 1H), 5.17 (s, 1H), 3.83–3.76 (m, 1H), 2.96–2.89 (m, 1H), 2.86–2.81 (m, 1H), 2.79–2.67 (m, 1H), 2.26 (s, 3H), 1.53 (s, 9H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 165.1, 164.6, 154.4, 142.0, 131.1, 129.1, 127.9, 126.9, 126.2, 122.8, 121.0, 119.8, 118.2, 118.1, 111.4, 110.7, 80.7, 59.8, 40.8, 29.7, 27.8, 23.6; mp 145–150 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>28</sub>N<sub>2</sub>O<sub>5</sub> 461.2063; found 461.2065 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzonitrile (<b>87</b>)</h4><div class="NLM_p last">Compound <b>87</b> was prepared via procedure I from 4-formylbenzonitrile (0.15 g, 1.1 mmol), tryptamine (0.18 g, 1.1 mmol), and <b>19</b> (0.25 g, 1.1 mmol) to yield a yellow solid (0.084 g, 17%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (s, 1H), 8.81 (s, 1H), 8.69 (d, <i>J</i> = 3.6 Hz, 1H), 8.01 (d, <i>J</i> = 7.8 Hz, 1H), 7.75 (d, <i>J</i> = 7.8 Hz, 2H), 7.50–7.47 (m, 3H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.31 (d, <i>J</i> = 7.8 Hz, 1H), 7.13 (s, 1H), 7.07 (t, <i>J</i> = 7.8 Hz, 1H), 6.94 (t, <i>J</i> = 7.2 Hz, 1H), 5.44 (s, 1H), 3.88–3.83 (m, 1H), 3.01–2.90 (m, 2H), 2.79–2.75 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.3, 165.1, 152.1, 150.2, 149.2, 142.5, 136.3, 133.9, 132.4, 129.0, 126.9, 123.9, 123.4, 122.9, 121.1, 118.6, 118.3, 118.1, 117.7, 111.5, 111.0, 110.7, 60.3, 41.2, 23.7; mp >250 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> 449.1608; found 449.1607 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-acetyl-3-hydroxy-5-(4-nitrophenyl)-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>88</b>)</h4><div class="NLM_p last">Compound <b>88</b> was prepared via procedure I from 4-nitrobenzaldehyde (0.50 g, 3.3 mmol), tryptamine (0.53 g, 3.3 mmol), and methyl acetopyruvate (0.48 g, 3.3 mmol) to yield a pale-yellow solid (1.0 g, 75%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (br s, 1H), 10.82 (s, 1H), 8.10 (d, <i>J</i> = 8.8 Hz, 2H), 7.37 (d, <i>J</i> = 8.8 Hz, 2H), 7.31 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (d, <i>J</i> = 1.6 Hz, 1H), 7.04 (t, <i>J</i> = 8.0 Hz, 1H), 6.91 (t, <i>J</i> = 7.6 Hz, 1H), 5.26 (s, 1H), 3.85–3.78 (m, 1H), 2.97–2.84 (m, 2H), 2.80–2.77 (m, 1H), 2.27 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.6, 165.2, 154.7, 147.1, 144.9, 136.2, 129.0, 126.8, 123.5, 122.9, 121.0, 118.2, 118.0, 111.4, 110.7, 59.4, 41.0, 29.8, 23.5 (note: carbon 3 is absent); mp 142–150 °C. HMS (APCI) calcd for C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub> 406.1398; found 406.1395 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzamide (<b>89</b>)</h4><div class="NLM_p last">Compound <b>89</b> was prepared via procedure I from <b>42</b> (0.29 g, 2.0 mmol), tryptamine (0.32 g, 2.0 mmol), and <b>19</b> (0.44 g, 2.0 mmol) to yield a yellow solid (0.70 g, 76%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 8.81 (s, 1H), 8.66 (s, 1H), 7.99 (d, J = 7.8 Hz, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.45–7.32 (m, 6H), 7.12–7.06 (m, 3H), 6.95 (t, J = 7.2 Hz, 1H), 5.39 (s, 1H), 3.91–3.86 (m, 1H), 3.04–2.98 (m, 2H), 2.83–2.79 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.1, 175.4, 167.3, 165.0, 148.7, 139.8, 136.1, 135.7, 135.3, 134.0, 133.9, 127.4, 127.2, 126.7, 122.8, 122.7, 122.4, 120.6, 117.7, 111.1, 110.7, 108.5, 60.2, 39.9, 13.7; mp 175–180 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub> 467.17138; found 467.17160 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-<i>N</i>-methylbenzamide (<b>90</b>)</h4><div class="NLM_p last">Compound <b>90</b> was prepared via procedure I from <b>43</b> (0.15 g, 0.93 mmol), tryptamine (0.15 g, 0.93 mmol), and <b>19</b> (0.21 g, 0.93 mmol) to yield a yellow solid (0.33 g, 73%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (s, 1H), 8.79 (s, 1H), 8.67 (d, <i>J</i> = 4.8 Hz, 1H), 8.24 (d, <i>J</i> = 3.6 Hz, 1H), 7.99 (d, <i>J</i> = 7.8 Hz, 1H), 7.75 (d, <i>J</i> = 7.8 Hz, 2H), 7.45 (t, <i>J</i> = 5.4 Hz, 1H), 7.39–7.34 (m, 4H), 7.11–7.05 (m, 2H), 6.94 (t, <i>J</i> = 7.2 Hz, 1H), 5.38 (s, 1H), 3.88–3.84 (m, 1H), 3.11–3.09 (m, 1H), 3.02–2.94 (m, 2H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.3, 165.0, 152.3, 149.3, 136.3, 136.1, 134.5, 128.1, 127.9, 127.3, 125.5, 123.4, 122.4, 122.9, 121.0, 118.5, 118.3, 118.14, 118.1, 111.6, 110.8, 60.4, 41.0, 26.2, 23.7 (note: carbon 4 is absent); mp 240–245 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> 481.1876; found 481.1879 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>91</b>)</h4><div class="NLM_p last">Compound <b>91</b> was prepared via procedure I from <b>19</b> (0.38 g, 1.7 mmol), tryptamine (0.27 g, 1.7 mmol), and <b>44</b> (0.30 g, 1.7 mmol) to yield a yellow solid (0.33 g, 39%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 8.81 (s, 1H), 8.69 (d, <i>J</i> = 4.8 Hz, 1H), 8.01 (d, <i>J</i> = 7.8 Hz, 1H), 7.49–7.47 (m, 2H), 7.36–7.29 (m, 4H), 7.14–7.10 (m, 2H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 6.92 (t, <i>J</i> = 7.2 Hz, 1H), 5.42 (s, 1H), 3.88–3.82 (m, 1H), 3.02–2.95 (m, 5H), 2.84 (s, 3H), 2.77–2.71 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.71, 164.9, 152.3, 149.3, 136.4, 136.3, 136.2, 128.1, 127.8, 127.2, 125.5, 123.4, 122.9, 121.2, 121.0, 118.5, 118.3, 118.1, 111.6, 111.5, 110.8, 60.5, 41.0, 40.0, 23.8, 23.2 (note: carbon 4 is absent); mp 210–212 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> 495.2040; found 495.2036 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5,-dihydro-1<i>H</i>-pyrrol-2-yl)benzenesulfonamide (<b>92</b>)</h4><div class="NLM_p last">Compound <b>92</b> was prepared via procedure I from 4-formylbenzenesulfonamide (0.19 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield a pale-orange solid (0.024 g, 5%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.86 (s, 1H), 8.81 (s, 1H), 8.69 (d, <i>J</i> = 4.2 Hz, 1H), 8.01 (d, <i>J</i> = 7.8 Hz, 1H), 7.76 (d, <i>J</i> = 9.0 Hz, 2H), 7.50–7.47 (m, 3H), 7.34 (d, <i>J</i> = 7.8 Hz, 2H), 7.32 (s, 2H), 7.14 (d, <i>J</i> = 1.8 Hz, 1H), 7.07 (t, <i>J</i> = 8.4 Hz, 1H), 6.96 (t, <i>J</i> = 7.2 Hz, 1H), 5.41 (s, 1H), 3.91–3.86 (m, 1H), 3.03–2.98 (m, 1H), 2.92–2.88 (m, 1H), 2.81–2.76 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 181.3, 165.0, 149.3, 149.1, 143.9, 140.6, 136.3, 133.9, 131.8, 128.6, 126.9, 125.9, 123.4, 122.9, 121.1, 118.4, 118.2, 111.5, 110.8, 60.1, 41.0, 23.7 (note: two of either carbons 1, 2, or 3 are absent); mp >250 °C. HMS (APCI) calcd for C<sub>26</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub>S 503.1384; found 503.1381 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-<i>N</i>-methylbenzenesulfonamide (<b>93</b>)</h4><div class="NLM_p last">Compound <b>93</b> was prepared via procedure I from 4-formyl-<i>N</i>-methylbenzenesulfonamide (0.20 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield an orange-yellow solid (0.11 g, 21%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (s, 1H), 8.80 (s, 1H), 8.50 (d, <i>J</i> = 4.8 Hz, 1H), 8.02–8.00 (m, 2H), 7.71 (d, <i>J</i> = 8.4 Hz, 2H), 7.48 (d, <i>J</i> = 7.8 Hz, 2H), 7.40 (d, <i>J</i> = 4.8 Hz, 1H), 7.34–7.29 (m, 3H), 7.09–7.05 (m, 2H), 6.94 (t, <i>J</i> = 7.8 Hz, 1H), 3.84–3.79 (m, 1H), 3.01–2.95 (m, 1H), 2.89–2.85 (m, 1H), 2.70–2.65 (m, 1H), 2.39 (d, <i>J</i> = 4.8 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.7, 149.9, 149.6, 149.5, 146.1, 138.0, 136.4, 136.3, 135.9, 128.5, 128.1, 127.0, 126.5, 125.6, 123.4, 122.7, 122.5, 121.0, 118.5, 118.3, 118.1, 111.5, 111.1, 60.3, 41.1, 28.7, 23.6; mp >220 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>S 517.1540; found 517.1545 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-hydroxy-4-nicotinoyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>94</b>)</h4><div class="NLM_p last">Compound <b>94</b> was prepared via procedure I from 4-(trifluoromethyl)benzaldehyde (0.17 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield a yellow solid (0.24 g, 49%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.94 (s, 1H), 8.83 (d, <i>J</i> = 1.2 Hz, 1H), 8.70 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.20 (br s, 1H), 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.66 (d, <i>J</i> = 7.8 Hz, 2H), 7.54–7.48 (m, 3H), 7.34 (d, <i>J</i> = 8.4 Hz, 1H), 7.24 (d, <i>J</i> = 7.8 Hz, 1H), 7.13 (s, 1H), 7.05 (t, <i>J</i> = 7.8 Hz, 1H), 6.91 (t, <i>J</i> = 7.2 Hz, 1H), 5.46 (s, 1H), 3.88–3.83 (m, 1H), 3.02–2.92 (m, 2H), 2.78–2.73 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 181.2, 165.3, 151.8, 149.0, 141.9, 136.6, 136.3, 134.2, 128.9, 128.2, 126.9, 125.5, 125.4, 123.5, 122.9, 121.2, 121.1, 118.2, 118.0, 111.5, 110.7, 60.3, 41.2, 23.7 (note: either carbon 1 or 2 is absent); mp 235–240 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> 492.1535; found 492.1532 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-2-hydroxybenzoate (<b>95</b>)</h4><div class="NLM_p last">Compound <b>95</b> was prepared via procedure I from <b>35</b> (0.15 g, 0.83 mmol), tryptamine (0.13 g, 0.83 mmol), and methyl acetopyruvate (0.12 g, 0.83 mmol) to yield a brown solid (0.10 g, 27%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 10.49 (s, 1H), 7.68 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 2.4 Hz, 1H), 7.34–7.30 (m, 2H), 7.10 (s, 1H), 7.05 (t, <i>J</i> = 6.8 Hz, 1H), 6.92 (t, <i>J</i> = 6.8 Hz, 1H), 6.84 (s, 1H), 6.64 (d, <i>J</i> = 8.0 Hz, 1H), 5.12 (s, 1H), 3.86 (s, 3H), 3.83–3.76 (m, 1H), 2.98–2.83 (m, 2H), 2.75–2.68 (m, 1H), 2.27 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.7, 168.8, 165.0, 159.8, 154.4, 154.1, 136.0, 130.3, 126.9, 122.8, 121.0, 119.6, 118.3, 118.2, 118.1, 117.0, 112.8, 111.4, 110.7, 59.6, 52.4, 40.9, 29.8, 23.5; mp 188–190 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>22</sub>N<sub>2</sub>O<sub>6</sub> 435.1551; found 435.1549 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-2-methoxybenzoate (<b>96</b>)</h4><div class="NLM_p last">Compound <b>96</b> was prepared via procedure I from <b>33</b> (0.1 g, 0.52 mmol), tryptamine (0.083 g, 0.52 mmol), and methyl acetopyruvate (0.074 g, 0.52 mmol) to yield a cream-colored solid (0.17 g, 74%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 7.55 (d, <i>J</i> = 8.0 Hz, 1H), 7.34–7.31 (m, 2H), 7.11 (s, 1H), 7.06 (t, <i>J</i> = 6.8 Hz, 1H), 6.94–6.91 (m, 2H), 6.70 (d, <i>J</i> = 8.0 Hz, 1H), 5.14 (s, 1H), 3.83–3.76 (m, 7H), 2.99–2.84 (m, 2H), 2.75–2.69 (m, 1H), 2.28 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.9, 165.0, 158.1, 136.2, 130.9, 128.1, 126.9, 125.5, 125.0, 122.9, 121.0, 119.6, 118.6, 118.3, 118.1, 111.5, 110.8, 60.0, 55.9, 51.9, 40.9, 40.0, 23.6 (note: carbons 3 and 4 are absent); mp 130–135 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub> 449.1707; found 449.1709 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-2-methylbenzoate (<b>97</b>)</h4><div class="NLM_p last">Compound <b>97</b> was prepared via procedure I from <b>40</b> (0.10 g, 0.56 mmol), tryptamine (0.090 g, 0.56 mmol), and methyl acetopyruvate (0.081 g, 0.56 mmol) to yield a pale-orange solid (0.13 g, 53%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (s, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.40–7.36 (m, 2H), 7.23 (t, <i>J</i> = 7.6 Hz, 1H), 7.11 (t, <i>J</i> = 7.6 Hz, 1H), 7.00 (s, 1H), 6.83 (d, <i>J</i> = 7.6 Hz, 1H), 6.74 (s, 1H), 4.76 (s, 1H), 4.07–4.02 (m, 1H), 3.90 (s, 3H), 3.11–2.93 (m, 3H), 2.51 (s, 3H), 1.98 (s, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 194.6, 167.6, 164.6, 159.8, 141.4, 139.0, 136.5, 131.5, 131.3, 130.5, 127.2, 125.2, 122.6, 122.3, 119.8, 119.5, 118.7, 112.4, 111.6, 61.4, 52.2, 41.3, 28.2, 24.4, 21.9; mp 40–43 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 433.1745; found 433.1745 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-2-chlorobenzoate (<b>98</b>)</h4><div class="NLM_p last">Compound <b>98</b> was prepared via procedure I from <b>39</b> (0.09 g, 0.45 mmol), tryptamine (0.073 g, 0.45 mmol), and methyl acetopyruvate (0.065 g, 0.45 mmol) to yield a pale-orange, amorphous solid (0.14 g, 68%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 7.71 (d, <i>J</i> = 8.0 Hz, 1H), 7.40–7.23 (m, 4H), 7.14–7.03 (m, 2H), 6.93 (t, <i>J</i> = 7.6 Hz, 1H), 5.13 (s, 1H), 3.83–3.78 (m, 4H), 2.98–2.82 (m, 2H), 2.75–2.68 (m, 1H), 2.27 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.8, 165.2, 142.8, 136.2, 131.8, 131.2, 130.5, 129.4, 128.0, 126.8, 126.0, 122.9, 121.0, 118.3, 118.0, 111.4, 110.7, 59.1, 52.5, 48.6, 40.8, 23.6 (note: carbons 1 and 2 are absent). HMS (APCI) calcd for 453.1225; found 453.1219 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-2-fluorobenzoate (<b>99</b>)</h4><div class="NLM_p last">Compound <b>99</b> was prepared via procedure I from <b>38</b> (0.08 g, 0.44 mmol), tryptamine (0.070 g, 0.44 mmol), and methyl acetopyruvate (0.063 g, 0.44 mmol) to yield a pale-orange solid (0.096 g, 50%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (s, 1H), 7.81 (t, <i>J</i> = 7.6 Hz, 1H), 7.40–7.27 (m, 2H), 7.20 (t, <i>J</i> = 7.2 Hz, 1H), 7.14–7.06 (m, 1H), 6.95 (d, <i>J</i> = 1.2 Hz, 1H), 6.78 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 7.6 Hz, 1H), 6.70 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 10.8 Hz, 1H), 4.80 (s, 1H), 4.09–4.03 (m, 1H), 3.92 (s, 3H), 3.10–2.96 (m, 3H), 2.19 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 198.1, 193.6, 165.5, 162.0 (d, <i>J</i> = 260.4 Hz), 142.8 (d, <i>J</i> = 7.4 Hz), 136.5, 132.8, 127.0, 123.5, 123.4 (d, <i>J</i> = 26.0 Hz), 122.5, 122.3, 122.1, 120.1, 119.7, 118.7, 118.5, 111.9, 111.7, 61.2, 52.6, 41.6, 29.2, 24.4; mp 40–45 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>5</sub> 437.1512; found 437.1512 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl) ethyl)-3-acetyl-4-hydroxy-5-oxo-2, 5-dihydro-1<i>H</i>-pyrrol-2-yl)-3-hydroxybenzoate (<b>100</b>)</h4><div class="NLM_p last">Compound <b>100</b> was prepared via procedure I from <b>34</b> (0.1 g, 0.56 mmol), tryptamine (0.089 g, 0.52 mmol), and methyl acetopyruvate (0.080 g, 0.56 mmol) to yield an off-white solid (0.020 g, 8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.68 (s, 1H), 10.07 (br s, 1H), 7.47 (s, 1H), 7.35–7.29 (m, 3H), 7.05–7.02 (m, 3H), 6.91 (t, <i>J</i> = 10.8 Hz, 1H), 5.58 (s, 1H), 3.83 (s, 3H), 3.80–3.74 (m, 1H), 3.02–2.88 (m, 2H), 2.76–2.68 (m, 1H), 2.27 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 196.6, 190.2, 163.6, 151.5, 136.4, 136.2, 127.0, 126.9, 123.5, 123.0, 122.5, 121.0, 118.32, 118.25, 118.0, 111.4, 111.2, 110.4, 94.5, 52.7, 52.2, 44.8, 29.3, 26.7; mp 194–197 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>22</sub>N<sub>2</sub>O<sub>6</sub> 435.1551; found 435.1552 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-3-methoxybenzoate (<b>101</b>)</h4><div class="NLM_p last">Compound <b>101</b> was prepared via procedure I from <b>41</b> (0.20 g, 1.0 mmol), tryptamine (0.17 g, 1.0 mmol), and methyl acetopyruvate (0.15 g, 1.0 mmol) to yield an off-white solid (0.16 g, 36%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 56 °C) δ 10.68 (s, 1H), 7.53 (s, 1H), 7.48 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.0 Hz, 1H), 7.32–7.28 (m, 2H), 7.06–7.02 (m, 3H), 6.92 (td, <i>J</i> = 7.2 Hz, <i>J =</i> 0.8 Hz, 1H), 5.59 (s, 1H), 3.86 (s, 6H), 3.81–3.72 (m, 1H), 2.97–2.85 (m, 2H), 2.84–2.69 (m, 1H), 2.27 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 165.9, 165.2, 157.9, 154.8, 136.2, 130.6, 126.9, 126.6, 122.7, 121.9, 121.0, 118.3, 117.8, 111.7, 111.5, 110.7, 56.0, 52.3, 41.0, 40.1, 29.7, 23.4 (note: carbon 3 and either carbon 1 or 2 are absent); mp 103–107 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub> 449.1707; found 449.1704 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-3-methylbenzoate (<b>102</b>)</h4><div class="NLM_p last">Compound <b>102</b> was prepared via procedure I from <b>36</b> (0.10 g, 0.56 mmol), tryptamine (0.090 g, 0.56 mmol), and methyl acetopyruvate (0.081 g, 0.56 mmol) to yield an orange solid (0.12 g, 50%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (s, 1H), 7.75 (s, 1H), 7.66 (d, <i>J</i> = 8.4 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.09 (d, <i>J</i> = 1.8 Hz, 1H), 7.04 (t, <i>J</i> = 7.2 Hz, 1H), 6.90 (t, <i>J</i> = 7.8 Hz, 1H), 6.84 (d, <i>J</i> = 8.4 Hz, 1H), 5.27 (s, 1H), 3.81 (s, 3H), 3.75 (dt, <i>J</i> = 8.4 Hz, <i>J</i> = 13.8 Hz, 1H), 2.94–2.89 (m, 1H), 2.76–2.69 (m, 2H), 2.31 (s, 3H), 2.25 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.0, 165.5, 140.6, 138.2, 136.3, 131.0, 128.8, 127.0, 126.8, 125.4, 122.9, 121.1, 118.3, 117.7, 111.5, 110.7, 55.6, 41.5, 40.1, 23.6, 18.5, 14.1 (note: carbons 3 and 4, and either carbons 1 or 2 are absent); mp 60–70 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 433.1763; found 433.1764 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-3-chlorobenzoate (<b>103</b>)</h4><div class="NLM_p last">Compound <b>103</b> was prepared via procedure I from <b>32</b> (0.10 g, 0.50 mmol), tryptamine (0.081 g, 0.50 mmol), and methyl acetopyruvate (0.073 g, 0.50 mmol) to yield a pale-yellow solid (0.080 g, 35%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.50 (br s, 1H), 10.81 (s, 1H), 7.95 (d, <i>J</i> = 1.6 Hz, 1H), 7.76 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.0 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 7.09–7.01 (m, 3H), 6.91 (t, <i>J</i> = 7.6 Hz, 1H), 5.68 (s, 1H), 3.85 (s, 3H), 3.80–3.73 (m, 1H), 2.97–2.84 (m, 2H), 2.77–2.72 (m, 1H), 2.28 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 192.5, 170.4, 165.5, 164.8, 139.8, 136.2, 134.7, 130.8, 129.8, 128.2, 127.8, 126.9, 122.8, 121.0, 118.3, 117.7, 111.5, 110.4, 59.8, 55.6, 52.6, 41.5, 23.5 (note: carbon 3 is absent); mp 55–60 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>5</sub> 453.1225; found 453.1222 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-3-fluorobenzoate (<b>104</b>)</h4><div class="NLM_p last">Compound <b>104</b> was prepared via procedure I from <b>37</b> (0.12 g, 0.67 mmol), tryptamine (0.11 g, 0.67 mmol), and methyl acetopyruvate (0.097 g, 0.67 mmol) to yield an orange, amorphous solid (0.033 g, 11%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (s, 1H), 7.65 (d, <i>J</i> = 8.8 Hz, 2H), 7.42 (d, <i>J</i> = 7.6 Hz, 1H), 7.31–7.27 (m, 2H), 7.11 (t, <i>J</i> = 7.2 Hz, 1H), 7.20 (t, <i>J</i> = 7.6 Hz, 1H), 6.93 (s, 1H), 5.52 (s, 1H), 4.02–3.97 (m, 1H), 3.88 (s, 3H), 3.02–2.87 (m, 3H), 2.35 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.9, 191.4, 171.1, 167.1 (d, <i>J</i> = 186.7 Hz), 162.7, 136.4, 132.6, 130.9, 127.4, 125.4, 122.3, 121.9, 119.2, 118.7, 116.9 (d, <i>J</i> = 23.8), 114.0, 112.5, 111.3, 102.3, 52.4, 45.9, 41.3, 28.4, 24.1. HMS (APCI) calcd for C<sub>24</sub>H<sub>21</sub>FN<sub>2</sub>O<sub>5</sub> 437.1507; found 437.1509 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Methyl 4-(4-Hydroxy-1-(2-(1-methyl-1<i>H</i>-Indol-3-yl)ethyl)-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>105</b>)</h4><div class="NLM_p last">Compound <b>105</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 2-(1-methyl-1<i>H</i>-indol-3-yl)ethanamine (0.17 g, 1.0 mmol) to yield cream-colored solid (0.21 g, 43%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.81 (d, <i>J</i> = 1.8 Hz, 1H), 8.70 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8, 1H), 8.01 (dt, <i>J</i> = 1.8 Hz, 8.4 Hz, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.50–7.46 (m, 3H), 7.36 (d, <i>J</i> = 9.0 Hz, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 7.14–7.10 (m, 2H), 6.96 (t, <i>J</i> = 7.8 Hz, 1H), 5.50 (s, 1H), 3.85–3.80 (m, 4H), 3.70 (s, 3H), 3.00–2.92 (m, 2H), 2.76–2.72 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 181.2, 165.9, 165.0, 153.9, 152.2, 149.1, 142.0, 136.6, 136.3, 133.9, 129.5, 129.4, 128.4, 127.3, 127.2, 123.5, 121.2, 118.4, 118.3, 110.1, 109.7, 60.4, 52.2, 41.3, 32.2, 23.5 (note: either carbon 1 or 2 is absent); mp 215–218 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub> 496.1867; found 496.1872 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Methyl 4-(3-Acetyl-4-hydroxy-1-(2-(2-methyl-1<i>H</i>-indol-3-yl)ethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>106</b>)</h4><div class="NLM_p last">Compound <b>106</b> was prepared via procedure I from methyl 4-formylbenzoate (0.094 g, 0.57 mmol), 2-(2-methyl-1<i>H</i>-indol-3-yl)ethanamine (0.10 g, 0.57 mmol), and methyl acetopyruvate (0.083 g, 0.57 mmol) to yield a cream-colored solid (0.18 g, 73%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.73 (s, 1H), 7.85 (d, <i>J</i> = 9.0 Hz, 2H), 7.21 (d, <i>J</i> = 7.8 Hz, 1H), 7.18–7.15 (m, 3H), 6.97 (t, <i>J</i> = 7.8 Hz, 1H), 6.86 (t, <i>J</i> = 7.8 Hz, 1H), 5.03 (s, 1H), 3.83 (s, 3H), 3.64–3.59 (m, 1H), 2.92–2.87 (m, 1H), 2.77–2.72 (m, 1H), 2.60–2.56 (m, 1H), 2.26 (s, 3H), 2.17 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.1, 165.9, 165.0, 142.4, 135.1, 132.2, 129.8, 129.7, 129.3, 128.1, 127.9, 125.6, 120.1, 118.2, 117.0, 110.5, 106.5, 60.1, 52.1, 40.9, 39.9, 24.5, 10.9; mp 182–187 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 433.1758; found 433.1759 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Methyl 4-(4-Hydroxy-1-(2-(4-methyl-1<i>H</i>-indol-3-yl)ethyl)-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>107</b>)</h4><div class="NLM_p last">Compound <b>107</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 2-(4-methyl-1<i>H</i>-indol-3-yl)ethanamine (0.17 g, 1.0 mmol) to yield a pale-yellow solid (0.05 g, 11%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (d, <i>J</i> = 1.8 Hz, 1H), 8.82 (d, <i>J</i> = 1.8 Hz, 1H), 8.70 (dd, <i>J =</i> 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.01 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 8.4 Hz, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.49–7.44 (m, 3H), 7.15 (d, <i>J</i> = 8.4 Hz, 1H), 7.04 (d, <i>J</i> = 2.4 Hz, 1H), 6.92 (t, <i>J</i> = 6.6 Hz, 1H), 6.67 (d, <i>J</i> = 7.2 Hz, 1H), 5.48 (s, 1H), 3.89–3.81 (m, 4H), 3.14–3.09 (m, 1H), 2.98–2.87 (m, 2H), 2.44 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.9, 165.9, 165.1, 152.3, 149.3, 142.2, 136.7, 136.2, 133.9, 129.5, 129.4, 128.3, 125.4, 123.4, 123.1, 122.9, 121.1, 120.1, 119.9, 118.2, 111.5, 109.6, 66.4, 60.4, 52.2, 25.5, 19.7; mp 170–175 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub> 496.1845; found 496.1850 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Methyl 4-(4-Hydroxy-1-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>108</b>)</h4><div class="NLM_p last">Compound <b>108</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 2-(5-methoxy-1<i>H</i>-indol-3-yl)ethanamine (0.19 g, 1.0 mmol) to yield a yellow solid (0.35 g, 68%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (s, 1H), 8.79 (d, <i>J</i> = 1.8 Hz, 1H), 8.68 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 7.99 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.48–7.46 (m, 1H), 7.44 (d, <i>J</i> = 7.8 Hz, 2H), 7.22–7.21 (m, 2H), 7.09 (d, <i>J</i> = 2.4 Hz, 1H), 6.75 (d, <i>J</i> = 2.4 Hz, 1H), 6.70 (dd, <i>J</i> = 2.4 Hz, <i>J</i> = 9.0 Hz, 1H), 5.44 (s, H), 3.85–3.80 (m, 4H), 2.68 (s, 3H), 2.98–2.89 (m, 2H), 2.73–2.70 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.7, 181.1, 165.9, 165.2, 153.0, 152.0, 149.1, 142.4, 136.3, 134.1, 131.4, 129.5, 129.4, 128.3, 127.2, 123.6, 123.5, 117.9, 112.2, 111.3, 110.5, 99.7, 60.4, 55.2, 52.2, 41.1, 23.8; mp 222–225 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>6</sub> 512.1816; found 512.1822 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Methyl 4-(1-(2-(6-Fluoro-1<i>H</i>-indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>109</b>)</h4><div class="NLM_p last">Compound <b>109</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 3-(6-fluoro-1<i>H</i>-indol-3-yl)ethanamine (0.18 g, 1.0 mmol) to yield a pale-orange solid (0.44 g, 87%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.94 (s, 1H), 8.82 (d, <i>J</i> = 0.6 Hz, 1H), 8.69 (d, <i>J</i> = 4.8 Hz, 1H), 8.01 (d, <i>J</i> = 7.8 Hz, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.80 (br s, 1H), 7.49–7.47 (m, 1H), 7.43 (d, <i>J</i> = 7.8 Hz, 2H), 7.33–7.30 (m, 1H), 7.31–7.10 (m, 2H), 6.79 (td, <i>J</i> = 9.6 Hz, <i>J</i> = 1.8 Hz, 1H), 5.44 (s, 1H), 3.89–3.82 (m, 4H), 2.98–2.91 (m, 2H), 2.80–2.76 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.9, 181.1, 165.9, 165.1, 159.7, 158.1, 152.3, 142.2, 136.3, 136.1, 133.9, 129.5, 129.3, 128.3, 125.5, 123.8, 123.4, 119.1, 118.1, 111.1, 106.7, 106.6, 60.4 (d, <i>J</i> = 14.4 Hz), 52.1, 41.1, 23.1; mp 162–167 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>5</sub> 500.1595; found 500.1600 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Methyl 4-(1-(2-(6-Chloro-1<i>H</i>-indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>110</b>)</h4><div class="NLM_p last">Compound <b>110</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 2-(6-chloro-1<i>H</i>-indol-3-yl)ethanamine (0.20 g, 1.0 mmol) to yield a yellow solid (0.44 g, 85%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (s, 1H), 8.80 (s, 1H), 8.68 (d, <i>J</i> = 3.6 Hz, 1H), 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 2H), 7.77 (br s, 1H), 7.48–7.41 (m, 3H), 7.37 (d, <i>J</i> = 1.2 Hz, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.17 (s, 1H), 6.94 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.4 Hz, 1H), 3.87–3.82 (m, 4H), 2.97–2.89 (m, 2H), 2.79–2.76 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 181.2, 165.9, 165.3, 149.2, 136.6, 136.2, 129.44, 129.36, 128.3, 128.1, 125.8, 125.7, 125.5, 124.7, 124.1, 123.3, 119.5, 118.8, 118.6, 111.2, 111.1, 109.8, 60.3, 52.1, 41.0, 23.4; mp 184–189 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>5</sub> 516.1321; found 516.1324 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Methyl 4-(4-Hydroxy-1-(2-(6-methyl-1<i>H</i>-indol-3-yl)ethyl)-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>111</b>)</h4><div class="NLM_p last">Compound <b>111</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 2-(6-methyl-1<i>H</i>-indol-3-yl)ethanamine (0.17 g, 1.0 mmol) to yield a cream-colored solid (0.10 g, 20%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.71 (s, 1H), 8.79 (s, 1H), 8.68 (d, <i>J</i> = 3.6 Hz, 1H), 7.99 (d, <i>J</i> = 6.6 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 2H), 7.47 (t, <i>J</i> = 6.0 Hz, 1H), 7.42 (d, <i>J</i> = 7.8 Hz, 2H), 7.17 (d, <i>J</i> = 7.8 Hz, 1H), 7.11 (s, 1H), 7.02 (s, 1H), 6.75 (d, <i>J</i> = 7.8 Hz, 1H), 5.40 (s, 1H), 3.90–3.82 (m, 4H), 2.99–2.89 (m, 2H), 2.74–2.71 (m, 1H), 2.37 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.7, 165.9, 165.1, 152.1, 149.1, 142.3, 136.7, 136.2, 134.0, 130.0, 129.5, 129.4, 128.4, 128.1, 125.5, 124.9, 123.4, 122.2, 120.0, 117.8, 111.3, 110.6, 60.4, 52.2, 41.1, 23.8, 21.4; mp 202–207 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub> 496.1867; found 496.1868 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Methyl 4-(4-Hydroxyl-1-(2-(6-methyoxy-1<i>H</i>-indol-3-yl)ethyl)-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>112</b>)</h4><div class="NLM_p last">Compound <b>112</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 2-(6-methoxy-1<i>H</i>-indol-3-yl)ethanamine (0.19 g, 1.0 mmol) to yield a pale-orange solid (0.39 g, 76%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.64 (s, 1H), 8.78 (s, 1H), 8.67 (s, 1H), 8.06 (d, <i>J</i> = 7.8 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 2H), 7.55 (d, <i>J</i> = 7.2 Hz, 1H), 7.41 (d, <i>J</i> = 7.8 Hz, 2H), 7.11 (d, <i>J</i> = 7.8 Hz, 1H), 6.96 (s, 1H), 6.83 (s, 1H), 6.58 (d, <i>J</i> = 7.8 Hz, 1H), 5.39 (s, 1H), 3.82 (s, 3H), 3.75–3.70 (m, 4H), 2.94–2.90 (m, 2H), 2.71–2.69 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.8, 155.6, 145.7, 137.6, 137.4, 137.0, 130.8, 130.4, 129.5, 129.4, 128.3, 128.11, 128.07, 125.5, 121.3, 118.7, 110.8, 108.5, 107.5, 94.5, 60.4, 55.2, 40.9, 23.8, 20.8 (note: two of either carbon 1, 2, or 3 are absent); mp 195–200 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>6</sub> 512.1816; found 512.1821 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Methyl 4-(1-(2-(7-Fluoro-1<i>H</i>-indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>113</b>)</h4><div class="NLM_p last">To a slurry of 2-(7-fluoro-1<i>H</i>-indol-3-yl)ethanamine hydrochloride (0.05 g, 0.23 mmol) in MeOH (0.026 mL) was added triethylamine (0.039 mL, 0.28 mmol). Ether (1.3 mL) was added, and the mixture was stirred at −10 °C for 1 h. The resulting triethylamine hydrochloride salt was filtered off, and the filtrate was concentrated in vacuo to afford a white solid (0.040 g, >99%) which was carried on immediately. Compound <b>113</b> was prepared via procedure I from methyl 4-formylbenzoate (0.039 g, 0.24 mmol), <b>19</b> (0.052 g, 0.24 mmol), and 2-(7-fluoro-1<i>H</i>-indol-3-yl)ethanamine hydrochloride (0.040 g, 0.24 mmol) to yield a pale-yellow solid (0.11 g, 97%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.30 (s, 1H), 10.11 (s, 1H), 8.74 (m, 1H), 8.46 (m, 1H), 7.98–7.97 (m, 1H), 7.87–7.86 (m, 1H), 7.37–7.33 (m, 2H), 7.28 (m, 1H), 7.16–7.14 (m, 2H), 6.89–6.87 (m, 2H), 5.23 (s, 1H), 3.84–3.76 (m, 4H), 2.92 (m, 1H), 2.79 (m, 1H), 2.73–2.68 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.0 (d, <i>J</i> = 13.4 Hz), 169.4, 166.2, 165.5, 150.0, 149.5, 148.4, 147.7, 139.1, 136.6, 134.3, 131.1, 129.7, 129.0, 128.7, 128.3, 127.7, 124.0, 118.6, 114.7, 112.4, 105.8, 60.0 (d, <i>J</i> = 45.5 Hz), 52.0 (d, <i>J</i> = 41.2 Hz), 40.1 (d, <i>J</i> = 21.8 Hz), 23.3; mp 65–69 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>5</sub> 500.1616; found 500.1616 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Methyl 4-(1-(2-(7-Chloro-1<i>H</i>-indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>114</b>)</h4><div class="NLM_p last">To a slurry of 2-(7-chloro-1<i>H</i>-indol-3-yl)ethanamine hydrochloride (0.15 g, 0.65 mmol) in MeOH (0.072 mL) was added triethylamine (0.11 mL, 0.78 mmol). Ether (3.62 mL) was added, and the mixture was stirred at −10 °C for 1 h. The resulting triethylamine hydrochloride salt was filtered off, and the filtrate was concentrated in vacuo to afford a white solid (0.074 g, 58%) which was carried on immediately. Compound <b>114</b> was prepared via procedure I from methyl 4-formylbenzoate (0.064 g, 0.39 mmol), <b>19</b> (0.086 g, 0.39 mmol), and 2-(7-chloro-1<i>H</i>-indol-3-yl)ethanamine hydrochloride (0.074 g, 0.39 mmol) to yield a yellow solid (0.009 g, 5%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.22 (s, 1H), 8.80 (s, 1H), 8.69 (d, <i>J</i> = 4.2 Hz, 1H), 8.00 (d, <i>J</i> = 7.8 Hz, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.49–7.44 (m, 3H), 7.31 (d, <i>J</i> = 7.8 Hz, 1H), 7.22 (d, <i>J</i> = 1.8 Hz, 1H), 7.14 (d, <i>J</i> = 7.2 Hz, 1H), 6.94 (t, <i>J</i> = 7.2 Hz, 1H), 5.49 (s, 1H), 3.89–3.82 (m, 4H), 3.00–2.91 (m, 2H), 2.83–2.78 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 181.3, 165.9, 165.0, 152.4, 149.3, 142.0, 136.2, 133.9, 133.0, 129.5, 129.4, 129.0, 128.3, 124.4, 123.5, 120.6, 119.4, 118.2, 117.3, 115.9, 112.3, 60.2, 52.2, 41.0, 23.6 (note: one of either carbon 1, 2, or 3 are absent); mp 246–249 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>5</sub> 516.1321; found 516.1325 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Methyl 4-(3-Acetyl-4-hydroxy-1-(2-(7-methyl-1<i>H</i>-indol-3-yl)ethyl)-5-oxo-2, 5-dihydro-1<i>H</i>-pyrrol-2-yl) benzoate (<b>115</b>)</h4><div class="NLM_p last">Compound <b>115</b> was prepared via procedure I from methyl 4-formylbenzoate (0.094 g, 0.57 mmol), 2-(7-methyl-1<i>H</i>-indol-3-yl) ethanamine (0.10 g, 0.57 mmol), and methyl acetopyruvate (0.083 g, 0.57 mmol) to yield a white solid (0.16 g, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.50 (br s, 1H), 10.78 (s, 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 2H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 7.12–7.07 (m, 2H), 6.83–6.82 (m, 2H), 5.20 (s, 1H), 3.83–3.76 (m, 4H), 2.98–2.80 (m, 2H), 2.80–2.66 (m, 1H), 2.41 (s, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.9, 165.0, 142.4, 135.7, 129.3, 128.1, 126.5, 125.5, 122.5, 121.5, 120.5, 118.5, 115.7, 111.1, 109.7, 59.7, 52.1, 40.8, 40.0, 23.7, 16.7 (note: carbons 3 and 4 are absent); mp 220–227 °C. HMS (APCI) calcd from C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 433.1758; found 433.1758 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Ethyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>116</b>)</h4><div class="NLM_p last">Compound <b>116</b> was prepared via procedure I from <b>19</b> (0.15 g, 0.68 mmol), tryptamine (0.11 g, 0.68 mmol), and <b>35</b> (0.12 g, 0.68 mmol) to yield a yellow solid (0.027 g, 8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (s, 1H), 8.75 (s, 1H), 8.48 (d, <i>J</i> = 3.2 Hz, 1H), 7.94 (d, <i>J</i> = 7.2 Hz, 1H), 7.83 (d, <i>J</i> = 8.0 Hz, 2H), 7.34–7.27 (m, 5H), 7.08–7.04 (m, 2H), 6.92 (t, <i>J</i> = 7.2 Hz, 1H), 5.33 (s, 1H), 4.28 (q, <i>J</i> = 7.6 Hz, 2H), 3.84–3.77 (m, 1H), 3.00–2.93 (m, 1H), 2.87–2.80 (m, 1H), 2.73–2.66 (m, 1H), 1.28 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.8, 182.1, 162.9, 155.0, 148.3, 148.1, 136.4, 136.3, 127.0, 123.8, 123.4, 123.2, 123.1, 121.5, 121.3, 120.8, 118.5, 118.2, 117.8, 111.8, 111.2, 109.5, 60.6, 45.3, 23.6, 23.3, 14.0; mp >250 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub> 496.1867; found 496.1872 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Ethyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-hydroxy-3-isonicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>117</b>)</h4><div class="NLM_p last">Compound <b>117</b> was prepared via procedure I from <b>45</b> (0.40 g, 2.3 mmol), tryptamine (0.36 g, 2.3 mmol), and <b>20</b> (0.50 g, 2.3 mmol) to yield a yellow solid (0.019 g, 2%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (s, 1H), 8.68 (d, <i>J</i> = 5.4 Hz, 2H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.51 (d, <i>J</i> = 5.4 Hz, 2H), 7.40 (d, <i>J</i> = 8.4 Hz, 2H), 7.34 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.12 (d, <i>J</i> = 1.8 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 6.92 (t, <i>J</i> = 7.2 Hz, 1H), 5.40 (s, 1H), 4.29 (q, <i>J</i> = 7.2 Hz, 2H), 3.88–3.82 (m, 1H), 3.00–2.90 (m, 2H), 2.78–2.73 (m, 1H), 1.29 (7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.0, 165.4, 165.0, 149.6, 145.8, 142.2, 136.2, 129.8, 129.7, 129.3, 128.3, 126.9, 122.9, 121.8, 121.1, 118.3, 118.1, 117.35, 111.5, 110.7, 60.7, 60.3, 41.1, 23.6, 14.2; mp 169–172 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub> 496.1880; found 496.1877 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Methyl 4-(4-Hydroxy-1-(2-(2-methyl-1<i>H</i>-indol-3-yl)ethyl)-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>118</b>)</h4><div class="NLM_p last">Compound <b>118</b> was prepared via procedure I from <b>19</b> (0.15 g, 0.68 mmol), 2-(2-methyl-1<i>H</i>-indol-3-yl)ethanamine (0.12 g, 0.68 mmol), and methyl 4-formylbenzoate (0.11 g, 0.68 mmol) to yield an orange solid (0.046 g, 14%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.75 (s, 1H), 8.73 (s, 1H), 8.48 (d, <i>J</i> = 4.4 Hz, 1H), 7.93 (s, 1H), 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.30–7.17 (m, 5H), 6.97 (t, <i>J</i> = 6.4 Hz, 1H), 6.86 (t, <i>J</i> = 7.2 Hz, 1H), 5.23 (s, 1H), 3.81 (s, 3H), 3.63–3.56 (m, 1H), 2.96–2.88 (m, 1H), 2.76–2.69 (m, 1H), 2.57–2.50 (m, 1H), 2.18 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 182.6, 166.0, 150.4, 150.1, 149.2, 136.8, 136.1, 135.5, 135.2, 132.2, 129.0, 128.6, 128.0, 123.6, 122.6, 120.1, 118.2, 117.0, 110.6, 106.7, 61.2, 52.0, 41.3, 22.6, 11.0 (note: two of carbons 1, 2, 3, or 4 are absent); mp >250 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub> 496.1867; found 496.1872 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Ethyl 4-(3-Acetyl-4-hydroxy-1-(2-(2-methyl-1<i>H</i>-indol-3-yl)ethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>119</b>)</h4><div class="NLM_p last">Compound <b>119</b> was prepared via procedure I from <b>45</b> (0.15 g, 0.84 mmol), 2-(2-methyl-1<i>H</i>-indol-3-yl)ethanamine (0.15 g, 0.84 mmol), and methyl acetopyruvate (0.12 g, 0.84 mmol) to yield a cream-colored solid (0.078 g, 21%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 80 °C) δ 10.5 (br s, 1H), 7.83 (d, <i>J</i> = 7.2 Hz, 2H), 7.23–7.18 (m, 4H), 6.95 (t, <i>J</i> = 7.2 Hz, 1H), 6.86 (t, <i>J</i> = 7.2 Hz, 1H), 5.09 (s, 1H), 4.30 (q, <i>J</i> = 7.2 Hz, 2H), 3.61–3.56 (m, 1H), 2.92–2.87 (m, 1H), 2.80–2.75 (m, 1H), 2.57–2.53 (m, 1H), 2.19 (s, 3H), 2.05 (s, 3H), 1.30 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.3, 189.3, 165.5, 135.1, 132.1, 129.1, 127.9, 120.1, 118.1, 117.0, 112.1, 110.5, 108.9, 106.6, 98.5, 90.2, 54.9, 48.7, 48.6, 40.0, 29.0, 14.2, 11.0 (note: one of either carbon 1, 2, or 4 is absent); mp 190–195 °C. HMS (APCI) calcd for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>O<sub>5</sub> 447.1928; found 447.30 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Ethyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)-3-hydroxybenzoate (<b>120</b>)</h4><div class="NLM_p last">Compound <b>120</b> was prepared via procedure I from <b>189</b> (0.15 g, 0.77 mmol), tryptamine (0.12 g, 0.77 mmol), and methyl acetopyruvate (0.11 g, 0.77 mmol) to yield a cream-colored solid (0.20 g, 57%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.81 (s, 1H), 10.42 (s, 1H), 7.59–7.46 (m, 1H), 7.34–7.23 (m, 3H), 7.12–7.02 (m, 2H), 6.97–6.89 (m, 2H), 5.76 (s, 1H), 4.28 (q, <i>J</i> = 7.2 Hz, 2H), 3.78–3.74 (m, 1H), 2.98–2.85 (m, 2H), 2.73–2.68 (m, 1H), 2.28 (s, 3H), 1.29 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.7, 165.5, 165.1, 156.2, 154.8, 136.2, 130.5, 128.1, 127.0, 126.7, 125.5, 122.7, 121.0, 120.2, 118.3, 118.0, 116.1, 111.4, 110.8, 60.7, 41.0, 40.0, 29.7, 23.4, 14.2; mp 200–205 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub> 449.1721; found 449.1723 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Methyl 4-(1-((1<i>H</i>-Indol-3-yl)methyl)-4-hydroxy-3-isonicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>121</b>)</h4><div class="NLM_p last">Compound <b>121</b> was prepared via procedure I from methyl 4-formylbenzoate (0.28 g, 1.7 mmol), (1<i>H</i>-indol-3-yl)methanamine (0.25 g, 1.7 mmol), and <b>20</b> (0.38 g, 1.7 mmol) to yield an orange solid (0.78 g, 98%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.08 (s, 1H), 8.66 (d, <i>J</i> = 5.6 Hz, 2H), 7.92 (d, <i>J</i> = 8.0 Hz, 2H), 7.51–7.37 (m, 6H), 7.13–7.08 (m, 2H), 6.97 (t, <i>J</i> = 7.2 Hz, 1H), 5.11–5.07 (m, 2H), 3.84 (s, 3H), 3.80 (d, <i>J</i> = 14.8 Hz, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.0, 165.1, 149.2, 129.45, 129.36, 128.2, 128.1, 126.2, 125.5, 125.1, 122.0, 121.7, 121.5, 119.0, 118.9, 118.6, 118.2, 111.7, 109.3, 59.2, 52.2, 35.5 (note: carbon 4 is absent); mp 240–243 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub> 468.1567; found 468.1566 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Methyl 4-(1-(3-(1<i>H</i>-Indol-3-yl)propyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>122</b>)</h4><div class="NLM_p last">Compound <b>122</b> was prepared via procedure I from methyl 4-formylbenzoate (0.16 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and 3-(1<i>H</i>-indol-3-yl)propan-1-amine (0.17 g, 1.0 mmol) to yield a yellow solid (0.35 g, 71%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.75 (s, 1H), 8.82 (s, 1H), 8.69 (d, <i>J</i> = 4.8 Hz, 1H), 8.02 (d, <i>J</i> = 7.8 Hz, 1H), 7.87 (d, <i>J</i> = 8.4 Hz, 2H), 7.49–7.47 (m, 3H), 7.37 (d, <i>J</i> = 7.8 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.06–7.03 (m, 2H), 6.92 (t, <i>J</i> = 7.2 Hz, 1H), 5.54 (s, 1H), 3.62–3.55 (m, 4H), 2.83–2.79 (m, 1H), 2.62–2.55 (m, 2H), 1.84–1.80 (m, 1H), 1.73–1.69 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.9, 165.9, 165.2, 154.4, 152.1, 149.2, 142.4, 136.3, 134.0, 129.5, 128.3, 127.0, 123.5, 122.4, 122.3, 120.8, 118.3, 118.0, 113.4, 111.4, 60.4, 52.3, 40.7, 28.0, 22.1 (note: either carbon 1 or 2 and carbon 3 are absent); mp 221–226 °C. HMS (APCI) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>3</sub>O<sub>5</sub> 496.1845; found 496.1852 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-methoxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>156</b>)</h4><div class="NLM_p last">To a solution of <b>1</b> (0.50 g, 1.2 mmol) in DCM:MeOH (1:1, 0.13M) was added (diazomethyl)trimethylsilane (0.72 mL, 1.4 mmol). The reaction mixture continued to stir at rt for 5 h before being concentrated in vacuo. The crude residue was then purified using flash column chromatography on SiO<sub>2</sub> (3% MeOH/DCM) to yield a pale-yellow solid (0.24 g, 46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 7.88 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.0 Hz, 2H), 7.33–7.24 (m, 4H), 7.09–7.03 (m, 2H), 6.92 (t, <i>J</i> = 7.6 Hz, 1H), 5.20 (s, 1H), 4.36 (s, 3H), 3.84 (s, 3H), 3.80–3.71 (m, 1H), 2.96–2.89 (m, 1H), 2.84–2.77 (m, 1H), 2.72–2.63 (m, 1H), 2.25 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.9, 165.9, 164.2, 154.0, 141.7, 136.2, 129.5, 129.3, 128.2, 126.8, 126.2, 122.9, 121.0, 118.3, 118.0, 111.5, 110.7, 59.5, 59.1, 52.2, 40.9, 30.3, 23.6; mp 40–45 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 433.1763; found 433.1761 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-acetyl-4-amino-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>157</b>)</h4><div class="NLM_p last">To a solution of <b>1</b> (0.50 g, 1.2 mmol) in 2-methoxyethanol (8.36 mL, 0.14 M) was added ammonium formate (0.11 mL, 2.2 mmol, 1.8 equiv). The reaction mixture was refluxed for 3 h before being concentrated in vacuo, ground with a mortar and pestle, and triturated with Et<sub>2</sub>O. Further purification was achieved via flash column chromatography on SiO<sub>2</sub> (10% MeOH/DCM) to yield a pale-yellow solid (0.070 g, 14%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 56 °C) δ 10.02 (br s, 1H), 8.36 (br s, 1H), 7.92 (d, <i>J</i> = 8.0 Hz, 2H), 7.39–7.34 (m, 2H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H), 7.08–7.02 (m, 3H), 6.97 (s, 1H), 6.44 (br s, 1H), 4.77 (s, 1H), 4.04–3.97 (m, 1H), 3.91 (s, 3H), 3.09–2.99 (m, 2H), 2.92–2.85 (m, 1H), 1.56 (s, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 177.8, 165.9, 164.4, 163.2, 144.7, 136.2, 129.7, 129.5, 128.3, 126.9, 122.7, 121.0, 118.2, 118.0, 111.4, 110.8, 105.6, 58.0, 52.1, 48.6, 41.0, 23.2; mp 50–54 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub> 418.1766; found 418.1766 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Methyl 4-(1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-4-acetoxy-3-acetyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>158</b>)</h4><div class="NLM_p last">To a solution of <b>1</b> (0.50 g, 1.2 mmol) in DCM (11 mL, 0.11 M) was added acetic anhydride (0.14 mL, 1.4 mmol, 1.2 equiv) and pyridine (0.14 mL, 1.8 mmol, 1.5 equiv). The reaction mixture was stirred at rt for 6<sup>1</sup>/<sub>2</sub> h before being concentrated in vacuo. The crude material was then purified by flash column chromatography on SiO<sub>2</sub> (3% MeOH/DCM). Additional purification was achieved using HPLC (75% ACN with 0.1% formic acid) to give a yellow oil (0.038 g, 7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.06 (s, 1H), 7.94–7.92 (m, 2H), 7.38 (d, <i>J</i> = 8.4 Hz, 2H), 7.21 (t, <i>J</i> = 8.0 Hz, 1H), 7.10–7.05 (m, 3H), 6.98 (d, <i>J</i> = 2.0 Hz, 1H), 4.93 (s, 1H), 4.07–4.00 (m, 1H), 3.91 (s, 3H), 3.08–2.89 (m, 3H), 2.47 (s, 3H), 2.26 (s, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 191.5, 167.0, 166.6, 163.8, 147.7, 139.2, 137.0, 136.6, 131.0, 130.4, 128.1, 127.4, 122.6, 122.2, 119.9, 118.7, 112.6, 111.5, 62.3, 62.4, 41.5, 30.1, 24.4, 20.8. HMS (APCI) calcd for C<sub>26</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub> 461.1721; found 461.1717 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Methyl 4-(3-Acetyl-4-(butyryloxy)-1-(2-(2-methyl-1<i>H</i>-indol-3-yl)ethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>159</b>)</h4><div class="NLM_p last">To a solution of <b>106</b> (0.30 g, 0.69 mmol) and triethylamine (0.19 mL, 1.4 mmol, 2.0 equiv) in THF (0.69 mL, 1.0 M) at −30 °C was added butyryl chloride (0.072 mL, 0.69 mmol, 1.0 equiv) dropwise over 20 min. The mixture was allowed to stir at −30 °C for 2 h before being concentrated in vacuo. The crude material was dissolved in EtOAc, washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification was achieved via flash column chromatography on SiO<sub>2</sub> (10% EtOAc:DCM) to afford a yellow, amorphous solid (0.12 g, 35%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.96 (s, 1H), 7.88 (d, <i>J</i> = 7.8 Hz, 2H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.20 (d, <i>J</i> = 7.2 Hz, 1H), 7.11 (t, <i>J</i> = 7.2 Hz, 1H), 7.01 (t, <i>J</i> = 7.2 Hz, 1H), 6.94 (d, <i>J</i> = 7.8 Hz, 2H), 4.78 (s, 1H), 3.89 (s, 3H), 3.87–3.82 (m, 1H), 3.02 (dt, <i>J</i> = 13.8 Hz, <i>J</i> = 8.4 Hz, 1H), 2.91 (dt, <i>J</i> = 13.8 Hz, <i>J =</i> 7.8 Hz, 1H), 2.82–2.78 (m, 1H), 2.70 (t, <i>J</i> = 7.8 Hz, 2H), 2.24 (s, 3H), 2.23 (s, 3H), 1.85 (sextet, 7.8 Hz, 2H), 1.09 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 191.6, 170.0, 166.6, 163.7, 147.9, 139.1, 136.9, 135.4, 132.1, 130.8, 130.2, 128.3, 128.0, 121.5, 119.7, 117.8, 110.6, 108.0, 62.5, 52.4, 41.4, 35.9, 30.2, 23.3, 18.4, 13.7, 11.5. HMS (APCI) calcd for C<sub>29</sub>H<sub>30</sub>N<sub>2</sub>O<sub>6</sub> 503.2168; found 503.2172 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Methyl 4-(3-Acetyl-4-(acryloyloxy)-1-(2-(2-methyl-1<i>H</i>-indol-3-yl)ethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>160</b>)</h4><div class="NLM_p last">To a solution of <b>106</b> (3.0 g, 6.9 mmol) and triethylamine (1.9 mL, 14 mmol, 2.0 equiv) in THF (6.9 mL, 1.0 M) at −30 °C was added acryloyl chloride (0.72 mL, 6.9 mmol, 1.0 equiv) dropwise over 20 min. The mixture was allowed to stir at −30 °C for 2 h before being concentrated in vacuo. The crude material was dissolved in EtOAc, washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Purification was achieved via flash column chromatography on SiO<sub>2</sub> (10% EtOAc:DCM) to afford a yellow, amorphous solid (0.68 g, 20%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.00 (s, 1H), 7.89 (d, <i>J</i> = 8.7 Hz, 2H), 7.27–7.20 (m, 2H), 7.11 (t, <i>J</i> = 7.2 Hz, 1H), 7.03–6.94 (m, 3H), 6.71 (d, <i>J</i> = 0.9 Hz, 1H), 6.43 (d, <i>J</i> = 10.2 Hz, 1H), 6.20 (d, <i>J =</i> 0.6 Hz, 1H), 4.81 (s, 1H), 3.89–3.81 (m, 4H), 3.08–2.76 (m, 3H), 2.24 (s, 6H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 196.1, 191.6, 186.7, 166.6, 163.6, 162.2, 147.6, 139.0, 137.3, 135.7, 135.4, 132.1, 130.8, 130.2, 128.3, 128.0, 126.0, 121.5, 119.6, 117.7, 110.7, 107.9, 62.6, 52.4, 41.5, 30.2, 23.3, 11.5. HMS (APCI) calcd for C<sub>28</sub>H<sub>26</sub>N<sub>2</sub>O<sub>6</sub> 487.1837; found 487.1860 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Methyl 4-(3-Acetyl-4-hydroxy-5-oxo-1-phenethyl-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>161</b>)</h4><div class="NLM_p last">Compound <b>161</b> was prepared via procedure I from methyl 4-formylbenzoate (0.34 g, 2.1 mmol), ethyl acetopyruvate (0.33 g, 2.1 mmol), and 2-phenylethanamine (0.25 g, 2.1 mmol) to yield a white solid (0.73 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.31–7.24 (m, 4H), 7.19 (d, <i>J</i> = 7.2 Hz, 1H), 7.10 (d, <i>J</i> = 6.8 Hz, 2H), 5.15 (s, 1H), 3.83–3.76 (m, 4H), 2.82–2.60 (m, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.9, 165.9, 165.0, 142.4, 138.5, 129.4, 129.4, 128.6, 128.5, 128.1, 126.4, 125.6, 119.7, 66.4, 59.7, 52.2, 41.5, 33.5; mp 123–128 °C. HMS (APCI) calcd for C<sub>22</sub>H<sub>21</sub>NO<sub>5</sub> 380.1493; found 380.1494 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Methyl 4-(4-Hydroxy-3-isonicotinoyl-1-(2-(naphthalen-1-yl)ethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>162</b>)</h4><div class="NLM_p last">Compound <b>162</b> was prepared via procedure I from methyl 4-formylbenzoate (0.40 g, 2.4 mmol), <b>188</b> (0.41 g, 2.4 mmol), and <b>20</b> (0.53 g, 2.4 mmol) to yield a yellow solid (0.67 g, 56%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70 (d, <i>J</i> = 3.6 Hz, 2H), 7.93–7.84 (m, 4H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7.57–7.40 (m, 7H), 7.30 (d, <i>J</i> = 6.6 Hz, 1H), 5.40 (s, 1H), 3.84–3.80 (m, 4H), 3.37–3.34 (m, 1H), 3.13–3.08 (m, 1H), 3.03–3.00 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 196.1, 165.9, 162.1, 160.1, 136.4, 136.3, 130.7, 129.5, 128.2, 128.0, 125.5, 123.4, 122.8, 121.2, 120.8, 118.48, 118.45, 118.2, 118.1, 115.2, 111.6, 111.3, 61.5, 52.2, 48.6, 26.2; mp 221–224 °C. HMS (APCI) calcd for C<sub>30</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> 493.1758; found 493.1756 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Methyl 4-(1-(2-(Benzofuran-3-yl)ethyl)-4-hydroxy-3-nicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>163</b>)</h4><div class="NLM_p last">Compound <b>163</b> was prepared via procedure I from methyl 4-formylbenzoate (0.20 g, 1.2 mmol), <b>19</b> (0.27 g, 1.2 mmol), and 2-(benzofuran-3-yl)ethanamine (0.20 g, 1.2 mmol) to yield a pale-yellow solid (0.028 g, 4.7%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (s, 1H), 8.57 (s, 1H), 7.99 (d, <i>J</i> = 7.2 Hz, 1H), 7.86 (d, <i>J</i> = 7.8 Hz, 2H), 7.77 (s, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 7.47–7.42 (m, 3H), 7.37 (t, <i>J</i> = 5.4 Hz, 1H), 7.29 (t, <i>J</i> = 7.2 Hz, 1H), 7.20 (t, <i>J</i> = 7.2 Hz, 1H), 5.44 (s, 1H), 3.87–3.82 (m, 4H), 2.97–2.92 (m, 2H), 2.76–2.75 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.3, 181.3, 166.0, 154.6, 150.6, 149.5, 142.4, 135.9, 129.1, 128.8, 128.1, 127.5, 124.4, 122.7, 122.4, 119.6, 117.0, 115.6, 111.3, 60.2, 52.1, 40.0, 21.7 (note: carbons 1, 2, and 3 are absent); mp 225–230 °C. HMS (APCI) calcd for C<sub>28</sub>H<sub>22</sub>N<sub>2</sub>O<sub>6</sub> 481.1397; found 481.1396 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Methyl 4-(1-(2-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)ethyl)-4-hydroxy-3-isonicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>164</b>)</h4><div class="NLM_p last">Compound <b>164</b> was prepared via procedure I from methyl 4-formylbenzoate (0.19 g, 1.1 mmol), 2-(1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)ethanamine (0.18 g, 1.1 mmol), and <b>20</b> (0.25 g, 1.1 mmol) to yield a yellow solid (0.40 g, 73%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (d, <i>J</i> = 1.3 Hz, 2H), 8.59 (s, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.67 (t, <i>J</i> = 5.2 Hz, 1H), 7.61 (t, <i>J</i> = 5.2 Hz, 1H), 7.52 (d, <i>J</i> = 5.6 Hz, 2H), 7.33–7.29 (m, 4H), 5.37 (s, 1H), 4.61–4.54 (m, 1H), 4.48–4.44 (m, 1H), 4.03–3.98 (m, 1H), 3.82 (s, 3H), 3.08–3.04 (m, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.2, 166.4, 165.9, 149.2, 146.4, 143.4, 142.6, 139.6, 132.9, 129.4, 128.4, 128.14, 128.06, 125.5, 123.5, 123.1, 122.1, 118.2, 111.0, 60.08, 52.2, 43.1 (note: one sp<sup>3</sup> carbon is under the DMSO peak); mp 135–140 °C. HMS (APCI) calcd for C<sub>27</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub> 483.1676; found 483.1674 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Methyl 4-(1-(2-(1<i>H</i>-Imidazol-4-yl)ethyl)-4-hydroxy-3-isonicotinoyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>165</b>)</h4><div class="NLM_p last">Compound <b>165</b> was prepared via procedure I from methyl 4-formylbenzoate (0.37 g, 2.3 mmol), 2-(1<i>H</i>-imidazol-4-yl)ethanamine (0.25 g, 2.3 mmol), and <b>20</b> (0.50 g, 2.3 mmol) to yield an orange solid (0.031 g, 3%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (s, 1H), 8.50 (d, <i>J</i> = 5.2 Hz, 2H), 7.88 (d, <i>J</i> = 8.0 Hz, 2H), 7.51 (d, <i>J</i> = 5.2 Hz, 2H), 7.40 (d, <i>J</i> = 8.0 Hz, 2H), 7.26 (s, 1H), 7.11 (s, 1H), 5.27 (s, 1H), 3.90–3.82 (m, 4H), 2.83–2.76 (m, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 182.5, 169.1, 166.1, 148.8, 148.0, 134.0, 131.2, 129.0, 128.5, 128.1, 127.8, 127.6, 122.4, 116.4, 111.6, 66.3, 52.0, 40.0, 22.3; mp 64–70 °C. HMS (APCI) calcd for C<sub>23</sub>H<sub>20</sub>N<sub>4</sub>O<sub>5</sub> 433.1512; found 433.1513 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Methyl 4-(3-Acetyl-4-hydroxy-1-(3-methylphenethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>166</b>)</h4><div class="NLM_p last">Compound <b>166</b> was prepared via procedure I from methyl 4-formylbenzoate (0.30 g, 1.8 mmol), ethyl acetopyruvate (0.29 g, 1.8 mmol), and 2-(<i>m</i>-tolyl)ethanamine (0.25 g, 1.8 mmol) to yield a white solid (0.56 g, 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 7.6 Hz, 2H), 7.28 (d, <i>J</i> = 7.6 Hz, 2H), 7.12 (t, <i>J</i> = 8.0 Hz, 1H), 6.99 (d, <i>J</i> = 7.6 Hz, 1H), 6.88–6.86 (m, 2H), 5.13 (s, 1H), 3.83 (s, 3H), 3.79–3.73 (m, 1H), 2.77–2.70 (m, 2H), 2.61–2.57 (m, 1H), 2.26 (s, 3H), 2.22 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 191.5, 166.0, 165.1, 142.4, 138.4, 137.5, 129.4, 129.2, 128.4, 128.1, 127.1, 126.9, 125.62, 125.56, 119.7, 66.4, 59.7, 52.2, 41.6, 33.4, 21.0; mp 118–123 °C. HMS (APCI) calcd for C<sub>23</sub>H<sub>23</sub>NO<sub>5</sub> 394.1649; found 394.1651 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Methyl 4-(3-Acetyl-1-(3-chlorophenethyl)-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>167</b>)</h4><div class="NLM_p last">Compound <b>167</b> was prepared via procedure I from methyl 4-formylbenzoate (0.26 g, 1.6 mmol), ethyl acetopyruvate (0.25 g, 1.6 mmol), and 2-(3-chlorophenyl)ethanamine (0.25 g, 1.6 mmol) to yield a pale-yellow solid (0.50 g, 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.32–7.20 (m, 5H), 7.08 (d, <i>J</i> = 7.2 Hz, 1H), 5.22 (s, 1H), 3.83–3.79 (m, 4H), 2.79–2.69 (m, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.9, 165.1, 142.3, 141.2, 133.0, 130.5, 130.2, 129.4, 128.5, 128.1, 127.6, 127.4, 126.4, 125.5, 59.5, 52.2, 41.1, 32.9, 29.7 (note: carbon 4 is absent); mp 118–122 °C. HMS (APCI) calcd for C<sub>22</sub>H<sub>20</sub>ClNO<sub>5</sub> 414.1108; found 414.1109 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Methyl 4-(3-Acetyl-1-(3-fluorophenethyl)-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>168</b>)</h4><div class="NLM_p last">Compound <b>168</b> was prepared via procedure I from methyl 4-formylbenzoate (0.30 g, 1.8 mmol), ethyl acetopyruvate (0.28 g, 1.8 mmol), and 2-(3-fluorophenyl)ethanamine (0.25 g, 1.8 mmol) to yield an off-white solid (0.57 g, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.31 (d, <i>J</i> = 8.0 Hz, 2H), 7.29–7.25 (m, 1H), 7.00–6.94 (m, 3H), 5.22 (s, 1H), 3.83–3.79 (m, 4H), 2.81–2.69 (m, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.9, 165.1, 162.2 (d, <i>J</i> = 241.8 Hz), 142.3, 141.6, 141.5, 130.3 (d, <i>J</i> = 8.1 Hz), 129.44, 129.40, 128.1, 125.6, 124.8, 115.3 (d, <i>J</i> = 20.9 Hz), 113.2 (d, <i>J</i> = 20.9 Hz), 59.5, 52.2, 41.1, 33.0, 15.2 (note: carbon 4 is absent); mp 114–119 °C. HMS (APCI) calcd for C<sub>22</sub>H<sub>20</sub>FNO<sub>5</sub> 398.1403; found 398.1404 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Methyl 4-(3-Acetyl-4-hydroxy-1-(3-methoxyphenethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>169</b>)</h4><div class="NLM_p last">Compound <b>169</b> was prepared via procedure I from methyl 4-formylbenzoate (0.27 g, 1.7 mmol), ethyl acetopyruvate (0.26 g, 1.7 mmol), and 2-(3-methoxyphenyl)ethanamine (0.25 g, 1.7 mmol) to yield an off-white solid (0.52 g, 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (d, <i>J</i> = 8.4 Hz, 2H), 7.30 (d, <i>J</i> = 8.0 Hz, 2H), 7.16 (t, <i>J</i> = 8.0 Hz, 1H), 6.75 (d, <i>J</i> = 7.6 Hz, 1H), 6.68–6.66 (m, 2H), 5.15 (s, 1H), 3.83–3.76 (m, 4H), 3.69 (s, 3H), 2.77–2.70 (m, 2H), 2.65–2.60 (m, 1H), 2.26 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.0, 165.0, 159.3, 145.8, 142.4, 140.1, 129.5, 129.42, 129.38, 128.1, 125.5, 120.8, 114.1, 111.9, 59.6, 54.9, 52.2, 41.4, 33.4, 29.7 (note: carbon 4 is absent); mp 150–153 °C. HMS (APCI) calcd for C<sub>23</sub>H<sub>23</sub>NO<sub>6</sub> 410.1603; found 410.1604 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Methyl 4-(3-Acetyl-4-hydroxy-1-(3-hydroxyphenethyl)-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>170</b>)</h4><div class="NLM_p last">Compound <b>170</b> was prepared via procedure I from methyl 4-formylbenzoate (0.55 g, 3.4 mmol), ethyl acetopyruvate (0.53 g, 3.4 mmol), and <b>190</b> (0.46 g, 3.4 mmol) to yield a cream-colored solid (1.0 g, 78%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.34 (br s, 1H), 7.93 (d, <i>J</i> = 8.8 Hz, 2H), 7.33 (d, <i>J</i> = 8.8 Hz, 2H), 7.08 (t, <i>J</i> = 7.6 Hz, 1H), 6.61 (dt, <i>J</i> = 1.6 Hz, <i>J</i> = 6.8 Hz, 1H), 6.54–6.52 (m, 2H), 5.16 (s, 1H), 3.87–3.83 (m, 4H), 2.74–2.69 (m, 2H), 2.56–2.52 (m, 1H), 2.30 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.0, 166.0, 165.0, 157.5, 142.4, 139.9, 129.9, 129.7, 129.5, 129.2, 128.1, 127.0, 119.2, 115.4, 113.5, 59.7, 52.2, 48.7, 41.6, 33.6; mp 98–104 °C. HMS (APCI) calcd for C<sub>22</sub>H<sub>21</sub>NO<sub>6</sub> 396.1447; found 396.1446 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Methyl 4-(4-Hydroxy-3-isonicotinoyl-5-oxo-1-(2-(pyridin-4-yl)ethyl)-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>171</b>)</h4><div class="NLM_p last">Compound <b>171</b> was prepared via procedure I from methyl 4-formylbenzoate (0.19 g, 1.1 mmol), 2-(pyridin-4-yl)ethanamine (0.14 g, 1.1 mmol), and <b>20</b> (0.25 g, 1.1 mmol) to yield a yellow solid (0.47 g, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (d, <i>J</i> = 6.0 Hz, 2H), 8.49–8.48 (m, 2H), 7.92 (d, <i>J</i> = 8.0 Hz, 2H), 7.56–7.53 (m, 2H), 7.50 (d, <i>J</i> = 8.0 Hz, 2H), 7.29–7.26 (m, 2H), 5.47 (s, 1H), 3.91–3.83 (m, 4H), 2.88–2.78 (m, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 190.1, 185.8, 182.0, 166.3, 166.0, 149.5, 149.2, 148.3, 146.6, 143.4, 129.4, 128.2, 124.6, 122.2, 115.6, 59.9, 52.2, 40.6, 32.7; mp 126–129 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub> 444.1567; found 444.1566 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Methyl 4-(4-Hydroxy-3-isonicotinoyl-5-oxo-1-(2-(pyridin-3-yl)ethyl)-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>172</b>)</h4><div class="NLM_p last">Compound <b>172</b> was prepared via procedure I from methyl 4-formylbenzoate (0.19 g, 1.1 mmol), 2-(pyridin-3-yl)ethanamine (0.14 g, 1.1 mmol), and <b>20</b> (0.25 g, 1.1 mmol) to yield a yellow solid (0.47 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (d, <i>J</i> = 6.0 Hz, 2H), 8.44 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 4.8 Hz, 1H), 8.41 (d, <i>J</i> = 1.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.4 Hz, 2H), 7.66 (d, <i>J</i> = 7.6 Hz, 1H), 7.55 (d, <i>J</i> = 6.0 Hz, 2H), 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 7.35 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 7.6 Hz, 1H), 5.51 (s, 1H), 3.91–3.83 (m, 4H), 2.91–2.77 (m, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 206.6, 186.6, 165.9, 165.6, 149.3, 148.9, 146.9, 146.1, 142.7, 137.3, 134.7, 129.5, 128.2, 128.1, 123.8, 122.0, 116.6, 59.9, 52.2, 41.3, 30.5; mp 160–163 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub> 444.1567; found 444.1565 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Methyl 4-(4-Hydroxy-3-isonicotinoyl-5-oxo-1-(2-(pyridin-2-yl)ethyl)-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (<b>173</b>)</h4><div class="NLM_p last">Compound <b>173</b> was prepared via procedure I from methyl 4-formylbenzoate (0.19 g, 1.1 mmol), 2-(pyridin-2-yl)ethanamine (0.14 g, 1.1 mmol), and <b>20</b> (0.25 g, 1.1 mmol) to yield a yellow solid (0.50 g, >99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (d, <i>J</i> = 6.0 Hz, 2H), 8.48 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 5.2 Hz, 1H), 7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.73 (td, <i>J</i> = 2.0 Hz, <i>J</i> = 7.6 Hz, 1H), 7.53 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 4.4 Hz, 2H), 7.46 (d, <i>J</i> = 8.0 Hz, 2H), 7.27 (s, 1H), 7.25 (t, <i>J</i> = 3.6 Hz, 1H), 5.44 (s, 1H), 4.00–3.93 (m, 1H), 3.82 (s, 3H), 3.07–2.97 (m, 2H), 2.92–2.84 (m, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 206.6, 186.7, 165.9, 165.5, 158.1, 156.6, 149.4, 148.7, 146.1, 142.6, 137.3, 129.5, 128.2, 125.6, 123.6, 122.0, 116.9, 60.1, 52.2, 40.3, 35.4; mp 187–190 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub> 444.1567; found 444.1564 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 1-(2-(1<i>H</i>-Indol-3-yl(ethyl)-3-hydroxy-4-nicotinoyl-5-(pyridine-4-yl)-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>173</b>)</h4><div class="NLM_p last">Compound <b>174</b> was prepared via procedure I from isonicotinaldehyde (0.11 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield a mustard-colored solid (0.32 g, 76%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.93 (s, 1H), 8.84 (d, <i>J</i> = 1.8 Hz, 1H), 8.67 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.53 (d, <i>J</i> = 5.4 Hz, 2H), 8.05 (dt, <i>J</i> = 2.4 Hz, <i>J</i> = 8.4 Hz, 1H), 7.49–7.47 (m, 2H), 7.42–7.34 (m, 3H), 7.30 (br s, 1H), 7.13 (d, <i>J</i> = 1.8 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 6.94 (t, <i>J</i> = 8.4 Hz, 1H), 5.34 (s, 1H), 3.92–3.87 (m, 1H), 3.02–2.91 (m, 2H), 2.82–2.77 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 185.5, 166.1, 151.3, 148.9, 148.4, 136.7, 136.3, 134.5, 126.9, 125.5, 123.6, 123.4, 123.0, 121.1, 118.3, 118.1, 116.1, 111.6, 110.8, 59.7, 41.2, 23.7 (note: either carbon 1 or 2 is absent); mp 225–230 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> 425.1608; found 425.1610 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-hydroxy-4-nicotinoyl-5-(pyridine-3-yl)-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>175</b>)</h4><div class="NLM_p last">Compound <b>175</b> was prepared via procedure I from nicotinaldehyde (0.11 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield an orange solid (0.29 g, 67%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.90 (s, 1H), 8.83 (d, <i>J</i> = 2.4 Hz, 1H), 8.68 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.57 (d, <i>J</i> = 1.8 Hz, 1H), 8.49 (dd, <i>J</i> = 2.4 Hz, <i>J</i> = 4.8 Hz, 1H), 8.04 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.74 (d, <i>J</i> = 8.4 Hz, 1H), 7.49–7.47 (m, 1H), 7.36–7.32 (m, 3H), 7.24 (s, 1H), 7.13 (d, <i>J</i> = 1.8 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 6.94 (t, <i>J</i> = 8.4 Hz, 1H), 5.39 (s, 1H), 3.89–3.85 (m, 1H), 3.02–2.93 (m, 2H), 2.79–2.75 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.3, 151.9, 149.3, 149.1, 148.9, 136.4, 136.3, 135.7, 134.1, 128.1, 126.9, 125.5, 124.0, 123.4, 122.9, 121.1, 118.3, 118.1, 111.5, 110.7, 58.4, 41.0, 23.7 (note: carbons 1 and 2 are absent); mp 225–227 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> 425.1608; found 425.1610 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-hydroxy-4-nicotinoyl-5-(pyridine-2-yl)-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>176</b>)</h4><div class="NLM_p last">Compound <b>176</b> was prepared via procedure I from picolinaldehyde (0.11 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield a yellow solid (0.30 g, 71%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.91 (s, 1H), 8.80 (d, <i>J</i> = 1.2 Hz, 1H), 8.69 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 4.8 Hz, 8.55 (d, <i>J</i> = 4.2 Hz, 1H), 8.00 (d, <i>J</i> = 7.2 Hz, 1H), 7.77 (td, <i>J</i> = 1.2 Hz, <i>J</i> = 7.2 Hz, 1H), 7.50–7.46 (m, 2H), 7.38–7.30 (m, 4H), 7.12 (d, <i>J</i> = 1.8 Hz, 1H), 7.05 (t, <i>J</i> = 7.8 Hz, 1H), 6.95 (t, <i>J</i> = 7.8 Hz, 1H), 5.54 (s, 1H), 3.87–3.82 (m, 1H), 3.01–2.91 (m, 2H), 2.72–2.67 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 189.2, 165.4, 156.1, 151.9, 149.4, 149.0, 137.2, 136.3, 134.2, 128.2, 126.9, 125.5, 123.8, 123.4, 122.8, 121.0, 118.3, 118.1, 111.5, 110.8, 62.1, 41.4, 23.6 (note: either carbon 1 or 2 and carbon 3 are absent); mp 218–223 °C. HMS (APCI) calcd for C<sub>25</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> 425.1613; found 425.1613 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-5-(furan-3-yl)-3-hydroxy-4-nicotinoyl-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>177</b>)</h4><div class="NLM_p last">Compound <b>177</b> was prepared via procedure I from furan-3-carbaldehyde (0.10 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield an orange solid (0.12 g, 28%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.86 (s, 1H), 8.85 (d, <i>J</i> = 1.8 Hz, 1H), 8.71 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 4.8 Hz, 1H), 8.05 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.74 (s, 1H), 7.50–7.48 (m, 1H), 7.45 (d, <i>J</i> = 7.8 Hz, 1H), 7.34 (d, <i>J</i> = 7.8 Hz, 1H), 7.18 (s, 1H), 7.15 (d, <i>J</i> = 1.8 Hz, 1H), 7.10 (s, 1H), 7.07 (t, <i>J</i> = 7.2 Hz, 1H), 6.98 (t, <i>J</i> = 7.8 Hz, 1H), 6.48 (d, <i>J</i> = 1.2 Hz, 1H), 5.40 (s, 1H), 3.89–3.84 (m, 1H), 3.12–3.00 (m, 2H), 2.84–2.80 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.4, 152.4, 149.5, 144.1, 142.7, 136.3, 133.8, 127.0, 125.5, 123.4, 122.9, 121.1, 120.8, 118.3, 118.2, 117.5, 111.5, 110.9, 108.6, 52.4, 40.7, 23.7 (note: carbon 1 and 2 are absent); mp 211–217 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub> 414.1448; found 414.1449 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-5-(furan-2-yl)-3-hydroxy-4-nicotinoyl-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>178</b>)</h4><div class="NLM_p last">Compound <b>178</b> was prepared via procedure I from furfural (0.10 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield a mustard-colored solid (0.06 g, 14%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.87 (s, 1H), 8.82 (d, <i>J</i> = 1.2 Hz, 1H), 8.72 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.03 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 5.4 Hz, 1H), 7.62 (t, <i>J</i> = 0.6 Hz, 1H), 7.53–7.52 (m, 1H), 7.48 (d, <i>J</i> = 7.8 Hz, 1H), 7.34 (d, <i>J</i> = 7.8 Hz, 1H), 7.18 (s, 1H), 7.15 (d, <i>J</i> = 2.4 Hz, 1H), 7.10–7.06 (m, 2H), 6.99 (t, <i>J</i> = 6.6 Hz, 1H), 6.52 (d, <i>J</i> = 3.0 Hz, 1H), 6.433–6.425 (m, 1H), 3.82–3.77 (m, 1H), 3.19–3.14 (m, 1H), 3.00–2.95 (m, 1H), 2.66–2.61 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.9, 164.5, 152.3, 149.1, 148.9, 143.4, 143.2, 136.3, 134.0, 127.0, 123.5, 122.9, 122.8, 121.0, 118.4, 118.3, 118.1, 115.0, 111.5, 110.8, 110.2, 54.5, 41.4, 23.7; mp 211–216 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub> 414.1448; found 414.1452 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-hydroxy-4-nicotinoyl-5-(thiophen-2-yl)-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>179</b>)</h4><div class="NLM_p last">Compound <b>179</b> was prepared via procedure I from thiophene-2-carbaldehyde (0.11 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield an orange solid (0.07 g, 16%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.87 (s, 1H), 8.81 (s, 1H), 8.72 (d, <i>J</i> = 4.8 Hz, 1H), 8.02 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 6.0 Hz, 1H), 7.53-<i>7.</i>51 (m, 1H), 7.48–7.44 (m, 2H), 7.34 (d, <i>J</i> = 7.8, 1H), 7.20 (d, <i>J</i> = 3.0 Hz, 1H), 7.15 (d, <i>J</i> = 1.8 Hz, 1H), 7.07 (t, <i>J</i> = 7.8 Hz, 2H), 7.00–6.96 (m, 2H), 5.76 (s, 1H), 3.87–3.83 (m, 1H), 3.14–3.09 (m, 1H), 3.05–3.00 (m, 1H), 2.77–2.72 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.2, 152.4, 149.2, 140.2, 136.3, 133.8, 130.3, 128.7, 127.02, 126.96, 126.5, 123.6, 122.9, 121.1, 118.3, 118.2, 111.5, 110.8, 56.1, 40.9, 23.6 (note: carbons 1, 2, and 3 are absent); mp 150–155 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>S 430.1226; found 430.1223 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> 1-(2-(1<i>H</i>-Indol-3-yl)ethyl)-3-hydroxy-4-nicotinoyl-5-(thiophen-3-yl)-1<i>H</i>-pyrrol-2(5<i>H</i>)-one (<b>180</b>)</h4><div class="NLM_p last">Compound <b>180</b> was prepared via procedure I from thiophene-3-carbaldehyde (0.11 g, 1.0 mmol), <b>19</b> (0.22 g, 1.0 mmol), and tryptamine (0.16 g, 1.0 mmol) to yield a yellow solid (0.11 g, 25%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.87 (s, 1H), 8.86 (s, 1H), 8.71 (d, <i>J</i> = 4.8 Hz, 1H), 8.06 (d, <i>J</i> = 7.8 Hz, 1H), 7.70 (d, <i>J</i> = 1.8 Hz, 1H), 7.50–7.47 (m, 2H), 7.40 (d, <i>J</i> = 7.8 Hz, 1H), 7.34 (d, <i>J</i> = 7.8 Hz, 1H), 7.25 (s, 1H), 7.14 (s, 1H), 7.08–7.06 (m, 2H), 6.96 (t, <i>J</i> = 7.8 Hz, 1H), 5.55 (s, 1H), 3.86–3.80 (m, 1H), 3.06–2.98 (m, 2H), 2.76–2.70 (m, 1H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 187.4, 181.2, 164.5, 152.5, 137.2, 136.3, 133.8, 127.05, 126.98, 126.2, 126.0, 125.4, 123.5, 122.9, 122.8, 121.1, 118.4, 118.2, 118.0, 111.5, 110.9, 55.0, 41.2, 23.9; mp 238–242 °C. HMS (APCI) calcd for C<sub>24</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>S 430.1198; found 430.1201 [M + H]<sup>+</sup>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i121"><a href="/doi/suppl/10.1021/jm401695d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental information and the generic formula for experimental test compounds described in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401695d/suppl_file/jm401695d_si_001.pdf">jm401695d_si_001.pdf (299.26 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401695d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen F. Traynelis</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e5969197849c8b80a580888a979ccb808190"><span class="__cf_email__" data-cfemail="d4a7a0a6b5adbab194b1b9bba6adfab1b0a1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis C. Liotta</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8febe3e6e0fbfbeecfeae2e0fdf6a1eaebfa"><span class="__cf_email__" data-cfemail="adc9c1c4c2d9d9ccedc8c0c2dfd483c8c9d8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sommer S. Zimmerman</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alpa Khatri</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ethel C. Garnier-Amblard</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Praseeda Mullasseril</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalie L. Kurtkaya</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefka Gyoneva</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kasper B. Hansen</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, Emory University School of Medicine, Rollins Research Center, 1510 Clifton Road, Atlanta, Georgia 30322, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written by all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Some authors are coinventors on Emory owned IP (S.S.Z., E.G.A., S.F.T., D.C.L.), have an equity position (S.F.T, D.C.L.), are Board members (D.C.L.), or paid consultants (S.F.T., K.B.H) for companies developing NMDA receptor modulators.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1579e8301-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i123">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41174" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41174" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Kimberly Vellano, Phuong Le, and Jing Zhang for excellent technical assistance. This work was supported by the NIH (NS065371, S.F.T.; MH094525, S.F.T.; ES012870, NS078873, A.K.) and a research grant from Lundbeck (S.F.T.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i124" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i124"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i125" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i125"> Abbreviations Used</h2><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl <span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">ATD</td><td class="NLM_def"><p class="first last">amino-terminal domain</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand-binding domain</p></td></tr><tr><td class="NLM_term">TMD</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr><tr><td class="NLM_term">CTD</td><td class="NLM_def"><p class="first last">carboxyl-terminal domain</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i126">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 17 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Furukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2873</span><span class="NLM_x">–</span> <span class="NLM_lpage">2885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1093%2Femboj%2Fcdg303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=12805203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Wqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=2873-2885&author=H.+Furukawaauthor=E.+Gouaux&title=Mechanisms+of+activation%2C+inhibition+and+specificity%3A+crystal+structures+of+the+NMDA+receptor+NR1+ligand-binding+core"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core</span></div><div class="casAuthors">Furukawa, Hiroyasu; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2873-2885</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Excitatory neurotransmission mediated by the N-methyl-d-aspartate subtype of ionotropic glutamate receptors is fundamental to the development and function of the mammalian central nervous system.  NMDA receptors require both glycine and glutamate for activation with NR1 and NR2 forming glycine and glutamate sites, resp.  Mechanisms to describe agonist and antagonist binding, and activation and desensitization of NMDA receptors have been hampered by the lack of high-resoln. structures.  Here, we describe the cocrystal structures of the NR1 S1S2 ligand-binding core with the agonists glycine and d-serine (DS), the partial agonist d-cycloserine (DCS) and the antagonist 5,7-dichlorokynurenic acid (DCKA).  The cleft of the S1S2 clamshell' is open in the presence of the antagonist DCKA and closed in the glycine, DS and DCS complexes.  In addn., the NR1 S1S2 structure reveals the fold and interactions of loop 1, a cysteine-rich region implicated in intersubunit allostery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPvduFLuWuIbVg90H21EOLACvtfcHk0ljYsxd9n4YC9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Wqsrk%253D&md5=77b3dcc427e5641d0d68b8d97db2f99b</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg303%26sid%3Dliteratum%253Aachs%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DMechanisms%2520of%2520activation%252C%2520inhibition%2520and%2520specificity%253A%2520crystal%2520structures%2520of%2520the%2520NMDA%2520receptor%2520NR1%2520ligand-binding%2520core%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D2873%26epage%3D2885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Furukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancusso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Subunit arrangement and function in NMDA receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x"> (</span><span class="NLM_issue">7065</span><span class="NLM_x">) </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=185-192&issue=7065&author=H.+Furukawaauthor=S.+K.+Singhauthor=R.+Mancussoauthor=E.+Gouaux&title=Subunit+arrangement+and+function+in+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DMancusso%26aufirst%3DR.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DSubunit%2520arrangement%2520and%2520function%2520in%2520NMDA%2520receptors%26jtitle%3DNature%26date%3D2005%26volume%3D438%26issue%3D7065%26spage%3D185%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Traynelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate Receptor Ion Channels: Structure, Regulation and Function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+Traynelisauthor=L.+Wollmuthauthor=C.+McBainauthor=F.+Mennitiauthor=K.+Vanceauthor=K.+Ogdenauthor=K.+Hansenauthor=H.+Yuanauthor=S.+Myersauthor=R.+Dingledine&title=Glutamate+Receptor+Ion+Channels%3A+Structure%2C+Regulation+and+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%26aulast%3DWollmuth%26aufirst%3DL.%26aulast%3DMcBain%26aufirst%3DC.%26aulast%3DMenniti%26aufirst%3DF.%26aulast%3DVance%26aufirst%3DK.%26aulast%3DOgden%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520Receptor%2520Ion%2520Channels%253A%2520Structure%252C%2520Regulation%2520and%2520Function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Akazawa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Differential expression of five <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1002%2Fcne.903470112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=7798379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1994&pages=150-160&author=C.+Akazawaauthor=R.+Shigemotoauthor=Y.+Besshoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Differential+expression+of+five+N-methyl-d-aspartate+receptor+subunit+mRNAs+in+the+cerebellum+of+developing+and+adult+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span></div><div class="casAuthors">Akazawa, Chihiro; Shigemoto, Ryuichi; Bessho, Yasumasa; Nakanishi, Shigetada; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-60</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    </div><div class="casAbstract">Five N-methyl-D-aspartate (NMDA) receptor subunits have been identified thus far: NR1, NR2A, NR2B, NR2C, and NR2D.  Here, the authors have analyzed the expression patterns of mRNAs for the NMDA receptor subunits in the developing and adult rats by in situ hybridization.  The developmental changes of the expression patterns were most salient in the cerebellum.  In the external granular layer, hybridization signals of mRNAs for NR1, NR2A, NR2B, and NR2C appeared by postnatal day 3, but no NR2D mRNA was expressed at any developmental stage examd.  The NR1 mRNA was expressed in all cerebellar neurons at all developmental stages examd.  The signals for the NR2A mRNA appeared in Purkinje cells and granule cells during the second postnatal week.  The signals for the NR2B mRNA in granule cells were seen transiently during the first 2 wk after birth.  The signals for NR2C mRNA appeared in granule cells and glial cells during the second postnatal week.  The signals for NR2D mRNA appeared transiently in Purkinje cells during the first 8 postnatal days; in adult rats, these were seen in stellate and Golgi cells.  In the cerebellar nuclei, mRNAs for NR1, NR2A, NR2B, and NR2D were more or less expressed on postnatal day 0, while expression signals for the NR2C mRNA were first detected in postnatal day 14.  Thus, the most conspicuous changes of expression patterns were obsd. in the cerebellar cortex during the first 2 wk after birth, when development and maturation of the cerebellum proceed most rapidly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3uXAbBlyr7Vg90H21EOLACvtfcHk0ljYsxd9n4YC9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D&md5=56ff09fd6667cd9c90a2bc8225261e5a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1002%2Fcne.903470112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.903470112%26sid%3Dliteratum%253Aachs%26aulast%3DAkazawa%26aufirst%3DC.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DBessho%26aufirst%3DY.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDifferential%2520expression%2520of%2520five%2520N-methyl-d-aspartate%2520receptor%2520subunit%2520mRNAs%2520in%2520the%2520cerebellum%2520of%2520developing%2520and%2520adult%2520rats%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1994%26volume%3D347%26spage%3D150%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnashev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeburg, P. H.</span><span> </span><span class="NLM_article-title">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1016%2F0896-6273%2894%2990210-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=7512349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=529-540&author=H.+Monyerauthor=N.+Burnashevauthor=D.+J.+Laurieauthor=B.+Sakmannauthor=P.+H.+Seeburg&title=Developmental+and+regional+expression+in+the+rat+brain+and+functional+properties+of+four+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span></div><div class="casAuthors">Monyer, Hannah; Burnashev, Nail; Laurie, David J.; Sakmann, Bert; Seeburg, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">ISS/REP#/MLT:  3</span>),
    <span class="NLM_cas:pages">529-40</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    </div><div class="casAbstract">An in situ study of mRNAs encoding NMDA receptor subunits in the developing rat CNS revealed that, at all stages, the NR1 gene is expressed in virtually all neurons, whereas the four NR2 transcripts display distinct expression patterns.  NR2B and NR2D mRNA occur prenatally, whereas NR2A and NR2C mRNAs are first detected near birth.  All transcripts except NR2D peak around P20.  NR2D mRNA, present mainly in midbrain structures, peaks around P7 and thereafter decreases to adult levels.  Postnatally, NR2B and NR2C transcript levels change in opposite directions in the cerebellar internal granule cell layer.  In the adult hippocampus, NR2A and NR2B mRNAs are prominent in CA1 and CA3 pyramidal cells, but NR2C and NR2D mRNAs occur in different subsets of interneurons.  Recombinant binary NR1-NR2 channels show comparable Ca2+ permeabilities, but marked differences in voltage-dependent Mg2+ block and in offset decay time consts.  Thus, the distinct expression profiles and functional properties of NR2 subunits provide a basis for NMDA channel heterogeneity in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfdrOkgeEJfbVg90H21EOLACvtfcHk0lhJUv7nepLBxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D&md5=9ff9985abba893a28ae4983c5099e913</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2894%2990210-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252894%252990210-0%26sid%3Dliteratum%253Aachs%26aulast%3DMonyer%26aufirst%3DH.%26aulast%3DBurnashev%26aufirst%3DN.%26aulast%3DLaurie%26aufirst%3DD.%2BJ.%26aulast%3DSakmann%26aufirst%3DB.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26atitle%3DDevelopmental%2520and%2520regional%2520expression%2520in%2520the%2520rat%2520brain%2520and%2520functional%2520properties%2520of%2520four%2520NMDA%2520receptors%26jtitle%3DNeuron%26date%3D1994%26volume%3D12%26spage%3D529%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vicini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, D. R.</span><span> </span><span class="NLM_article-title">Functional and pharmacological differences between recombinant <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors</span> <span class="citation_source-journal">J Neurophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1998&pages=555-566&author=S.+Viciniauthor=J.+F.+Wangauthor=J.+H.+Liauthor=W.+J.+Zhuauthor=Y.+H.+Wangauthor=J.+H.+Luoauthor=B.+B.+Wolfeauthor=D.+R.+Grayson&title=Functional+and+pharmacological+differences+between+recombinant+N-methyl-d-aspartate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVicini%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DLuo%26aufirst%3DJ.%2BH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DGrayson%26aufirst%3DD.%2BR.%26atitle%3DFunctional%2520and%2520pharmacological%2520differences%2520between%2520recombinant%2520N-methyl-d-aspartate%2520receptors%26jtitle%3DJ%2520Neurophysiol.%26date%3D1998%26volume%3D72%26spage%3D555%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Control of NMDA receptor function by the NR2 subunit amino-terminal domain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12045</span><span class="NLM_x">–</span> <span class="NLM_lpage">12058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1523%2FJNEUROSCI.1365-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=19793963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12qu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12045-12058&author=H.+Yuanauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=S.+F.+Traynelis&title=Control+of+NMDA+receptor+function+by+the+NR2+subunit+amino-terminal+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Control of NMDA receptor function by the NR2 subunit amino-terminal domain</span></div><div class="casAuthors">Yuan, Hongjie; Hansen, Kasper B.; Vance, Katie M.; Ogden, Kevin K.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">12045-12058</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors comprised of different NR2 subunits exhibit strikingly unique biophys. and pharmacol. properties.  Here, we report that the extracellular amino-terminal domain (ATD) of the NR2 subunit controls pharmacol. and kinetic properties of recombinant NMDA receptors, such as agonist potency, deactivation time course, open probability (POPEN), and mean open/shut duration.  Using ATD deletion mutants of NR2A, NR2B, NR2C, NR2D, and chimeras of NR2A and NR2D with interchanged ATD [NR2A-(2D-ATD) and NR2D-(2A-ATD)], we show that the ATD contributes to the low glutamate potency of NR2A-contg. NMDA receptors and the high glutamate potency of NR2D-contg. receptors.  The ATD influences the deactivation time courses of NMDA receptors, as removal of the ATD from NR2A slows the deactivation rate, while removal of the ATD from NR2B, NR2C and NR2D accelerates the deactivation rate.  Open probability also is influenced by the ATD.  Removal of the ATD from NR2A or replacement of the NR2A-ATD with that of NR2D decreases POPEN in single-channel recordings from outside-out patches of HEK 293 cells.  In contrast, deletion of the ATD from NR2D or replacement of the NR2D ATD with that of NR2A increases POPEN and mean open duration.  These data demonstrate the modular nature of NMDA receptors, and show that the ATD of the different NR2 subunits plays an important role in fine-tuning the functional properties of the individual NMDA receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqAYFuCYDzeLVg90H21EOLACvtfcHk0lhJUv7nepLBxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12qu7%252FE&md5=2fa9cf03945b968b214633b58ec1ef78</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1365-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1365-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DControl%2520of%2520NMDA%2520receptor%2520function%2520by%2520the%2520NR2%2520subunit%2520amino-terminal%2520domain%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12045%26epage%3D12058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Paoletti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyton, J.</span><span> </span><span class="NLM_article-title">NMDA receptor subunits: function and pharmacology</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1016%2Fj.coph.2006.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=17088105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=39-47&author=P.+Paolettiauthor=J.+Neyton&title=NMDA+receptor+subunits%3A+function+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunits: function and pharmacology</span></div><div class="casAuthors">Paoletti, Pierre; Neyton, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels widely expressed in the central nervous system that play key roles in excitatory synaptic transmission.  Because of their involvement in numerous neurol. disorders, NMDARs are also targets of therapeutic interest.  NMDARs occur as multiple subtypes which differ in their subunit compn. and in their biophys. and pharmacol. properties.  In particular, NMDARs contain a diversity of sites at which endogenous ligands or pharmacol. agents can act to modulate receptor activity in a subunit-selective manner, and recent structural and functional data have started to reveal the mol. determinants for this subunit selectivity.  These include the binding sites for glutamate, the ion-channel pore and the recently identified allosteric sites on the N-terminal domain.  Other potential sites yet unexplored by medicinal chem. programs are also considered, in particular at the interface between subunits.  Given the growing body of evidence that diverse brain disorders implicate different NMDAR subtypes, such as NR2B in pain or NR3A in white matter injury, there is a growing interest in exploiting the pharmacol. heterogeneity of NMDARs for the development of novel NMDAR subtype-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ5E8KNWeeb7Vg90H21EOLACvtfcHk0lhJUv7nepLBxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D&md5=18296410fb9b50af0b2a7ceae124faf4</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DNeyton%26aufirst%3DJ.%26atitle%3DNMDA%2520receptor%2520subunits%253A%2520function%2520and%2520pharmacology%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2007%26volume%3D7%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Molecular diversity of glutamate receptors and implications for brain function</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=597-603&author=S.+Nakanishi&title=Molecular+diversity+of+glutamate+receptors+and+implications+for+brain+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DMolecular%2520diversity%2520of%2520glutamate%2520receptors%2520and%2520implications%2520for%2520brain%2520function%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D597%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nicoll, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenka, R. C.</span><span> </span><span class="NLM_article-title">Expression mechanisms underlying NMDA receptor-dependent long-term potentiation</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">868</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=868&publication_year=1999&pages=515-525&author=R.+A.+Nicollauthor=R.+C.+Malenka&title=Expression+mechanisms+underlying+NMDA+receptor-dependent+long-term+potentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicoll%26aufirst%3DR.%2BA.%26aulast%3DMalenka%26aufirst%3DR.%2BC.%26atitle%3DExpression%2520mechanisms%2520underlying%2520NMDA%2520receptor-dependent%2520long-term%2520potentiation%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D868%26spage%3D515%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Choi, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, S. M.</span><span> </span><span class="NLM_article-title">The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal Death</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1146%2Fannurev.ne.13.030190.001131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=1970230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaK3cXkslGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=171-182&author=D.+W.+Choiauthor=S.+M.+Rothman&title=The+Role+of+Glutamate+Neurotoxicity+in+Hypoxic-Ischemic+Neuronal+Death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death</span></div><div class="casAuthors">Choi, Dennis W.; Rothman, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">171-82</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    </div><div class="casAbstract">A review with 87 refs. of in vitro and in vivo studies which suggest that glutamate neurotoxicity plays an important role in the pathogenesis of hypoxic-ischemic brain injury.  Rational stroke therapy based on this neurotoxicity is considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdbdpT_WB6LVg90H21EOLACvtfcHk0lgOUqlQ9HkhbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslGksr4%253D&md5=07241a3ba705bd24077ccbd7a806625d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ne.13.030190.001131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ne.13.030190.001131%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BW.%26aulast%3DRothman%26aufirst%3DS.%2BM.%26atitle%3DThe%2520Role%2520of%2520Glutamate%2520Neurotoxicity%2520in%2520Hypoxic-Ischemic%2520Neuronal%2520Death%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1990%26volume%3D13%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hu, N.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrejcak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, M. J.</span><span> </span><span class="NLM_article-title">Glutamate receptors in preclinical research on Alzheimer’s disease: update on recent advances</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2012&pages=855-862&author=N.-W.+Huauthor=T.+Ondrejcakauthor=M.+J.+Rowan&title=Glutamate+receptors+in+preclinical+research+on+Alzheimer%E2%80%99s+disease%3A+update+on+recent+advances"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DN.-W.%26aulast%3DOndrejcak%26aufirst%3DT.%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26atitle%3DGlutamate%2520receptors%2520in%2520preclinical%2520research%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520update%2520on%2520recent%2520advances%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2012%26volume%3D100%26spage%3D855%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benneyworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopaske, G.</span><span> </span><span class="NLM_article-title">Glutamatergic synaptic disregulation in schizophrenia: therapeutic implications</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1007%2F978-3-642-25758-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=23027419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2012&pages=267-295&author=J.+T.+Coyleauthor=A.+Basuauthor=M.+Benneyworthauthor=D.+Baluauthor=G.+Konopaske&title=Glutamatergic+synaptic+disregulation+in+schizophrenia%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications</span></div><div class="casAuthors">Coyle, Joseph T.; Basu, Alo; Benneyworth, Michael; Balu, Darrick; Konopaske, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">267-295</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Schizophrenia affects approx. 1% of the population and continues to be assocd. with poor outcome because of the limited efficacy of and noncompliance with existing antipsychotic medications.  An alternative hypothesis invoking the excitatory neurotransmitter, glutamate, arose out of clin. observations that NMDA receptor antagonists, the dissociative anesthetics like ketamine, can replicate in normal individuals the full range of symptoms of schizophrenia including psychosis, neg. symptoms, and cognitive impairments.  Low dose ketamine can also re-create a no. of physiol. abnormalities characteristic of schizophrenia.  Postmortem studies have revealed abnormalities in endogenous modulators of NMDA receptors in schizophrenia as well as components of a postsynaptic d. where NMDA receptors are localized.  Gene assocn. studies have revealed several genes that affect NMDA receptor function whose allelic variants are assocd. with increased risk for schizophrenia including genes encoding D-amino acid oxidase, its modulator G72, dysbindin, and neuregulin.  The parvalbumin-pos., fast-firing GABAergic interneurons that provide recurrent inhibition to cortical-limbic pyramidal neurons seem to be most sensitive to NMDA receptor hypofunction.  As a consequence, disinhibition of glutamatergic efferents disrupts cortical processing, causing cognitive impairments and neg. symptoms, and drives subcortical dopamine release, resulting in psychosis.  Drugs designed to correct the cortical-limbic dysregulated glutamatergic neurotransmission show promise for reducing neg. and cognitive symptoms of schizophrenia as well as its pos. symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUOYchIYYK7Vg90H21EOLACvtfcHk0lgOUqlQ9HkhbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D&md5=1cda996ff05ed79c6ff89bc9cac0d050</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBenneyworth%26aufirst%3DM.%26aulast%3DBalu%26aufirst%3DD.%26aulast%3DKonopaske%26aufirst%3DG.%26atitle%3DGlutamatergic%2520synaptic%2520disregulation%2520in%2520schizophrenia%253A%2520therapeutic%2520implications%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D213%26spage%3D267%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mathew, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapidus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermeyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrough, J. W.</span><span> </span><span class="NLM_article-title">Ketamine for Treatment-Resistant Unipolar Depression</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=189-204&author=S.+J.+Mathewauthor=A.+Shahauthor=K.+Lapidusauthor=C.+Clarkauthor=N.+Jarunauthor=B.+Ostermeyerauthor=J.+W.+Murrough&title=Ketamine+for+Treatment-Resistant+Unipolar+Depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DLapidus%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DJarun%26aufirst%3DN.%26aulast%3DOstermeyer%26aufirst%3DB.%26aulast%3DMurrough%26aufirst%3DJ.%2BW.%26atitle%3DKetamine%2520for%2520Treatment-Resistant%2520Unipolar%2520Depression%26jtitle%3DCNS%2520Drugs%26date%3D2012%26volume%3D26%26spage%3D189%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hallett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoelgen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunah, A. W.</span><span> </span><span class="NLM_article-title">Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">4690</span><span class="NLM_x">–</span> <span class="NLM_lpage">4700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1523%2FJNEUROSCI.0792-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=16641250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFWqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=4690-4700&author=P.+J.+Hallettauthor=R.+Spoelgenauthor=B.+T.+Hymanauthor=D.+G.+Standaertauthor=A.+W.+Dunah&title=Dopamine+D1+Activation+Potentiates+Striatal+NMDA+Receptors+by+Tyrosine+Phosphorylation-Dependent+Subunit+Trafficking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking</span></div><div class="casAuthors">Hallett, Penelope J.; Spoelgen, Robert; Hyman, Bradley T.; Standaert, David G.; Dunah, Anthone W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4690-4700</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Interactions between dopaminergic and glutamatergic afferents in the striatum are essential for motor learning and the regulation of movement.  An important mechanism for these interactions is the ability of dopamine, through D1 receptors, to potentiate NMDA glutamate receptor function.  Here we show that, in striatal neurons, D1 receptor activation leads to rapid trafficking of NMDA receptor subunits, with increased NR1 and NR2B subunits in dendrites, enhanced coclustering of these subunits with the postsynaptic d. scaffolding mol. postsynaptic d.-95, and increased surface expression.  The dopamine D1 receptor-mediated NMDA receptor trafficking is blocked by an inhibitor of tyrosine kinases.  Blockers of tyrosine phosphatases also induce NMDA subunit trafficking, but this effect is nonselective and alters both NR2A- and NR2B-contg. receptors.  Furthermore, tyrosine phosphatase inhibition leads to the clustering of tyrosine-phosphorylated NR2B subunit along dendritic shafts.  Our findings reveal that D1 receptor activation can potentiate striatal NMDA subunit function by directly promoting the surface insertion of the receptor complexes.  This effect is regulated by the reciprocal actions of protein tyrosine phosphatases and tyrosine kinases.  Modification of these pathways may be a useful therapeutic target for Parkinson's disease and other basal ganglia disorders in which abnormal function of striatal NMDA receptors contributes to the symptoms of the diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIxPqagk0j8LVg90H21EOLACvtfcHk0liRws06g41SVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFWqu7w%253D&md5=46db98f3a599e3b1de6f2fdb234c3063</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0792-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0792-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DSpoelgen%26aufirst%3DR.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26atitle%3DDopamine%2520D1%2520Activation%2520Potentiates%2520Striatal%2520NMDA%2520Receptors%2520by%2520Tyrosine%2520Phosphorylation-Dependent%2520Subunit%2520Trafficking%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D4690%26epage%3D4700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hallett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span> </span><span class="NLM_article-title">Rationale for and use of NMDA receptor antagonists in Parkinson’s disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1016%2Fj.pharmthera.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=15163596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2004&pages=155-174&author=P.+J.+Hallettauthor=D.+G.+Standaert&title=Rationale+for+and+use+of+NMDA+receptor+antagonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale for and use of NMDA receptor antagonists in Parkinson's disease</span></div><div class="casAuthors">Hallett, Penelope J.; Standaert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-174</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  N-Methyl-D-aspartate (NMDA) glutamate receptors are a class of excitatory amino acid receptors, which have several important functions in the motor circuits of the basal ganglia, and are viewed as important targets for the development of new drugs to prevent or treat Parkinson's disease (PD).  NMDA receptors are ligand-gated ion channels composed of multiple subunits, each of which has distinct cellular and regional patterns of expression.  They have complex regulatory properties, with both agonist and co-agonist binding sites and regulation by phosphorylation and protein-protein interactions.  They are found in all of the structures of the basal ganglia, although the subunit compn. in the various structures is different.  NMDA receptors present in the striatum are crucial for dopamine-glutamate interactions.  The abundance, structure, and function of striatal receptors are altered by the dopamine depletion and further modified by the pharmacol. treatments used in PD.  In animal models, NMDA receptor antagonists are effective antiparkinsonian agents and can reduce the complications of chronic dopaminergic therapy (wearing off and dyskinesias).  Use of these agents in humans has been limited because of the adverse effects assocd. with nonselective blockade of NMDA receptor function, but the development of more potent and selective pharmaceuticals holds the promise of an important new therapeutic approach for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ar05ZbM9e7Vg90H21EOLACvtfcHk0liRws06g41SVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D&md5=9a8db709281a9e22c8d77438d6862562</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26atitle%3DRationale%2520for%2520and%2520use%2520of%2520NMDA%2520receptor%2520antagonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D102%26spage%3D155%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hallett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunah, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravenscroft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crossman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span> </span><span class="NLM_article-title">Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson’s disease</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=503-516&author=P.+J.+Hallettauthor=A.+W.+Dunahauthor=P.+Ravenscroftauthor=S.+Zhouauthor=E.+Bezardauthor=A.+R.+Crossmanauthor=J.+M.+Brotchieauthor=D.+G.+Standaert&title=Alterations+of+striatal+NMDA+receptor+subunits+associated+with+the+development+of+dyskinesia+in+the+MPTP-lesioned+primate+model+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26aulast%3DRavenscroft%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DCrossman%26aufirst%3DA.%2BR.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26atitle%3DAlterations%2520of%2520striatal%2520NMDA%2520receptor%2520subunits%2520associated%2520with%2520the%2520development%2520of%2520dyskinesia%2520in%2520the%2520MPTP-lesioned%2520primate%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D48%26spage%3D503%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Duty, S.</span><span> </span><span class="NLM_article-title">Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1017-1032&author=S.+Duty&title=Targeting+Glutamate+Receptors+to+Tackle+the+Pathogenesis%2C+Clinical+Symptoms+and+Levodopa-Induced+Dyskinesia+Associated+with+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuty%26aufirst%3DS.%26atitle%3DTargeting%2520Glutamate%2520Receptors%2520to%2520Tackle%2520the%2520Pathogenesis%252C%2520Clinical%2520Symptoms%2520and%2520Levodopa-Induced%2520Dyskinesia%2520Associated%2520with%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drugs%26date%3D2012%26volume%3D26%26spage%3D1017%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Excitatory amino acids, S-nitrosylation, and protein misfolding in neurodegenerative disease protection by memantine and nitromemantine at NMDA-gated channels</span> <span class="citation_source-journal">Oxid. Stress Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">Micronutrients and Brain Health</span><span class="NLM_x">) </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVansrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=59-78&issue=Micronutrients+and+Brain+Health&author=T.+Nakamuraauthor=S.+A.+Lipton&title=Excitatory+amino+acids%2C+S-nitrosylation%2C+and+protein+misfolding+in+neurodegenerative+disease+protection+by+memantine+and+nitromemantine+at+NMDA-gated+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acids, S-Nitrosylation, and protein misfolding in neurodegenerative disease protection by memantine and nitromemantine at NMDA-gated channels</span></div><div class="casAuthors">Nakamura, Tomohiro; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative Stress and Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Micronutrients and Brain Health</span>),
    <span class="NLM_cas:pages">59-78</span>CODEN:
                <span class="NLM_cas:coden">OSDIFK</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">CRC Press</span>)
        </div><div class="casAbstract">A review.  A review presents the specific examples showing that S-nitrosylation of ubiquitin E3 ligases, such as parkin, or endoplasmic reticulum chaperones, such as protein disulfide isomerase (PDI), is crit. for the accumulation of misfolded proteins in neurodegenerative diseases such as Parkinson's disease and other conditions.  It also discusses the neuroprotective mechanism of action of N-methyl-D-aspartate (NMDA) open-channel blockers such as memantine and NO-related drugs for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKCRz7LIDdJrVg90H21EOLACvtfcHk0lh7b6Fz5fGNeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVansrk%253D&md5=5708a8514f51ec4dd924c34b0c77aa96</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DExcitatory%2520amino%2520acids%252C%2520S-nitrosylation%252C%2520and%2520protein%2520misfolding%2520in%2520neurodegenerative%2520disease%2520protection%2520by%2520memantine%2520and%2520nitromemantine%2520at%2520NMDA-gated%2520channels%26jtitle%3DOxid.%2520Stress%2520Dis.%26date%3D2010%26volume%3D26%26issue%3DMicronutrients%2520and%2520Brain%2520Health%26spage%3D59%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santangelo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S.</span><span> </span><span class="NLM_article-title">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span> <span class="citation_source-journal">Nature Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1038%2Fncomms1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=90&author=P.+Mullasserilauthor=K.+Hansenauthor=K.+Vanceauthor=K.+Ogdenauthor=H.+Yuanauthor=N.+Kurtkayaauthor=R.+Santangeloauthor=A.+Orrauthor=P.+Leauthor=K.+Vellanoauthor=D.+Liottaauthor=S.+Traynelis&title=A+subunit-selective+potentiator+of+NR2C-+and+NR2D-containing+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span></div><div class="casAuthors">Mullasseril Praseeda; Hansen Kasper B; Vance Katie M; Ogden Kevin K; Yuan Hongjie; Kurtkaya Natalie L; Santangelo Rose; Orr Anna G; Le Phuong; Vellano Kimberly M; Liotta Dennis C; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors are tetrameric complexes of NR1 and NR2A-D subunits that mediate excitatory synaptic transmission and have a role in neurological disorders.  In this article, we identify a novel subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit, which could allow selective modification of circuit function in regions expressing NR2C/D subunits.  The substituted tetrahydroisoquinoline CIQ (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone) enhances receptor responses two-fold with an EC(50) of 3 μM by increasing channel opening frequency without altering mean open time or EC(50) values for glutamate or glycine.  The actions of CIQ depend on a single residue in the M1 region (NR2D Thr592) and on the linker between the N-terminal domain and agonist binding domain.  CIQ potentiates native NR2D-containing NMDA receptor currents from subthalamic neurons.  Our identification of a subunit-selective NMDA receptor modulator reveals a new class of pharmacological tools with which to probe the role of NR2C- and NR2D-containing NMDA receptors in brain function and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtyzdcP07UmufW6udTcc2eaEwPdp1zsRMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D&md5=8cde7c73dc6bf72ea3050c21db4f5ad4</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fncomms1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1085%26sid%3Dliteratum%253Aachs%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DVance%26aufirst%3DK.%26aulast%3DOgden%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DKurtkaya%26aufirst%3DN.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DOrr%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DTraynelis%26aufirst%3DS.%26atitle%3DA%2520subunit-selective%2520potentiator%2520of%2520NR2C-%2520and%2520NR2D-containing%2520NMDA%2520receptors%26jtitle%3DNature%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mosley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellano, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5476</span><span class="NLM_x">–</span> <span class="NLM_lpage">5490</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100027p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5476-5490&author=C.+A.+Mosleyauthor=T.+M.+Ackerauthor=K.+B.+Hansenauthor=P.+Mullasserilauthor=K.+T.+Andersenauthor=P.+Leauthor=K.+M.+Vellanoauthor=H.+Br%C3%A4uner-Osborneauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=Quinazolin-4-one+Derivatives%3A+A+Novel+Class+of+Noncompetitive+NR2C%2FD+Subunit-Selective+N-Methyl-d-aspartate+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm100027p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100027p%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DC.%2BA.%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DAndersen%26aufirst%3DK.%2BT.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DQuinazolin-4-one%2520Derivatives%253A%2520A%2520Novel%2520Class%2520of%2520Noncompetitive%2520NR2C%252FD%2520Subunit-Selective%2520N-Methyl-d-aspartate%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5476%26epage%3D5490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bettini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carignani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senar-Sancho, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardullo, F.</span><span> </span><span class="NLM_article-title">Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1124%2Fjpet.110.172544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=20810618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=636-644&author=E.+Bettiniauthor=A.+Savaauthor=C.+Griffanteauthor=C.+Carignaniauthor=A.+Busonauthor=A.+M.+Capelliauthor=M.+Negriauthor=F.+Andreetaauthor=S.+A.+Senar-Sanchoauthor=L.+Guiralauthor=F.+Cardullo&title=Identification+and+characterization+of+novel+NMDA+receptor+antagonists+selective+for+NR2A-+over+NR2B-containing+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors</span></div><div class="casAuthors">Bettini, Ezio; Sava, Anna; Griffante, Cristiana; Carignani, Corrado; Buson, Alberto; Capelli, Anna Maria; Negri, Michele; Andreetta, Filippo; Senar-Sancho, Sergio A.; Guiral, Lorena; Cardullo, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-644</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NR1/NR2A is a subtype of N-methyl-D-aspartate receptors (NMDARs), which are glutamate and glycine-gated Ca2+-permeable channels highly expressed in the central nervous system.  A high-throughput screening (HTS) campaign using human osteosarcoma (U-2 OS) cells transiently transduced with NR1/NR2A NMDAR subunits, tested in a specifically designed fluorometric imaging plate reader (FLIPR)/Ca2+ assay, identified sulfonamide deriv. series, exemplified by 3-chloro-4-fluoro-N-[(4-{[2-(phenylcarbonyl)hydrazino]carbonyl}phenyl)methyl]benzenesulfonamide (compd. 1) and thiodiazole deriv. N-(cyclohexylmethyl)-2-({5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio)acetamide (compd. 13) as novel NR1/NR2A receptor antagonists.  Compds. 1 and 13 displayed submicromolar and micromolar potency at NR1/NR2A receptor, resp., although they did not show activity at NR2B-contg. receptor up to 50 μM concn.  Addn. of 1 mM glycine, but not 1 mM L-glutamate, was able to surmount compd. 1 and 13 inhibitory effects in FLIPR NR1/NR2A assay.  However, compds. 1 and 13 displaced a glutamate site antagonist [3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid ([3H]CGP 39653) to a greater extent than the glycine site antagonist [3H]3-[(E)-2-carboxy-2-phenylethenyl]-4,6-dichloro-1H-indole-2-carboxylic acid ([3H]MDL 105,519), in rat brain cortex binding assay.  Results of FLIPR cell-based, electrophysiol., and biochem. binding assays suggest that compds. 1 and 13 are the prototypes of novel classes of NMDAR ligands, which to the best of our knowledge are the first selective antagonists at NR1/NR2A over NR1/NR2B receptor, and might constitute useful tools able to elucidate the relative role of the NR2A subunit in physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFB-QKFiC9sLVg90H21EOLACvtfcHk0liL6TotbQdGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK&md5=0bffd70be964ba27d17b9fbd877eaef0</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172544%26sid%3Dliteratum%253Aachs%26aulast%3DBettini%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DCarignani%26aufirst%3DC.%26aulast%3DBuson%26aufirst%3DA.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAndreeta%26aufirst%3DF.%26aulast%3DSenar-Sancho%26aufirst%3DS.%2BA.%26aulast%3DGuiral%26aufirst%3DL.%26aulast%3DCardullo%26aufirst%3DF.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520novel%2520NMDA%2520receptor%2520antagonists%2520selective%2520for%2520NR2A-%2520over%2520NR2B-containing%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D636%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo-Martin, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skifter, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, D. T.</span><span> </span><span class="NLM_article-title">A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1124%2Fjpet.110.174144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=20858708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=614-621&author=B.+M.+Costaauthor=M.+W.+Irvineauthor=G.+Fangauthor=R.+J.+Eavesauthor=M.+B.+Mayo-Martinauthor=D.+A.+Skifterauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=A+Novel+Family+of+Negative+and+Positive+Allosteric+Modulators+of+NMDA+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of negative and positive allosteric modulators of NMDA receptors</span></div><div class="casAuthors">Costa, Blaise Mathias; Irvine, Mark W.; Fang, Guangyu; Eaves, Richard J.; Mayo-Martin, Marie Belen; Skifter, Donald A.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-621</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor family regulates various central nervous system functions, such as synaptic plasticity.  However, hypo- or hyperactivation of NMDA receptors is critically involved in many neurol. and psychiatric conditions, such as pain, stroke, epilepsy, neurodegeneration, schizophrenia, and depression.  Consequently, subtype-selective pos. and neg. modulators of NMDA receptor function have many potential therapeutic applications not addressed by currently available compds.  We have identified allosteric modulators with several novel patterns of NMDA receptor subtype selectivity that have a novel mechanism of action.  In a series of carboxylated naphthalene and phenanthrene derivs., compds. were identified that selectively potentiate responses at GluN1/GluN2A [e.g., 9-iodophenanthrene-3-carboxylic acid (UBP512)]; GluN1/GluN2A and GluN1/GluN2B [9-cyclopropylphenanthrene-3-carboxylic acid (UBP710)]; GluN1/GluN2D [3,5-dihydroxynaphthalene-2-carboxylic acid (UBP551)]; or GluN1/GluN2C and GluN1/GluN2D receptors [6-, 7-, 8-, and 9-nitro isomers of naphth[1,2-c][1,2,5]oxadiazole-5-sulfonic acid (NSC339614)] and have no effect or inhibit responses at the other NMDA receptors.  Selective inhibition was also obsd.; UBP512 inhibits only GluN1/GluN2C and GluN1/GluN2D receptors, whereas 6-bromo-2-oxo-2H-chromene-3-carboxylic acid (UBP608) inhibits GluN1/GluN2A receptors with a 23-fold selectivity compared with GluN1/GluN2D receptors.  The actions of these compds. were not competitive with the agonists L-glutamate or glycine and were not voltage-dependent.  Whereas the N-terminal regulatory domain was not necessary for activity of either potentiators or inhibitors, segment 2 of the agonist ligand-binding domain was important for potentiating activity, whereas subtype-specific inhibitory activity was dependent upon segment 1.  In terms of chem. structure, activity profile, and mechanism of action, these modulators represent a new class of pharmacol. agents for the study of NMDA receptor subtype function and provide novel lead compds. for a variety of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9F9N6PVoh7Vg90H21EOLACvtfcHk0liL6TotbQdGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI&md5=cefc65523d06856f6dd704274ecb6f22</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174144%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DEaves%26aufirst%3DR.%2BJ.%26aulast%3DMayo-Martin%26aufirst%3DM.%2BB.%26aulast%3DSkifter%26aufirst%3DD.%2BA.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DA%2520Novel%2520Family%2520of%2520Negative%2520and%2520Positive%2520Allosteric%2520Modulators%2520of%2520NMDA%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D614%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Mechanism for Noncompetitive Inhibition by Novel GluN2C/D <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate Receptor Subunit-Selective Modulators</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=782-795&author=T.+M.+Ackerauthor=H.+Yuanauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+S.+Jensenauthor=P.+B.+Burgerauthor=P.+Mullasserilauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=Mechanism+for+Noncompetitive+Inhibition+by+Novel+GluN2C%2FD+N-Methyl-d-aspartate+Receptor+Subunit-Selective+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DMechanism%2520for%2520Noncompetitive%2520Inhibition%2520by%2520Novel%2520GluN2C%252FD%2520N-Methyl-d-aspartate%2520Receptor%2520Subunit-Selective%2520Modulators%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D782%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Santangelo Freel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chepiga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of Tetrahydroisoquinoline-Based Potentiators of GluN2C and GluN2D Containing <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5351</span><span class="NLM_x">–</span> <span class="NLM_lpage">5381</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400177t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5351-5381&author=R.+M.+Santangelo+Freelauthor=K.+K.+Ogdenauthor=K.+L.+Strongauthor=A.+Khatriauthor=K.+M.+Chepigaauthor=H.+S.+Jensenauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+Tetrahydroisoquinoline-Based+Potentiators+of+GluN2C+and+GluN2D+Containing+N-Methyl-d-aspartate+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1021%2Fjm400177t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400177t%26sid%3Dliteratum%253Aachs%26aulast%3DSantangelo%2BFreel%26aufirst%3DR.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DChepiga%26aufirst%3DK.%2BM.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Tetrahydroisoquinoline-Based%2520Potentiators%2520of%2520GluN2C%2520and%2520GluN2D%2520Containing%2520N-Methyl-d-aspartate%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5351%26epage%3D5381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slabber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacsa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships and Pharmacophore Model of a Noncompetitive Pyrazoline Containing Class of GluN2C/GluN2D Selective Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6434</span><span class="NLM_x">–</span> <span class="NLM_lpage">6456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400652r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6434-6456&author=T.+M.+Ackerauthor=A.+Khatriauthor=K.+M.+Vanceauthor=C.+Slabberauthor=J.+Bacsaauthor=J.+P.+Snyderauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Structure%E2%80%93Activity+Relationships+and+Pharmacophore+Model+of+a+Noncompetitive+Pyrazoline+Containing+Class+of+GluN2C%2FGluN2D+Selective+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1021%2Fjm400652r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400652r%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DSlabber%26aufirst%3DC.%26aulast%3DBacsa%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520and%2520Pharmacophore%2520Model%2520of%2520a%2520Noncompetitive%2520Pyrazoline%2520Containing%2520Class%2520of%2520GluN2C%252FGluN2D%2520Selective%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6434%26epage%3D6456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Hansen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Subunit-selective allosteric inhibition of glycine binding to NMDA receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">6197</span><span class="NLM_x">–</span> <span class="NLM_lpage">6208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1523%2FJNEUROSCI.5757-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=22553026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFeit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=6197-6208&author=B.+K.+Hansenauthor=K.+K.+Ogdenauthor=S.+F.+Traynelis&title=Subunit-selective+allosteric+inhibition+of+glycine+binding+to+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11hR"><div class="casContent"><span class="casTitleNuber">11h</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-selective allosteric inhibition of glycine binding to NMDA receptors</span></div><div class="casAuthors">Hansen, Kasper B.; Ogden, Kevin K.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6197-6208</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors are ligand-gated ion channels that mediate excitatory neurotransmission in the brain and are involved in numerous neuropathol. conditions.  NMDA receptors are activated upon simultaneous binding of coagonists glycine and glutamate to the GluN1 and GluN2 subunits, resp.  Subunit-selective modulation of NMDA receptor function by ligand binding to modulatory sites distinct from the agonist binding sites could allow pharmacol. intervention with therapeutically beneficial mechanisms.  Here, we show the mechanism of action for 3-chloro-4-fluoro-N-[(4-[(2-(phenylcarbonyl)hydrazino)carbonyl]phenyl)methyl]-benzenesulfonamide (TCN-201), a new GluN1/GluN2A-selective NMDA receptor antagonist whose inhibition can be surmounted by glycine.  Electrophysiol. recordings from chimeric and mutant rat NMDA receptors suggest that TCN-201 binds to a novel allosteric site located at the dimer interface between the GluN1 and GluN2 agonist binding domains.  Furthermore, we demonstrate that occupancy of this site by TCN-201 inhibits NMDA receptor function by reducing glycine potency.  TCN-201 is therefore a neg. allosteric modulator of glycine binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_V305_Cww-rVg90H21EOLACvtfcHk0lgOxI_bZI3foA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFeit7g%253D&md5=ce1b6e1eb6403591bf460fda8a6550b1</span></div><a href="/servlet/linkout?suffix=cit11h&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5757-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5757-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DB.%2BK.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-selective%2520allosteric%2520inhibition%2520of%2520glycine%2520binding%2520to%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D6197%26epage%3D6208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gauuan, P. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trova, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor-Boros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocckino, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crapo, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span> </span><span class="NLM_article-title">Superoxide dismutase mimetics: synthesis and structure–activity relationship study of MnTBAP analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3013</span><span class="NLM_x">–</span> <span class="NLM_lpage">3021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3013-3021&author=P.+J.+F.+Gauuanauthor=M.+P.+Trovaauthor=L.+Gregor-Borosauthor=S.+B.+Bocckinoauthor=J.+D.+Crapoauthor=B.+J.+Day&title=Superoxide+dismutase+mimetics%3A+synthesis+and+structure%E2%80%93activity+relationship+study+of+MnTBAP+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGauuan%26aufirst%3DP.%2BJ.%2BF.%26aulast%3DTrova%26aufirst%3DM.%2BP.%26aulast%3DGregor-Boros%26aufirst%3DL.%26aulast%3DBocckino%26aufirst%3DS.%2BB.%26aulast%3DCrapo%26aufirst%3DJ.%2BD.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26atitle%3DSuperoxide%2520dismutase%2520mimetics%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520MnTBAP%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3013%26epage%3D3021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kelly, M. G.; Kincaid, J.; Duncton, M.; Sahasrabudhe, K.; Janagani, S.; Upasani, R. B.; Wu, G.; Fang, Y.; Weig, Z.-L.</span><span> </span><span class="NLM_article-title">Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using same</span>. US 2006/0194801,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+G.+Kelly&author=J.+Kincaid&author=M.+Duncton&author=K.+Sahasrabudhe&author=S.+Janagani&author=R.+B.+Upasani&author=G.+Wu&author=Y.+Fang&author=Z.-L.+Weig&title=Amide+derivatives+as+ion-channel+ligands+and+pharmaceutical+compositions+and+methods+of+using+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BG.%26atitle%3DAmide%2520derivatives%2520as%2520ion-channel%2520ligands%2520and%2520pharmaceutical%2520compositions%2520and%2520methods%2520of%2520using%2520same%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Widmer, U.</span><span> </span><span class="NLM_article-title">A convenient preparation of <i>t</i>-butyl esters</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1055%2Fs-1983-30253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaL3sXhsVamtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=135-136&author=U.+Widmer&title=A+convenient+preparation+of+t-butyl+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient preparation of tert-butyl esters</span></div><div class="casAuthors">Widmer, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-6</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Heating carboxylic acids RCO2H (R = aryl, 1-pentenyl, 1-heptynyl, 3-oxobutyl, protected prolyl residue) with 4 equiv (Me3CO)2CHNMe2 (I) in benzene or toluene at 80° gave RCO2CMe3 in 55-83% yields.  Diesters (CH2)n(CO2CMe3)2 (n = 2, 3) were obtained similarly using 8 equiv I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4MbvHNZLT5bVg90H21EOLACvtfcHk0lgOxI_bZI3foA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhsVamtbk%253D&md5=f3dbb22aef634cfaacd5f9df144fa782</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-1983-30253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1983-30253%26sid%3Dliteratum%253Aachs%26aulast%3DWidmer%26aufirst%3DU.%26atitle%3DA%2520convenient%2520preparation%2520of%2520t-butyl%2520esters%26jtitle%3DSynthesis%26date%3D1983%26spage%3D135%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risgaard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perszyk, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Structural determinants of agonist efficacy at the glutamate binding site of <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=114-127&author=K.+B.+Hansenauthor=N.+Tajimaauthor=R.+Risgaardauthor=R.+E.+Perszykauthor=L.+J%C3%B8rgensenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=R.+P.+Clausenauthor=H.+Furukawaauthor=S.+F.+Traynelis&title=Structural+determinants+of+agonist+efficacy+at+the+glutamate+binding+site+of+N-methyl-d-aspartate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTajima%26aufirst%3DN.%26aulast%3DRisgaard%26aufirst%3DR.%26aulast%3DPerszyk%26aufirst%3DR.%2BE.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DL.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DClausen%26aufirst%3DR.%2BP.%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520determinants%2520of%2520agonist%2520efficacy%2520at%2520the%2520glutamate%2520binding%2520site%2520of%2520N-methyl-d-aspartate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D114%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.2174%2F138620708784246040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=18473740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslCisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=304-315&author=K.+B.+Hansenauthor=H.+Brauner-Osborneauthor=J.+Egebjerg&title=Pharmacological+characterization+of+ligands+at+recombinant+NMDA+receptor+subtypes+by+electrophysiological+recordings+and+intracellular+calcium+measurements"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements</span></div><div class="casAuthors">Hansen, Kasper B.; Brauner-Osborne, Hans; Egebjerg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">304-315</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Generation of in vitro cellular assays using fluorescence measurements at heterologously expressed NMDA receptors would speed up the process of ligand characterization and enable high-throughput screening.  The major drawback to the development of such assays is the cytotoxicity caused by Ca2+-flux into the cell via NMDA receptors upon prolonged activation by agonists present in the culture medium.  In the present study, we established four cell lines with stable expression of NMDA receptor subtypes NR1/NR2A, NR1/NR2B, NR1/NR2C, or NR1/NR2D in BHK-21 cells.  To assess the usefulness of the stable cell lines in conjunction with intracellular calcium ([Ca2+]i) measurements for evaluation of NMDA receptor pharmacol., several ligands were characterized using this method.  The results were compared to parallel data obtained by electrophysiol. recordings at NMDA receptors expressed in Xenopus oocytes.  This comparison showed that agonist potencies detd. by [Ca2+]i measurements and electrophysiol. recordings correlated well, meaning that the stable cell lines in conjunction with [Ca2+]i measurements provide a useful tool for characterization of NMDA receptor ligands.  The agonist series of conformationally constrained glutamate analogs (2S,3R,4S)-α-(carboxycyclopropyl)glycine (CCG), 1-aminocyclobutane-r-1,cis-3-dicarboxylic acid (trans-ACBD), and (±)-1-aminocyclopentane-r-1,cis-3-dicarboxylic acid (cis-ACPD), as well as the highly potent agonist tetrazolylglycine were among the characterized ligands that were assessed with respect to subtype selectivity at NMDA receptors.  However, none of the characterized agonists displays more than 2-3 fold selectivity toward a specific NMDA receptor subtype.  Thus, the present study provides a broad pharmacol. characterization of structurally diverse ligands at recombinant NMDA receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYuZIWYgVeGbVg90H21EOLACvtfcHk0ljrOjqxhObO9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslCisb4%253D&md5=4e07adfe9e1d8d9e4a0dd9f69ca15eeb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F138620708784246040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620708784246040%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DEgebjerg%26aufirst%3DJ.%26atitle%3DPharmacological%2520characterization%2520of%2520ligands%2520at%2520recombinant%2520NMDA%2520receptor%2520subtypes%2520by%2520electrophysiological%2520recordings%2520and%2520intracellular%2520calcium%2520measurements%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2008%26volume%3D11%26spage%3D304%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvist, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span> </span><span class="NLM_article-title">Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1124%2Fjpet.110.166256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=20197375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFCls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=650-662&author=K.+B.+Hansenauthor=P.+Mullasserilauthor=S.+Dawitauthor=N.+Kurtkayaauthor=H.+Yuanauthor=K.+Vanceauthor=A.+Orrauthor=T.+Kvistauthor=K.+Ogdenauthor=P.+Le&title=Implementation+of+a+fluorescence-based+screening+assay+identifies+histamine+H3+receptor+antagonists+clobenpropit+and+iodophenpropit+as+subunit-selective+N-methyl-d-aspartate+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists</span></div><div class="casAuthors">Hansen, Kasper B.; Mullasseril, Praseeda; Dawit, Sara; Kurtkaya, Natalie L.; Yuan, Hongjie; Vance, Katie M.; Orr, Anna G.; Kvist, Trine; Ogden, Kevin K.; Le, Phuong; Vellano, Kimberly M.; Lewis, Iestyn; Kurtkaya, Serdar; Du, Yuhong; Qui, Min; Murphy, T. J.; Snyder, James P.; Brauner-Osborne, Hans; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">650-662</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-Methyl-D-aspartate (NMDA) receptors are ligand-gated ion channels that mediate a slow, Ca2+-permeable component of excitatory synaptic transmission in the central nervous system and play a pivotal role in synaptic plasticity, neuronal development, and several neurol. diseases.  The authors describe a fluorescence-based assay that measures NMDA receptor-mediated changes in intracellular calcium in a BHK-21 cell line stably expressing NMDA receptor NR2D with NR1 under the control of a tetracycline-inducible promoter (Tet-On).  The assay selectively identifies allosteric modulators by using supramaximal concns. of glutamate and glycine to minimize detection of competitive antagonists.  The assay is validated by successfully identifying known noncompetitive, but not competitive NMDA receptor antagonists among 1800 screened compds. from two small focused libraries, including the com. available library of pharmacol. active compds.  Hits from the primary screen are validated through a secondary screen that used two-electrode voltage-clamp recordings on recombinant NMDA receptors expressed in Xenopus laevis oocytes.  This strategy identified several novel modulators of NMDA receptor function, including the histamine H3 receptor antagonists clobenpropit and iodophenpropit, as well as the vanilloid receptor transient receptor potential cation channel, subfamily V, member 1 (TRPV1) antagonist capsazepine.  These compds. are noncompetitive antagonists and the histamine H3 receptor ligand showed submicromolar potency at NR1/NR2B NMDA receptors, which raises the possibility that compds. can be developed that act with high potency on both glutamate and histamine receptor systems simultaneously.  Furthermore, it is possible that some actions attributed to histamine H3 receptor inhibition in vivo may also involve NMDA receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3wxHd8lp7dLVg90H21EOLACvtfcHk0ljrOjqxhObO9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFCls78%253D&md5=b11728641a7d25df2e021fb5d53eb2e9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166256%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DDawit%26aufirst%3DS.%26aulast%3DKurtkaya%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DVance%26aufirst%3DK.%26aulast%3DOrr%26aufirst%3DA.%26aulast%3DKvist%26aufirst%3DT.%26aulast%3DOgden%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DP.%26atitle%3DImplementation%2520of%2520a%2520fluorescence-based%2520screening%2520assay%2520identifies%2520histamine%2520H3%2520receptor%2520antagonists%2520clobenpropit%2520and%2520iodophenpropit%2520as%2520subunit-selective%2520N-methyl-d-aspartate%2520receptor%2520antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D650%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e','cit11f','cit11g','cit11h'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Katie L. Strong, Matthew P. Epplin, Kevin K. Ogden, Pieter B. Burger, Thomas M. Kaiser, Timothy J. Wilding, Hiro Kusumoto, Chad R. Camp, Gil Shaulsky, Subhrajit Bhattacharya, Riley E. Perszyk, David S. Menaldino, Miranda J. McDaniel, Jing Zhang, Phuong Le, Tue G. Banke, Kasper B. Hansen, James E. Huettner, Dennis C. Liotta, <span class="NLM_string-name hlFld-ContribAuthor">Stephen F. Traynelis</span>. </span><span class="cited-content_cbyCitation_article-title">Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-d-aspartate Receptors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 79-98. <a href="https://doi.org/10.1021/acschemneuro.0c00561" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00561%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDistinct%252BGluN1%252Band%252BGluN2%252BStructural%252BDeterminants%252Bfor%252BSubunit-Selective%252BPositive%252BAllosteric%252BModulation%252Bof%252BN-Methyl-d-aspartate%252BReceptors%26aulast%3DStrong%26aufirst%3DKatie%2BL.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26082020%26date%3D12112020%26date%3D16122020%26volume%3D12%26issue%3D1%26spage%3D79%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew P. Epplin, Ayush Mohan, Lynnea D. Harris, Zongjian Zhu, Katie L. Strong, John Bacsa, Phuong Le, David S. Menaldino, Stephen F. Traynelis, <span class="NLM_string-name hlFld-ContribAuthor">Dennis C. Liotta</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the N-Methyl-d-Aspartate (NMDA) Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7569-7600. <a href="https://doi.org/10.1021/acs.jmedchem.9b01733" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01733%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDihydropyrrolo%25255B1%25252C2-a%25255Dpyrazin-3%2525284H%252529-one-Based%252BSecond-Generation%252BGluN2C-%252Band%252BGluN2D-Selective%252BPositive%252BAllosteric%252BModulators%252B%252528PAMs%252529%252Bof%252Bthe%252BN-Methyl-d-Aspartate%252B%252528NMDA%252529%252BReceptor%26aulast%3DEpplin%26aufirst%3DMatthew%2BP.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17032020%26date%3D06072020%26date%3D15062020%26volume%3D63%26issue%3D14%26spage%3D7569%26epage%3D7600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel S. La, Francesco G. Salituro, Gabriel Martinez Botella, Andrew M. Griffin, Zhu Bai, Michael A. Ackley, Jing Dai, James J. Doherty, Boyd L. Harrison, Ethan C. Hoffmann, Tatiana M. Kazdoba, Michael C. Lewis, Michael C. Quirk, <span class="NLM_string-name hlFld-ContribAuthor">Albert J. Robichaud</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroactive Steroid N-Methyl-d-aspartate Receptor Positive Allosteric Modulators: Synthesis, SAR, and Pharmacological Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7526-7542. <a href="https://doi.org/10.1021/acs.jmedchem.9b00591" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00591%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNeuroactive%252BSteroid%252BN-Methyl-d-aspartate%252BReceptor%252BPositive%252BAllosteric%252BModulators%25253A%252BSynthesis%25252C%252BSAR%25252C%252Band%252BPharmacological%252BActivity%26aulast%3DLa%26aufirst%3DDaniel%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07052019%26date%3D13082019%26date%3D07082019%26volume%3D62%26issue%3D16%26spage%3D7526%26epage%3D7542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Erica
S. Burnell, Mark Irvine, Guangyu Fang, Kiran Sapkota, David E. Jane, <span class="NLM_string-name hlFld-ContribAuthor">Daniel T. Monaghan</span>. </span><span class="cited-content_cbyCitation_article-title">Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure–Activity Relationships and Mechanisms of Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 3-23. <a href="https://doi.org/10.1021/acs.jmedchem.7b01640" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01640%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositive%252Band%252BNegative%252BAllosteric%252BModulators%252Bof%252BN-Methyl-d-aspartate%252B%252528NMDA%252529%252BReceptors%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BMechanisms%252Bof%252BAction%26aulast%3DBurnell%26aufirst%3DErica%2BS.%26date%3D2019%26date%3D2018%26date%3D2017%26date%3D06112017%26date%3D05032018%26date%3D15022018%26volume%3D62%26issue%3D1%26spage%3D3%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanpeng  Xing</span>, <span class="hlFld-ContribAuthor ">Jun  Zuo</span>, <span class="hlFld-ContribAuthor ">Paul  Krogstad</span>, and <span class="hlFld-ContribAuthor ">Michael E.  Jung</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1688-1703. <a href="https://doi.org/10.1021/acs.jmedchem.7b01863" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01863%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252BStudies%252Bof%252BNovel%252BPyrazolopyridine%252BDerivatives%252Bas%252BInhibitors%252Bof%252BEnterovirus%252BReplication%26aulast%3DXing%26aufirst%3DYanpeng%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D20122017%26date%3D31012018%26date%3D22022018%26date%3D18012018%26volume%3D61%26issue%3D4%26spage%3D1688%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharon A.  Swanger</span>, <span class="hlFld-ContribAuthor ">Katie M.  Vance</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Acker</span>, <span class="hlFld-ContribAuthor ">Sommer S.  Zimmerman</span>, <span class="hlFld-ContribAuthor ">John O.  DiRaddo</span>, <span class="hlFld-ContribAuthor ">Scott J.  Myers</span>, <span class="hlFld-ContribAuthor ">Christoffer  Bundgaard</span>, <span class="hlFld-ContribAuthor ">Cara A.  Mosley</span>, <span class="hlFld-ContribAuthor ">Samantha L.  Summer</span>, <span class="hlFld-ContribAuthor ">David S.  Menaldino</span>, <span class="hlFld-ContribAuthor ">Henrik S.  Jensen</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>, and <span class="hlFld-ContribAuthor ">Stephen F.  Traynelis</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 306-319. <a href="https://doi.org/10.1021/acschemneuro.7b00329" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00329%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BNovel%252BNegative%252BAllosteric%252BModulator%252BSelective%252Bfor%252BGluN2C%25252F2D-Containing%252BNMDA%252BReceptors%252BInhibits%252BSynaptic%252BTransmission%252Bin%252BHippocampal%252BInterneurons%26aulast%3DSwanger%26aufirst%3DSharon%2BA.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28082017%26date%3D18102017%26date%3D02112017%26date%3D21022018%26date%3D18102017%26volume%3D9%26issue%3D2%26spage%3D306%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katie L.  Strong</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Epplin</span>, <span class="hlFld-ContribAuthor ">John  Bacsa</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Butch</span>, <span class="hlFld-ContribAuthor ">Pieter B.  Burger</span>, <span class="hlFld-ContribAuthor ">David S.  Menaldino</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Traynelis</span>, and <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>  . </span><span class="cited-content_cbyCitation_article-title">The Structure–Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5556-5585. <a href="https://doi.org/10.1021/acs.jmedchem.7b00239" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00239%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252Ba%252BTetrahydroisoquinoline%252BClass%252Bof%252BN-Methyl-d-Aspartate%252BReceptor%252BModulators%252Bthat%252BPotentiates%252BGluN2B-Containing%252BN-Methyl-d-Aspartate%252BReceptors%26aulast%3DStrong%26aufirst%3DKatie%2BL.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14022017%26date%3D26062017%26date%3D13072017%26date%3D06062017%26volume%3D60%26issue%3D13%26spage%3D5556%26epage%3D5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tongqing  Li</span>, <span class="hlFld-ContribAuthor ">Ning  Yin</span>, <span class="hlFld-ContribAuthor ">Hongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Inhibitors of Toxin HipA Reduce Multidrug Tolerant Persisters. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (5)
                                     , 449-453. <a href="https://doi.org/10.1021/acsmedchemlett.5b00420" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00420%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BInhibitors%252Bof%252BToxin%252BHipA%252BReduce%252BMultidrug%252BTolerant%252BPersisters%26aulast%3DLi%26aufirst%3DTongqing%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D30102015%26date%3D13032016%26date%3D15032016%26date%3D12052016%26date%3D13032016%26volume%3D7%26issue%3D5%26spage%3D449%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan M.  Marschner</span>, <span class="hlFld-ContribAuthor ">Ritesh  Haldar</span>, <span class="hlFld-ContribAuthor ">Olaf  Fuhr</span>, <span class="hlFld-ContribAuthor ">Christof  Wöll</span>, <span class="hlFld-ContribAuthor ">Stefan  Bräse</span>. </span><span class="cited-content_cbyCitation_article-title">Modular Synthesis of
              trans
              ‐A
              2
              B
              2
              ‐Porphyrins with Terminal Esters: Systematically Extending the Scope of Linear Linkers for Porphyrin‐Based MOFs. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (4)
                                     , 1390-1401. <a href="https://doi.org/10.1002/chem.202003885" title="DOI URL">https://doi.org/10.1002/chem.202003885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202003885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202003885%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DModular%252BSynthesis%252Bof%252Btrans%252B%2525E2%252580%252590A%252B2%252BB%252B2%252B%2525E2%252580%252590Porphyrins%252Bwith%252BTerminal%252BEsters%25253A%252BSystematically%252BExtending%252Bthe%252BScope%252Bof%252BLinear%252BLinkers%252Bfor%252BPorphyrin%2525E2%252580%252590Based%252BMOFs%26aulast%3DMarschner%26aufirst%3DStefan%2BM.%26date%3D2021%26date%3D2020%26volume%3D27%26issue%3D4%26spage%3D1390%26epage%3D1401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Bao‐Le</span>, <span class="hlFld-ContribAuthor ">Hong‐Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia‐Qi  Di</span>, <span class="hlFld-ContribAuthor ">Zhan‐Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Polyoxometalate immobilized on MOF‐5 as an environment‐friendly catalyst for the synthesis of poly‐functionalized 3‐pyrrolin‐2‐ones. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2021,</strong> <em>35 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/aoc.6064" title="DOI URL">https://doi.org/10.1002/aoc.6064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.6064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.6064%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DPolyoxometalate%252Bimmobilized%252Bon%252BMOF%2525E2%252580%2525905%252Bas%252Ban%252Benvironment%2525E2%252580%252590friendly%252Bcatalyst%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpoly%2525E2%252580%252590functionalized%252B3%2525E2%252580%252590pyrrolin%2525E2%252580%2525902%2525E2%252580%252590ones%26aulast%3DBao%25E2%2580%2590Le%26aufirst%3DLi%26date%3D2021%26date%3D2020%26volume%3D35%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shishir  Sharma</span>, <span class="hlFld-ContribAuthor ">Jingyao  Liu</span>, <span class="hlFld-ContribAuthor ">Xue  Zhang</span>, <span class="hlFld-ContribAuthor ">Sangeeta Shrestha  Sharma</span>, <span class="hlFld-ContribAuthor ">Erik J.  Sorensen</span>, <span class="hlFld-ContribAuthor ">Matthias  Bureik</span>. </span><span class="cited-content_cbyCitation_article-title">New luciferin-based probe substrates for human CYP26A1. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry and Biophysics Reports</span><span> <strong>2020,</strong> <em>24 </em>, 100861. <a href="https://doi.org/10.1016/j.bbrep.2020.100861" title="DOI URL">https://doi.org/10.1016/j.bbrep.2020.100861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrep.2020.100861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrep.2020.100861%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520and%2520Biophysics%2520Reports%26atitle%3DNew%252Bluciferin-based%252Bprobe%252Bsubstrates%252Bfor%252Bhuman%252BCYP26A1%26aulast%3DSharma%26aufirst%3DShishir%26date%3D2020%26volume%3D24%26spage%3D100861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nenad  Joksimović</span>, <span class="hlFld-ContribAuthor ">Nenad  Janković</span>, <span class="hlFld-ContribAuthor ">Goran  Davidović</span>, <span class="hlFld-ContribAuthor ">Zorica  Bugarčić</span>. </span><span class="cited-content_cbyCitation_article-title">2,4-Diketo esters: Crucial intermediates for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104343. <a href="https://doi.org/10.1016/j.bioorg.2020.104343" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104343%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D2%25252C4-Diketo%252Besters%25253A%252BCrucial%252Bintermediates%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DJoksimovi%25C4%2587%26aufirst%3DNenad%26date%3D2020%26volume%3D105%26spage%3D104343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hazem  Ahmed</span>, <span class="hlFld-ContribAuthor ">Ahmed  Haider</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">N
              -Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (10)
                                     , 743-767. <a href="https://doi.org/10.1080/13543776.2020.1811234" title="DOI URL">https://doi.org/10.1080/13543776.2020.1811234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1811234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1811234%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DN%252B-Methyl-D-Aspartate%252B%252528NMDA%252529%252Breceptor%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282015-present%252529%26aulast%3DAhmed%26aufirst%3DHazem%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D10%26spage%3D743%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Yi</span>, <span class="hlFld-ContribAuthor ">Nirvan  Rouzbeh</span>, <span class="hlFld-ContribAuthor ">Kasper B.  Hansen</span>, <span class="hlFld-ContribAuthor ">Yuelian  Xu</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Fanger</span>, <span class="hlFld-ContribAuthor ">Earl  Gordon</span>, <span class="hlFld-ContribAuthor ">Kathy  Paschetto</span>, <span class="hlFld-ContribAuthor ">Frank S.  Menniti</span>, <span class="hlFld-ContribAuthor ">Robert A.  Volkmann</span>. </span><span class="cited-content_cbyCitation_article-title">PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>173 </em>, 107971. <a href="https://doi.org/10.1016/j.neuropharm.2020.107971" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.107971</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.107971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.107971%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DPTC-174%25252C%252Ba%252Bpositive%252Ballosteric%252Bmodulator%252Bof%252BNMDA%252Breceptors%252Bcontaining%252BGluN2C%252Bor%252BGluN2D%252Bsubunits%26aulast%3DYi%26aufirst%3DFeng%26date%3D2020%26volume%3D173%26spage%3D107971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Goldsmith</span>. </span><span class="cited-content_cbyCitation_article-title">NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (24)
                                     , 2239-2253. <a href="https://doi.org/10.2174/1568026619666191011095341" title="DOI URL">https://doi.org/10.2174/1568026619666191011095341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191011095341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191011095341%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DNMDAR%252BPAMs%25253A%252BMultiple%252BChemotypes%252Bfor%252BMultiple%252BBinding%252BSites%26aulast%3DGoldsmith%26aufirst%3DPaul%2BJ.%26date%3D2019%26volume%3D19%26issue%3D24%26spage%3D2239%26epage%3D2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinxu  Liu</span>, <span class="hlFld-ContribAuthor ">Gajanan P.  Shelkar</span>, <span class="hlFld-ContribAuthor ">Fabao  Zhao</span>, <span class="hlFld-ContribAuthor ">Rasmus P.  Clausen</span>, <span class="hlFld-ContribAuthor ">Shashank M.  Dravid</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of Burst Firing of Neurons in Nucleus Reticularis of the Thalamus by GluN2C-Containing NMDA Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (2)
                                     , 193-203. <a href="https://doi.org/10.1124/mol.119.116780" title="DOI URL">https://doi.org/10.1124/mol.119.116780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.116780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.116780%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DModulation%252Bof%252BBurst%252BFiring%252Bof%252BNeurons%252Bin%252BNucleus%252BReticularis%252Bof%252Bthe%252BThalamus%252Bby%252BGluN2C-Containing%252BNMDA%252BReceptors%26aulast%3DLiu%26aufirst%3DJinxu%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D2%26spage%3D193%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nenad  Joksimović</span>, <span class="hlFld-ContribAuthor ">Jelena  Petronijević</span>, <span class="hlFld-ContribAuthor ">Nenad  Janković</span>, <span class="hlFld-ContribAuthor ">Dejan  Baskić</span>, <span class="hlFld-ContribAuthor ">Suzana  Popović</span>, <span class="hlFld-ContribAuthor ">Danijela  Todorović</span>, <span class="hlFld-ContribAuthor ">Sanja  Matić</span>, <span class="hlFld-ContribAuthor ">Goran A.  Bogdanović</span>, <span class="hlFld-ContribAuthor ">Milan  Vraneš</span>, <span class="hlFld-ContribAuthor ">Aleksandar  Tot</span>, <span class="hlFld-ContribAuthor ">Zorica  Bugarčić</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, anticancer evaluation and mechanisms of cytotoxic activity of novel 3-hydroxy-3-pyrrolin-2-ones bearing thenoyl fragment: DNA, BSA interactions and molecular docking study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>88 </em>, 102954. <a href="https://doi.org/10.1016/j.bioorg.2019.102954" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.102954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.102954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.102954%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Banticancer%252Bevaluation%252Band%252Bmechanisms%252Bof%252Bcytotoxic%252Bactivity%252Bof%252Bnovel%252B3-hydroxy-3-pyrrolin-2-ones%252Bbearing%252Bthenoyl%252Bfragment%25253A%252BDNA%25252C%252BBSA%252Binteractions%252Band%252Bmolecular%252Bdocking%252Bstudy%26aulast%3DJoksimovi%25C4%2587%26aufirst%3DNenad%26date%3D2019%26volume%3D88%26spage%3D102954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark W.  Irvine</span>, <span class="hlFld-ContribAuthor ">Guangyu  Fang</span>, <span class="hlFld-ContribAuthor ">Kiran  Sapkota</span>, <span class="hlFld-ContribAuthor ">Erica S.  Burnell</span>, <span class="hlFld-ContribAuthor ">Arturas  Volianskis</span>, <span class="hlFld-ContribAuthor ">Blaise M.  Costa</span>, <span class="hlFld-ContribAuthor ">Georgia  Culley</span>, <span class="hlFld-ContribAuthor ">Graham L.  Collingridge</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Monaghan</span>, <span class="hlFld-ContribAuthor ">David E.  Jane</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 471-498. <a href="https://doi.org/10.1016/j.ejmech.2018.12.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252Bthe%252Bstructural%252Brequirements%252Bfor%252BN-methyl-D-aspartate%252Breceptor%252Bpositive%252Band%252Bnegative%252Ballosteric%252Bmodulators%252Bbased%252Bon%252B2-naphthoic%252Bacid%26aulast%3DIrvine%26aufirst%3DMark%2BW.%26date%3D2019%26volume%3D164%26spage%3D471%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jürgen  Vahter</span>, <span class="hlFld-ContribAuthor ">Kaido  Viht</span>, <span class="hlFld-ContribAuthor ">Asko  Uri</span>, <span class="hlFld-ContribAuthor ">Ganesh babu  Manoharan</span>, <span class="hlFld-ContribAuthor ">Erki  Enkvist</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (18)
                                     , 5062-5068. <a href="https://doi.org/10.1016/j.bmc.2018.09.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThiazole-%252Band%252Bselenazole-comprising%252Bhigh-affinity%252Binhibitors%252Bpossess%252Bbright%252Bmicrosecond-scale%252Bphotoluminescence%252Bin%252Bcomplex%252Bwith%252Bprotein%252Bkinase%252BCK2%26aulast%3DVahter%26aufirst%3DJ%25C3%25BCrgen%26date%3D2018%26volume%3D26%26issue%3D18%26spage%3D5062%26epage%3D5068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Kaiser</span>, <span class="hlFld-ContribAuthor ">Steven A.  Kell</span>, <span class="hlFld-ContribAuthor ">Hirofumi  Kusumoto</span>, <span class="hlFld-ContribAuthor ">Gil  Shaulsky</span>, <span class="hlFld-ContribAuthor ">Subhrajit  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Epplin</span>, <span class="hlFld-ContribAuthor ">Katie L.  Strong</span>, <span class="hlFld-ContribAuthor ">Eric J.  Miller</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Cox</span>, <span class="hlFld-ContribAuthor ">David S.  Menaldino</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Traynelis</span>, <span class="hlFld-ContribAuthor ">Pieter B.  Burger</span>. </span><span class="cited-content_cbyCitation_article-title">The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>93 </em>
                                    (2)
                                     , 141-156. <a href="https://doi.org/10.1124/mol.117.110940" title="DOI URL">https://doi.org/10.1124/mol.117.110940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.117.110940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.117.110940%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DThe%252BBioactive%252BProtein-Ligand%252BConformation%252Bof%252BGluN2C-Selective%252BPositive%252BAllosteric%252BModulators%252BBound%252Bto%252Bthe%252BNMDA%252BReceptor%26aulast%3DKaiser%26aufirst%3DThomas%2BM.%26date%3D2018%26date%3D2017%26volume%3D93%26issue%3D2%26spage%3D141%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaotao  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Qian</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Wei</span>, <span class="hlFld-ContribAuthor ">Jian-Dong  Huang</span>, <span class="hlFld-ContribAuthor ">Hongli  Bao</span>. </span><span class="cited-content_cbyCitation_article-title">Protection of COOH and OH groups in acid, base and salt free reactions. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2018,</strong> <em>20 </em>
                                    (7)
                                     , 1444-1447. <a href="https://doi.org/10.1039/C8GC00037A" title="DOI URL">https://doi.org/10.1039/C8GC00037A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8GC00037A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8GC00037A%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DProtection%252Bof%252BCOOH%252Band%252BOH%252Bgroups%252Bin%252Bacid%25252C%252Bbase%252Band%252Bsalt%252Bfree%252Breactions%26aulast%3DZhu%26aufirst%3DXiaotao%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D7%26spage%3D1444%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divyan A.  Chopra</span>, <span class="hlFld-ContribAuthor ">Kiran  Sapkota</span>, <span class="hlFld-ContribAuthor ">Mark W.  Irvine</span>, <span class="hlFld-ContribAuthor ">Guangyu  Fang</span>, <span class="hlFld-ContribAuthor ">David E.  Jane</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Monaghan</span>, <span class="hlFld-ContribAuthor ">Shashank M.  Dravid</span>. </span><span class="cited-content_cbyCitation_article-title">A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-07292-8" title="DOI URL">https://doi.org/10.1038/s41598-017-07292-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-07292-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-07292-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bsingle-channel%252Bmechanism%252Bfor%252Bpharmacological%252Bpotentiation%252Bof%252BGluN1%25252FGluN2A%252BNMDA%252Breceptors%26aulast%3DChopra%26aufirst%3DDivyan%2BA.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joni F.  Baker</span>, <span class="hlFld-ContribAuthor ">Marshall E.  Cates</span>, <span class="hlFld-ContribAuthor ">David R.  Luthin</span>. </span><span class="cited-content_cbyCitation_article-title">D-cycloserine in the treatment of posttraumatic stress disorder. </span><span class="cited-content_cbyCitation_journal-name">Mental Health Clinician</span><span> <strong>2017,</strong> <em>7 </em>
                                    (2)
                                     , 88-94. <a href="https://doi.org/10.9740/mhc.2017.03.088" title="DOI URL">https://doi.org/10.9740/mhc.2017.03.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.9740/mhc.2017.03.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.9740%2Fmhc.2017.03.088%26sid%3Dliteratum%253Aachs%26jtitle%3DMental%2520Health%2520Clinician%26atitle%3DD-cycloserine%252Bin%252Bthe%252Btreatment%252Bof%252Bposttraumatic%252Bstress%252Bdisorder%26aulast%3DBaker%26aufirst%3DJoni%2BF.%26date%3D2017%26volume%3D7%26issue%3D2%26spage%3D88%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasper B.  Hansen</span>, <span class="hlFld-ContribAuthor ">Feng  Yi</span>, <span class="hlFld-ContribAuthor ">Riley E.  Perszyk</span>, <span class="hlFld-ContribAuthor ">Frank S.  Menniti</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Traynelis</span>. </span><span class="cited-content_cbyCitation_article-title">NMDA Receptors in the Central Nervous System. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-80. <a href="https://doi.org/10.1007/978-1-4939-7321-7_1" title="DOI URL">https://doi.org/10.1007/978-1-4939-7321-7_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7321-7_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7321-7_1%26sid%3Dliteratum%253Aachs%26atitle%3DNMDA%252BReceptors%252Bin%252Bthe%252BCentral%252BNervous%252BSystem%26aulast%3DHansen%26aufirst%3DKasper%2BB.%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D80%26pub%3DSpringer%2520New%2520York%26atitle%3DNMDA%252BReceptors%26aulast%3DBurnashev%26aufirst%3DNail%26date%3D2017%26volume%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David H.  Hackos</span>, <span class="hlFld-ContribAuthor ">Jesse E.  Hanson</span>. </span><span class="cited-content_cbyCitation_article-title">Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>112 </em>, 34-45. <a href="https://doi.org/10.1016/j.neuropharm.2016.07.037" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2016.07.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2016.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2016.07.037%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DDiverse%252Bmodes%252Bof%252BNMDA%252Breceptor%252Bpositive%252Ballosteric%252Bmodulation%25253A%252BMechanisms%252Band%252Bconsequences%26aulast%3DHackos%26aufirst%3DDavid%2BH.%26date%3D2017%26volume%3D112%26spage%3D34%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zixiu  Xiang</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">Novel PAMs Targeting NMDAR GluN2A Subunit. </span><span class="cited-content_cbyCitation_journal-name">Neuron</span><span> <strong>2016,</strong> <em>89 </em>
                                    (5)
                                     , 884-886. <a href="https://doi.org/10.1016/j.neuron.2016.02.025" title="DOI URL">https://doi.org/10.1016/j.neuron.2016.02.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuron.2016.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuron.2016.02.025%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuron%26atitle%3DNovel%252BPAMs%252BTargeting%252BNMDAR%252BGluN2A%252BSubunit%26aulast%3DXiang%26aufirst%3DZixiu%26date%3D2016%26volume%3D89%26issue%3D5%26spage%3D884%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brooke M.  Katzman</span>, <span class="hlFld-ContribAuthor ">Riley E.  Perszyk</span>, <span class="hlFld-ContribAuthor ">Hongjie  Yuan</span>, <span class="hlFld-ContribAuthor ">Yesim Altas  Tahirovic</span>, <span class="hlFld-ContribAuthor ">Ayodeji E.  Sotimehin</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Traynelis</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of negative allosteric modulators of NMDA receptor function. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (23)
                                     , 5583-5588. <a href="https://doi.org/10.1016/j.bmcl.2015.10.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.10.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.10.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.10.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bnovel%252Bclass%252Bof%252Bnegative%252Ballosteric%252Bmodulators%252Bof%252BNMDA%252Breceptor%252Bfunction%26aulast%3DKatzman%26aufirst%3DBrooke%2BM.%26date%3D2015%26volume%3D25%26issue%3D23%26spage%3D5583%26epage%3D5588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayme L.  Dahlin</span>, <span class="hlFld-ContribAuthor ">J. Willem M.  Nissink</span>, <span class="hlFld-ContribAuthor ">Subhashree  Francis</span>, <span class="hlFld-ContribAuthor ">Jessica M.  Strasser</span>, <span class="hlFld-ContribAuthor ">Kristen  John</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Walters</span>. </span><span class="cited-content_cbyCitation_article-title">Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2 H -pyrrol-2-one actives verified by ALARM NMR. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (21)
                                     , 4740-4752. <a href="https://doi.org/10.1016/j.bmcl.2015.08.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.08.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.08.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPost-HTS%252Bcase%252Breport%252Band%252Bstructural%252Balert%25253A%252BPromiscuous%252B4-aroyl-1%25252C5-disubstituted-3-hydroxy-2%252BH%252B-pyrrol-2-one%252Bactives%252Bverified%252Bby%252BALARM%252BNMR%26aulast%3DDahlin%26aufirst%3DJayme%2BL.%26date%3D2015%26volume%3D25%26issue%3D21%26spage%3D4740%26epage%3D4752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin T.  Pelkey</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Pelkey</span>, <span class="hlFld-ContribAuthor ">Jessica G.  Greger</span>. </span><span class="cited-content_cbyCitation_article-title">De Novo Synthesis of 3-Pyrrolin-2-Ones. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 151-285. <a href="https://doi.org/10.1016/bs.aihch.2015.04.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2015.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2015.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2015.04.001%26sid%3Dliteratum%253Aachs%26atitle%3DDe%252BNovo%252BSynthesis%252Bof%252B3-Pyrrolin-2-Ones%26aulast%3DPelkey%26aufirst%3DErin%2BT.%26date%3D2015%26spage%3D151%26epage%3D285%26pub%3DElsevier%26date%3D2015%26volume%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mir Mohammad  Masood</span>, <span class="hlFld-ContribAuthor ">Vijay K.  Pillalamarri</span>, <span class="hlFld-ContribAuthor ">Mohammad  Irfan</span>, <span class="hlFld-ContribAuthor ">Babita  Aneja</span>, <span class="hlFld-ContribAuthor ">Mohamad Aman  Jairajpuri</span>, <span class="hlFld-ContribAuthor ">Md.  Zafaryab</span>, <span class="hlFld-ContribAuthor ">M. Moshahid A.  Rizvi</span>, <span class="hlFld-ContribAuthor ">Umesh  Yadava</span>, <span class="hlFld-ContribAuthor ">Anthony  Addlagatta</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abid</span>. </span><span class="cited-content_cbyCitation_article-title">Diketo acids and their amino acid/dipeptidic analogues as promising scaffolds for the development of bacterial methionine aminopeptidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (43)
                                     , 34173-34183. <a href="https://doi.org/10.1039/C5RA03354C" title="DOI URL">https://doi.org/10.1039/C5RA03354C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA03354C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA03354C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiketo%252Bacids%252Band%252Btheir%252Bamino%252Bacid%25252Fdipeptidic%252Banalogues%252Bas%252Bpromising%252Bscaffolds%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bbacterial%252Bmethionine%252Baminopeptidase%252Binhibitors%26aulast%3DMasood%26aufirst%3DMir%2BMohammad%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D43%26spage%3D34173%26epage%3D34183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katie L  Strong</span>, <span class="hlFld-ContribAuthor ">Yao  Jing</span>, <span class="hlFld-ContribAuthor ">Anthony R  Prosser</span>, <span class="hlFld-ContribAuthor ">Stephen F  Traynelis</span>, <span class="hlFld-ContribAuthor ">Dennis C  Liotta</span>. </span><span class="cited-content_cbyCitation_article-title">NMDA receptor modulators: an updated patent review (2013 – 2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (12)
                                     , 1349-1366. <a href="https://doi.org/10.1517/13543776.2014.972938" title="DOI URL">https://doi.org/10.1517/13543776.2014.972938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.972938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.972938%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNMDA%252Breceptor%252Bmodulators%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252B%2525282013%252B%2525E2%252580%252593%252B2014%252529%26aulast%3DStrong%26aufirst%3DKatie%2BL%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D12%26spage%3D1349%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alpa  Khatri</span>, <span class="hlFld-ContribAuthor ">Pieter B.  Burger</span>, <span class="hlFld-ContribAuthor ">Sharon A.  Swanger</span>, <span class="hlFld-ContribAuthor ">Kasper B.  Hansen</span>, <span class="hlFld-ContribAuthor ">Sommer  Zimmerman</span>, <span class="hlFld-ContribAuthor ">Erkan  Karakas</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>, <span class="hlFld-ContribAuthor ">Hiro  Furukawa</span>, <span class="hlFld-ContribAuthor ">James P.  Snyder</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Traynelis</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants and Mechanism of Action of a GluN2C-selective NMDA Receptor Positive Allosteric Modulator. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2014,</strong> <em>86 </em>
                                    (5)
                                     , 548-560. <a href="https://doi.org/10.1124/mol.114.094516" title="DOI URL">https://doi.org/10.1124/mol.114.094516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.114.094516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.114.094516%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DStructural%252BDeterminants%252Band%252BMechanism%252Bof%252BAction%252Bof%252Ba%252BGluN2C-selective%252BNMDA%252BReceptor%252BPositive%252BAllosteric%252BModulator%26aulast%3DKhatri%26aufirst%3DAlpa%26date%3D2014%26date%3D2014%26volume%3D86%26issue%3D5%26spage%3D548%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of screening hit. Chemical structure of methyl 4-(1-(2-(1<i>H</i>-indol-3-yl)ethyl)-3-acetyl-4-hydroxy-5-oxo-2,5-dihydro-1<i>H</i>-pyrrol-2-yl)benzoate (compound <b>1</b>) that was identified as a positive modulator using a fluorescence-based screen of compound libraries in a cell line expressing diheteromeric GluN1/GluN2C NMDA receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1<i>H</i>-Pyrrol-2(5<i>H</i>)-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: PPTS, rt, 1–24 h, 2% to >99% (procedure I). Final compounds <b>161</b>–<b>180</b>, in which either the A or B ring is replaced, were also prepared using these conditions.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route for the Synthesis of Pyruvate Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) diethyl oxalate, NaOEt, EtOH, 0 °C to rt, 4 h, 15% to >99% (procedure II); (b) TIPSCl, imidazole, rt, 6 h, >99%; (c) diethyl oxalate, NaOEt, EtOH, 0 °C to rt, 4 h, 28% (procedure II); (d) TBAF, 0 °C to rt, 1 h, 43%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes to Access Substituted Benzaldehydes <b>32</b>–<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 2.0 equiv NBS, (PhCOO)<sub>2</sub>, reflux, 4 h, then AgNO<sub>3</sub>, rt, 3 h, 38–63%; (b) dibutyl vinylboronate, 5 mol % (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, NaCO<sub>3</sub>, reflux, 2 h, 68–80%; (c) O<sub>3</sub>; then (CH<sub>3</sub>)<sub>2</sub>S, −78 °C to rt, 12 h, 60–87%; (d) <i>i</i>-PrMgCl, DMF, −15 °C to rt, 3 h, 70%; (e) CO<sub>(g)</sub>, (PPh<sub>3</sub>)<sub>2</sub>PdCl<sub>2</sub>, NaCO<sub>3</sub>, 110 °C, 8–24% (procedure IV); (f) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, rt, 3 h, 58%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Routes for the Synthesis of Amides <b>42</b>–<b>44</b> and Esters <b>45</b>–<b>47</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) Vilsmeier reagent, aq NH<sub>3</sub>, 0 °C, 16 h, 30%; (b) R<sup>2a</sup>R<sup>2b</sup>N where R<sup>2a</sup> = H and R<sup>2b</sup> = Me or where R<sup>2a</sup> = R<sup>2b</sup> = Me, DMAP, EDCI, 0 °C to rt, 24 h, 14–51%; (c) R<sup>2</sup>I where R<sup>2</sup> = Et or R<sup>2</sup> = <i>i</i>-Pr, K<sub>2</sub>CO<sub>3</sub>, rt, 4 h, 24–87%; (d) (CH<sub>3</sub>)<sub>2</sub>NCH(O<i>t</i>-Bu)<sub>2</sub>, reflux, 1<sup>1</sup>/<sub>2</sub> h, 81%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Route to Modifications at R<sup>11</sup><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) TMSCH<sub>2</sub>N<sub>2</sub>, rt, 5 h, 46%; (b) NH<sub>4</sub>HCO<sub>2</sub>, reflux, 3 h, 14%; (c) Ac<sub>2</sub>O, pyridine, rt, 6<sup>1</sup>/<sub>2</sub> h, 7%; (d) R<sup>11</sup>C(O)Cl where R<sup>11</sup> = CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub> or R<sup>11</sup> = CH═CH<sub>2</sub>, TEA, −30 °C, 2 h, 20–35%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> selectively potentiates the GluN1/GluN2C response. (A) Current traces for <b>1</b> at the GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, and the GluN1/GluN2D receptors. (B) Compound <b>1</b> selectively potentiates the GluN1/GluN2C receptor to a fitted maximum of 275 ± 10% with an EC<sub>50</sub> of 24 ± 2.4, <i>n</i> = 12. (C) The EC<sub>50</sub> for glycine in the absence and presence of <b>1</b> is 0.20 ± 0.01 μM (<i>n</i> = 6) and 0.16 ± 0.02 μM (<i>n</i> = 4), respectively. The EC<sub>50</sub> for glutamate in the absence and presence of <b>1</b> is 0.8 ± 0.07 μM (<i>n</i> = 8) and 1.2 ± 0.04 μM (<i>n</i> = 6), respectively. The presence of <b>1</b> did not shift the glycine or glutamate EC<sub>50</sub> values significantly. (D) The reversal potential is −5.1 ± 0.8 mV when activated by coagonists (100 μM glutamate and 30 μM glycine) and is −5.0 ± 1.2 mV (<i>n</i> = 6) when the GluN1/GluN2C receptor is potentiated by <b>1</b>. The reversal potential was not significantly shifted in the presence of <b>1</b>, suggesting that potentiation is independent of membrane potential.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/medium/jm-2013-01695d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Composite concentration–effect curves for <b>106</b> enantiomers. Concentration–effect curves for the enantiomers of <b>106</b> demonstrate that only one enantiomer, <b>106a</b>, is active, potentiating the GluN1/GluN2C receptor to a fitted maximum of 259 ± 8% of control with an EC<sub>50</sub> of 18 ± 0.6 μM (<i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401695d/20150210/images/large/jm-2013-01695d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401695d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i126">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 17 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Furukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2873</span><span class="NLM_x">–</span> <span class="NLM_lpage">2885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1093%2Femboj%2Fcdg303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=12805203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1Wqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=2873-2885&author=H.+Furukawaauthor=E.+Gouaux&title=Mechanisms+of+activation%2C+inhibition+and+specificity%3A+crystal+structures+of+the+NMDA+receptor+NR1+ligand-binding+core"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core</span></div><div class="casAuthors">Furukawa, Hiroyasu; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2873-2885</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Excitatory neurotransmission mediated by the N-methyl-d-aspartate subtype of ionotropic glutamate receptors is fundamental to the development and function of the mammalian central nervous system.  NMDA receptors require both glycine and glutamate for activation with NR1 and NR2 forming glycine and glutamate sites, resp.  Mechanisms to describe agonist and antagonist binding, and activation and desensitization of NMDA receptors have been hampered by the lack of high-resoln. structures.  Here, we describe the cocrystal structures of the NR1 S1S2 ligand-binding core with the agonists glycine and d-serine (DS), the partial agonist d-cycloserine (DCS) and the antagonist 5,7-dichlorokynurenic acid (DCKA).  The cleft of the S1S2 clamshell' is open in the presence of the antagonist DCKA and closed in the glycine, DS and DCS complexes.  In addn., the NR1 S1S2 structure reveals the fold and interactions of loop 1, a cysteine-rich region implicated in intersubunit allostery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPvduFLuWuIbVg90H21EOLACvtfcHk0lhbHxkOSlgiHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1Wqsrk%253D&md5=77b3dcc427e5641d0d68b8d97db2f99b</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg303%26sid%3Dliteratum%253Aachs%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DMechanisms%2520of%2520activation%252C%2520inhibition%2520and%2520specificity%253A%2520crystal%2520structures%2520of%2520the%2520NMDA%2520receptor%2520NR1%2520ligand-binding%2520core%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D2873%26epage%3D2885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Furukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancusso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Subunit arrangement and function in NMDA receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x"> (</span><span class="NLM_issue">7065</span><span class="NLM_x">) </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=185-192&issue=7065&author=H.+Furukawaauthor=S.+K.+Singhauthor=R.+Mancussoauthor=E.+Gouaux&title=Subunit+arrangement+and+function+in+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26aulast%3DMancusso%26aufirst%3DR.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DSubunit%2520arrangement%2520and%2520function%2520in%2520NMDA%2520receptors%26jtitle%3DNature%26date%3D2005%26volume%3D438%26issue%3D7065%26spage%3D185%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Traynelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate Receptor Ion Channels: Structure, Regulation and Function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+Traynelisauthor=L.+Wollmuthauthor=C.+McBainauthor=F.+Mennitiauthor=K.+Vanceauthor=K.+Ogdenauthor=K.+Hansenauthor=H.+Yuanauthor=S.+Myersauthor=R.+Dingledine&title=Glutamate+Receptor+Ion+Channels%3A+Structure%2C+Regulation+and+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%26aulast%3DWollmuth%26aufirst%3DL.%26aulast%3DMcBain%26aufirst%3DC.%26aulast%3DMenniti%26aufirst%3DF.%26aulast%3DVance%26aufirst%3DK.%26aulast%3DOgden%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520Receptor%2520Ion%2520Channels%253A%2520Structure%252C%2520Regulation%2520and%2520Function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Akazawa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Differential expression of five <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1002%2Fcne.903470112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=7798379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1994&pages=150-160&author=C.+Akazawaauthor=R.+Shigemotoauthor=Y.+Besshoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Differential+expression+of+five+N-methyl-d-aspartate+receptor+subunit+mRNAs+in+the+cerebellum+of+developing+and+adult+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats</span></div><div class="casAuthors">Akazawa, Chihiro; Shigemoto, Ryuichi; Bessho, Yasumasa; Nakanishi, Shigetada; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-60</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    </div><div class="casAbstract">Five N-methyl-D-aspartate (NMDA) receptor subunits have been identified thus far: NR1, NR2A, NR2B, NR2C, and NR2D.  Here, the authors have analyzed the expression patterns of mRNAs for the NMDA receptor subunits in the developing and adult rats by in situ hybridization.  The developmental changes of the expression patterns were most salient in the cerebellum.  In the external granular layer, hybridization signals of mRNAs for NR1, NR2A, NR2B, and NR2C appeared by postnatal day 3, but no NR2D mRNA was expressed at any developmental stage examd.  The NR1 mRNA was expressed in all cerebellar neurons at all developmental stages examd.  The signals for the NR2A mRNA appeared in Purkinje cells and granule cells during the second postnatal week.  The signals for the NR2B mRNA in granule cells were seen transiently during the first 2 wk after birth.  The signals for NR2C mRNA appeared in granule cells and glial cells during the second postnatal week.  The signals for NR2D mRNA appeared transiently in Purkinje cells during the first 8 postnatal days; in adult rats, these were seen in stellate and Golgi cells.  In the cerebellar nuclei, mRNAs for NR1, NR2A, NR2B, and NR2D were more or less expressed on postnatal day 0, while expression signals for the NR2C mRNA were first detected in postnatal day 14.  Thus, the most conspicuous changes of expression patterns were obsd. in the cerebellar cortex during the first 2 wk after birth, when development and maturation of the cerebellum proceed most rapidly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3uXAbBlyr7Vg90H21EOLACvtfcHk0lhbHxkOSlgiHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1alt74%253D&md5=56ff09fd6667cd9c90a2bc8225261e5a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1002%2Fcne.903470112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.903470112%26sid%3Dliteratum%253Aachs%26aulast%3DAkazawa%26aufirst%3DC.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DBessho%26aufirst%3DY.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDifferential%2520expression%2520of%2520five%2520N-methyl-d-aspartate%2520receptor%2520subunit%2520mRNAs%2520in%2520the%2520cerebellum%2520of%2520developing%2520and%2520adult%2520rats%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1994%26volume%3D347%26spage%3D150%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnashev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurie, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeburg, P. H.</span><span> </span><span class="NLM_article-title">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1016%2F0896-6273%2894%2990210-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=7512349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=529-540&author=H.+Monyerauthor=N.+Burnashevauthor=D.+J.+Laurieauthor=B.+Sakmannauthor=P.+H.+Seeburg&title=Developmental+and+regional+expression+in+the+rat+brain+and+functional+properties+of+four+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</span></div><div class="casAuthors">Monyer, Hannah; Burnashev, Nail; Laurie, David J.; Sakmann, Bert; Seeburg, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">ISS/REP#/MLT:  3</span>),
    <span class="NLM_cas:pages">529-40</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    </div><div class="casAbstract">An in situ study of mRNAs encoding NMDA receptor subunits in the developing rat CNS revealed that, at all stages, the NR1 gene is expressed in virtually all neurons, whereas the four NR2 transcripts display distinct expression patterns.  NR2B and NR2D mRNA occur prenatally, whereas NR2A and NR2C mRNAs are first detected near birth.  All transcripts except NR2D peak around P20.  NR2D mRNA, present mainly in midbrain structures, peaks around P7 and thereafter decreases to adult levels.  Postnatally, NR2B and NR2C transcript levels change in opposite directions in the cerebellar internal granule cell layer.  In the adult hippocampus, NR2A and NR2B mRNAs are prominent in CA1 and CA3 pyramidal cells, but NR2C and NR2D mRNAs occur in different subsets of interneurons.  Recombinant binary NR1-NR2 channels show comparable Ca2+ permeabilities, but marked differences in voltage-dependent Mg2+ block and in offset decay time consts.  Thus, the distinct expression profiles and functional properties of NR2 subunits provide a basis for NMDA channel heterogeneity in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfdrOkgeEJfbVg90H21EOLACvtfcHk0lgCjULG2ORAIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKku7w%253D&md5=9ff9985abba893a28ae4983c5099e913</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2894%2990210-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252894%252990210-0%26sid%3Dliteratum%253Aachs%26aulast%3DMonyer%26aufirst%3DH.%26aulast%3DBurnashev%26aufirst%3DN.%26aulast%3DLaurie%26aufirst%3DD.%2BJ.%26aulast%3DSakmann%26aufirst%3DB.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26atitle%3DDevelopmental%2520and%2520regional%2520expression%2520in%2520the%2520rat%2520brain%2520and%2520functional%2520properties%2520of%2520four%2520NMDA%2520receptors%26jtitle%3DNeuron%26date%3D1994%26volume%3D12%26spage%3D529%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vicini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, D. R.</span><span> </span><span class="NLM_article-title">Functional and pharmacological differences between recombinant <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors</span> <span class="citation_source-journal">J Neurophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1998&pages=555-566&author=S.+Viciniauthor=J.+F.+Wangauthor=J.+H.+Liauthor=W.+J.+Zhuauthor=Y.+H.+Wangauthor=J.+H.+Luoauthor=B.+B.+Wolfeauthor=D.+R.+Grayson&title=Functional+and+pharmacological+differences+between+recombinant+N-methyl-d-aspartate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVicini%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BH.%26aulast%3DLuo%26aufirst%3DJ.%2BH.%26aulast%3DWolfe%26aufirst%3DB.%2BB.%26aulast%3DGrayson%26aufirst%3DD.%2BR.%26atitle%3DFunctional%2520and%2520pharmacological%2520differences%2520between%2520recombinant%2520N-methyl-d-aspartate%2520receptors%26jtitle%3DJ%2520Neurophysiol.%26date%3D1998%26volume%3D72%26spage%3D555%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Control of NMDA receptor function by the NR2 subunit amino-terminal domain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12045</span><span class="NLM_x">–</span> <span class="NLM_lpage">12058</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1523%2FJNEUROSCI.1365-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=19793963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12qu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12045-12058&author=H.+Yuanauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=S.+F.+Traynelis&title=Control+of+NMDA+receptor+function+by+the+NR2+subunit+amino-terminal+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Control of NMDA receptor function by the NR2 subunit amino-terminal domain</span></div><div class="casAuthors">Yuan, Hongjie; Hansen, Kasper B.; Vance, Katie M.; Ogden, Kevin K.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">12045-12058</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors comprised of different NR2 subunits exhibit strikingly unique biophys. and pharmacol. properties.  Here, we report that the extracellular amino-terminal domain (ATD) of the NR2 subunit controls pharmacol. and kinetic properties of recombinant NMDA receptors, such as agonist potency, deactivation time course, open probability (POPEN), and mean open/shut duration.  Using ATD deletion mutants of NR2A, NR2B, NR2C, NR2D, and chimeras of NR2A and NR2D with interchanged ATD [NR2A-(2D-ATD) and NR2D-(2A-ATD)], we show that the ATD contributes to the low glutamate potency of NR2A-contg. NMDA receptors and the high glutamate potency of NR2D-contg. receptors.  The ATD influences the deactivation time courses of NMDA receptors, as removal of the ATD from NR2A slows the deactivation rate, while removal of the ATD from NR2B, NR2C and NR2D accelerates the deactivation rate.  Open probability also is influenced by the ATD.  Removal of the ATD from NR2A or replacement of the NR2A-ATD with that of NR2D decreases POPEN in single-channel recordings from outside-out patches of HEK 293 cells.  In contrast, deletion of the ATD from NR2D or replacement of the NR2D ATD with that of NR2A increases POPEN and mean open duration.  These data demonstrate the modular nature of NMDA receptors, and show that the ATD of the different NR2 subunits plays an important role in fine-tuning the functional properties of the individual NMDA receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqAYFuCYDzeLVg90H21EOLACvtfcHk0lgCjULG2ORAIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12qu7%252FE&md5=2fa9cf03945b968b214633b58ec1ef78</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1365-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1365-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DControl%2520of%2520NMDA%2520receptor%2520function%2520by%2520the%2520NR2%2520subunit%2520amino-terminal%2520domain%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12045%26epage%3D12058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Paoletti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyton, J.</span><span> </span><span class="NLM_article-title">NMDA receptor subunits: function and pharmacology</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1016%2Fj.coph.2006.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=17088105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=39-47&author=P.+Paolettiauthor=J.+Neyton&title=NMDA+receptor+subunits%3A+function+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunits: function and pharmacology</span></div><div class="casAuthors">Paoletti, Pierre; Neyton, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-47</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels widely expressed in the central nervous system that play key roles in excitatory synaptic transmission.  Because of their involvement in numerous neurol. disorders, NMDARs are also targets of therapeutic interest.  NMDARs occur as multiple subtypes which differ in their subunit compn. and in their biophys. and pharmacol. properties.  In particular, NMDARs contain a diversity of sites at which endogenous ligands or pharmacol. agents can act to modulate receptor activity in a subunit-selective manner, and recent structural and functional data have started to reveal the mol. determinants for this subunit selectivity.  These include the binding sites for glutamate, the ion-channel pore and the recently identified allosteric sites on the N-terminal domain.  Other potential sites yet unexplored by medicinal chem. programs are also considered, in particular at the interface between subunits.  Given the growing body of evidence that diverse brain disorders implicate different NMDAR subtypes, such as NR2B in pain or NR3A in white matter injury, there is a growing interest in exploiting the pharmacol. heterogeneity of NMDARs for the development of novel NMDAR subtype-selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ5E8KNWeeb7Vg90H21EOLACvtfcHk0lgCjULG2ORAIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlGitQ%253D%253D&md5=18296410fb9b50af0b2a7ceae124faf4</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DNeyton%26aufirst%3DJ.%26atitle%3DNMDA%2520receptor%2520subunits%253A%2520function%2520and%2520pharmacology%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2007%26volume%3D7%26spage%3D39%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Molecular diversity of glutamate receptors and implications for brain function</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=597-603&author=S.+Nakanishi&title=Molecular+diversity+of+glutamate+receptors+and+implications+for+brain+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DMolecular%2520diversity%2520of%2520glutamate%2520receptors%2520and%2520implications%2520for%2520brain%2520function%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D597%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nicoll, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenka, R. C.</span><span> </span><span class="NLM_article-title">Expression mechanisms underlying NMDA receptor-dependent long-term potentiation</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">868</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=868&publication_year=1999&pages=515-525&author=R.+A.+Nicollauthor=R.+C.+Malenka&title=Expression+mechanisms+underlying+NMDA+receptor-dependent+long-term+potentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicoll%26aufirst%3DR.%2BA.%26aulast%3DMalenka%26aufirst%3DR.%2BC.%26atitle%3DExpression%2520mechanisms%2520underlying%2520NMDA%2520receptor-dependent%2520long-term%2520potentiation%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D868%26spage%3D515%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Choi, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, S. M.</span><span> </span><span class="NLM_article-title">The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal Death</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1146%2Fannurev.ne.13.030190.001131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=1970230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaK3cXkslGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1990&pages=171-182&author=D.+W.+Choiauthor=S.+M.+Rothman&title=The+Role+of+Glutamate+Neurotoxicity+in+Hypoxic-Ischemic+Neuronal+Death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death</span></div><div class="casAuthors">Choi, Dennis W.; Rothman, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">171-82</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    </div><div class="casAbstract">A review with 87 refs. of in vitro and in vivo studies which suggest that glutamate neurotoxicity plays an important role in the pathogenesis of hypoxic-ischemic brain injury.  Rational stroke therapy based on this neurotoxicity is considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdbdpT_WB6LVg90H21EOLACvtfcHk0lhJhVv6vsv_Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkslGksr4%253D&md5=07241a3ba705bd24077ccbd7a806625d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.ne.13.030190.001131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.ne.13.030190.001131%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BW.%26aulast%3DRothman%26aufirst%3DS.%2BM.%26atitle%3DThe%2520Role%2520of%2520Glutamate%2520Neurotoxicity%2520in%2520Hypoxic-Ischemic%2520Neuronal%2520Death%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1990%26volume%3D13%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hu, N.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondrejcak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, M. J.</span><span> </span><span class="NLM_article-title">Glutamate receptors in preclinical research on Alzheimer’s disease: update on recent advances</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2012&pages=855-862&author=N.-W.+Huauthor=T.+Ondrejcakauthor=M.+J.+Rowan&title=Glutamate+receptors+in+preclinical+research+on+Alzheimer%E2%80%99s+disease%3A+update+on+recent+advances"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DN.-W.%26aulast%3DOndrejcak%26aufirst%3DT.%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26atitle%3DGlutamate%2520receptors%2520in%2520preclinical%2520research%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520update%2520on%2520recent%2520advances%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2012%26volume%3D100%26spage%3D855%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Coyle, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benneyworth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopaske, G.</span><span> </span><span class="NLM_article-title">Glutamatergic synaptic disregulation in schizophrenia: therapeutic implications</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1007%2F978-3-642-25758-2_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=23027419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2012&pages=267-295&author=J.+T.+Coyleauthor=A.+Basuauthor=M.+Benneyworthauthor=D.+Baluauthor=G.+Konopaske&title=Glutamatergic+synaptic+disregulation+in+schizophrenia%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications</span></div><div class="casAuthors">Coyle, Joseph T.; Basu, Alo; Benneyworth, Michael; Balu, Darrick; Konopaske, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">Novel Antischizophrenia Treatments</span>),
    <span class="NLM_cas:pages">267-295</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Schizophrenia affects approx. 1% of the population and continues to be assocd. with poor outcome because of the limited efficacy of and noncompliance with existing antipsychotic medications.  An alternative hypothesis invoking the excitatory neurotransmitter, glutamate, arose out of clin. observations that NMDA receptor antagonists, the dissociative anesthetics like ketamine, can replicate in normal individuals the full range of symptoms of schizophrenia including psychosis, neg. symptoms, and cognitive impairments.  Low dose ketamine can also re-create a no. of physiol. abnormalities characteristic of schizophrenia.  Postmortem studies have revealed abnormalities in endogenous modulators of NMDA receptors in schizophrenia as well as components of a postsynaptic d. where NMDA receptors are localized.  Gene assocn. studies have revealed several genes that affect NMDA receptor function whose allelic variants are assocd. with increased risk for schizophrenia including genes encoding D-amino acid oxidase, its modulator G72, dysbindin, and neuregulin.  The parvalbumin-pos., fast-firing GABAergic interneurons that provide recurrent inhibition to cortical-limbic pyramidal neurons seem to be most sensitive to NMDA receptor hypofunction.  As a consequence, disinhibition of glutamatergic efferents disrupts cortical processing, causing cognitive impairments and neg. symptoms, and drives subcortical dopamine release, resulting in psychosis.  Drugs designed to correct the cortical-limbic dysregulated glutamatergic neurotransmission show promise for reducing neg. and cognitive symptoms of schizophrenia as well as its pos. symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUOYchIYYK7Vg90H21EOLACvtfcHk0lhJhVv6vsv_Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Giu7w%253D&md5=1cda996ff05ed79c6ff89bc9cac0d050</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-25758-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-25758-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBenneyworth%26aufirst%3DM.%26aulast%3DBalu%26aufirst%3DD.%26aulast%3DKonopaske%26aufirst%3DG.%26atitle%3DGlutamatergic%2520synaptic%2520disregulation%2520in%2520schizophrenia%253A%2520therapeutic%2520implications%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D213%26spage%3D267%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mathew, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapidus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermeyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrough, J. W.</span><span> </span><span class="NLM_article-title">Ketamine for Treatment-Resistant Unipolar Depression</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=189-204&author=S.+J.+Mathewauthor=A.+Shahauthor=K.+Lapidusauthor=C.+Clarkauthor=N.+Jarunauthor=B.+Ostermeyerauthor=J.+W.+Murrough&title=Ketamine+for+Treatment-Resistant+Unipolar+Depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DLapidus%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DJarun%26aufirst%3DN.%26aulast%3DOstermeyer%26aufirst%3DB.%26aulast%3DMurrough%26aufirst%3DJ.%2BW.%26atitle%3DKetamine%2520for%2520Treatment-Resistant%2520Unipolar%2520Depression%26jtitle%3DCNS%2520Drugs%26date%3D2012%26volume%3D26%26spage%3D189%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hallett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spoelgen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunah, A. W.</span><span> </span><span class="NLM_article-title">Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">4690</span><span class="NLM_x">–</span> <span class="NLM_lpage">4700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1523%2FJNEUROSCI.0792-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=16641250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFWqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=4690-4700&author=P.+J.+Hallettauthor=R.+Spoelgenauthor=B.+T.+Hymanauthor=D.+G.+Standaertauthor=A.+W.+Dunah&title=Dopamine+D1+Activation+Potentiates+Striatal+NMDA+Receptors+by+Tyrosine+Phosphorylation-Dependent+Subunit+Trafficking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking</span></div><div class="casAuthors">Hallett, Penelope J.; Spoelgen, Robert; Hyman, Bradley T.; Standaert, David G.; Dunah, Anthone W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4690-4700</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Interactions between dopaminergic and glutamatergic afferents in the striatum are essential for motor learning and the regulation of movement.  An important mechanism for these interactions is the ability of dopamine, through D1 receptors, to potentiate NMDA glutamate receptor function.  Here we show that, in striatal neurons, D1 receptor activation leads to rapid trafficking of NMDA receptor subunits, with increased NR1 and NR2B subunits in dendrites, enhanced coclustering of these subunits with the postsynaptic d. scaffolding mol. postsynaptic d.-95, and increased surface expression.  The dopamine D1 receptor-mediated NMDA receptor trafficking is blocked by an inhibitor of tyrosine kinases.  Blockers of tyrosine phosphatases also induce NMDA subunit trafficking, but this effect is nonselective and alters both NR2A- and NR2B-contg. receptors.  Furthermore, tyrosine phosphatase inhibition leads to the clustering of tyrosine-phosphorylated NR2B subunit along dendritic shafts.  Our findings reveal that D1 receptor activation can potentiate striatal NMDA subunit function by directly promoting the surface insertion of the receptor complexes.  This effect is regulated by the reciprocal actions of protein tyrosine phosphatases and tyrosine kinases.  Modification of these pathways may be a useful therapeutic target for Parkinson's disease and other basal ganglia disorders in which abnormal function of striatal NMDA receptors contributes to the symptoms of the diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIxPqagk0j8LVg90H21EOLACvtfcHk0liTJl0J8Nmmxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFWqu7w%253D&md5=46db98f3a599e3b1de6f2fdb234c3063</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0792-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0792-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DSpoelgen%26aufirst%3DR.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26atitle%3DDopamine%2520D1%2520Activation%2520Potentiates%2520Striatal%2520NMDA%2520Receptors%2520by%2520Tyrosine%2520Phosphorylation-Dependent%2520Subunit%2520Trafficking%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D4690%26epage%3D4700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hallett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span> </span><span class="NLM_article-title">Rationale for and use of NMDA receptor antagonists in Parkinson’s disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1016%2Fj.pharmthera.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=15163596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2004&pages=155-174&author=P.+J.+Hallettauthor=D.+G.+Standaert&title=Rationale+for+and+use+of+NMDA+receptor+antagonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale for and use of NMDA receptor antagonists in Parkinson's disease</span></div><div class="casAuthors">Hallett, Penelope J.; Standaert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-174</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  N-Methyl-D-aspartate (NMDA) glutamate receptors are a class of excitatory amino acid receptors, which have several important functions in the motor circuits of the basal ganglia, and are viewed as important targets for the development of new drugs to prevent or treat Parkinson's disease (PD).  NMDA receptors are ligand-gated ion channels composed of multiple subunits, each of which has distinct cellular and regional patterns of expression.  They have complex regulatory properties, with both agonist and co-agonist binding sites and regulation by phosphorylation and protein-protein interactions.  They are found in all of the structures of the basal ganglia, although the subunit compn. in the various structures is different.  NMDA receptors present in the striatum are crucial for dopamine-glutamate interactions.  The abundance, structure, and function of striatal receptors are altered by the dopamine depletion and further modified by the pharmacol. treatments used in PD.  In animal models, NMDA receptor antagonists are effective antiparkinsonian agents and can reduce the complications of chronic dopaminergic therapy (wearing off and dyskinesias).  Use of these agents in humans has been limited because of the adverse effects assocd. with nonselective blockade of NMDA receptor function, but the development of more potent and selective pharmaceuticals holds the promise of an important new therapeutic approach for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ar05ZbM9e7Vg90H21EOLACvtfcHk0liTJl0J8Nmmxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVCiur4%253D&md5=9a8db709281a9e22c8d77438d6862562</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26atitle%3DRationale%2520for%2520and%2520use%2520of%2520NMDA%2520receptor%2520antagonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D102%26spage%3D155%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hallett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunah, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravenscroft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crossman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D. G.</span><span> </span><span class="NLM_article-title">Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson’s disease</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=503-516&author=P.+J.+Hallettauthor=A.+W.+Dunahauthor=P.+Ravenscroftauthor=S.+Zhouauthor=E.+Bezardauthor=A.+R.+Crossmanauthor=J.+M.+Brotchieauthor=D.+G.+Standaert&title=Alterations+of+striatal+NMDA+receptor+subunits+associated+with+the+development+of+dyskinesia+in+the+MPTP-lesioned+primate+model+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHallett%26aufirst%3DP.%2BJ.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26aulast%3DRavenscroft%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DCrossman%26aufirst%3DA.%2BR.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26aulast%3DStandaert%26aufirst%3DD.%2BG.%26atitle%3DAlterations%2520of%2520striatal%2520NMDA%2520receptor%2520subunits%2520associated%2520with%2520the%2520development%2520of%2520dyskinesia%2520in%2520the%2520MPTP-lesioned%2520primate%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D48%26spage%3D503%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Duty, S.</span><span> </span><span class="NLM_article-title">Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1017-1032&author=S.+Duty&title=Targeting+Glutamate+Receptors+to+Tackle+the+Pathogenesis%2C+Clinical+Symptoms+and+Levodopa-Induced+Dyskinesia+Associated+with+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuty%26aufirst%3DS.%26atitle%3DTargeting%2520Glutamate%2520Receptors%2520to%2520Tackle%2520the%2520Pathogenesis%252C%2520Clinical%2520Symptoms%2520and%2520Levodopa-Induced%2520Dyskinesia%2520Associated%2520with%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCNS%2520Drugs%26date%3D2012%26volume%3D26%26spage%3D1017%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipton, S. A.</span><span> </span><span class="NLM_article-title">Excitatory amino acids, S-nitrosylation, and protein misfolding in neurodegenerative disease protection by memantine and nitromemantine at NMDA-gated channels</span> <span class="citation_source-journal">Oxid. Stress Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">Micronutrients and Brain Health</span><span class="NLM_x">) </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVansrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=59-78&issue=Micronutrients+and+Brain+Health&author=T.+Nakamuraauthor=S.+A.+Lipton&title=Excitatory+amino+acids%2C+S-nitrosylation%2C+and+protein+misfolding+in+neurodegenerative+disease+protection+by+memantine+and+nitromemantine+at+NMDA-gated+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acids, S-Nitrosylation, and protein misfolding in neurodegenerative disease protection by memantine and nitromemantine at NMDA-gated channels</span></div><div class="casAuthors">Nakamura, Tomohiro; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative Stress and Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Micronutrients and Brain Health</span>),
    <span class="NLM_cas:pages">59-78</span>CODEN:
                <span class="NLM_cas:coden">OSDIFK</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">CRC Press</span>)
        </div><div class="casAbstract">A review.  A review presents the specific examples showing that S-nitrosylation of ubiquitin E3 ligases, such as parkin, or endoplasmic reticulum chaperones, such as protein disulfide isomerase (PDI), is crit. for the accumulation of misfolded proteins in neurodegenerative diseases such as Parkinson's disease and other conditions.  It also discusses the neuroprotective mechanism of action of N-methyl-D-aspartate (NMDA) open-channel blockers such as memantine and NO-related drugs for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKCRz7LIDdJrVg90H21EOLACvtfcHk0ljkFtsNOaIZfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVansrk%253D&md5=5708a8514f51ec4dd924c34b0c77aa96</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DLipton%26aufirst%3DS.%2BA.%26atitle%3DExcitatory%2520amino%2520acids%252C%2520S-nitrosylation%252C%2520and%2520protein%2520misfolding%2520in%2520neurodegenerative%2520disease%2520protection%2520by%2520memantine%2520and%2520nitromemantine%2520at%2520NMDA-gated%2520channels%26jtitle%3DOxid.%2520Stress%2520Dis.%26date%3D2010%26volume%3D26%26issue%3DMicronutrients%2520and%2520Brain%2520Health%26spage%3D59%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santangelo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S.</span><span> </span><span class="NLM_article-title">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span> <span class="citation_source-journal">Nature Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1038%2Fncomms1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=90&author=P.+Mullasserilauthor=K.+Hansenauthor=K.+Vanceauthor=K.+Ogdenauthor=H.+Yuanauthor=N.+Kurtkayaauthor=R.+Santangeloauthor=A.+Orrauthor=P.+Leauthor=K.+Vellanoauthor=D.+Liottaauthor=S.+Traynelis&title=A+subunit-selective+potentiator+of+NR2C-+and+NR2D-containing+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span></div><div class="casAuthors">Mullasseril Praseeda; Hansen Kasper B; Vance Katie M; Ogden Kevin K; Yuan Hongjie; Kurtkaya Natalie L; Santangelo Rose; Orr Anna G; Le Phuong; Vellano Kimberly M; Liotta Dennis C; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors are tetrameric complexes of NR1 and NR2A-D subunits that mediate excitatory synaptic transmission and have a role in neurological disorders.  In this article, we identify a novel subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit, which could allow selective modification of circuit function in regions expressing NR2C/D subunits.  The substituted tetrahydroisoquinoline CIQ (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone) enhances receptor responses two-fold with an EC(50) of 3 μM by increasing channel opening frequency without altering mean open time or EC(50) values for glutamate or glycine.  The actions of CIQ depend on a single residue in the M1 region (NR2D Thr592) and on the linker between the N-terminal domain and agonist binding domain.  CIQ potentiates native NR2D-containing NMDA receptor currents from subthalamic neurons.  Our identification of a subunit-selective NMDA receptor modulator reveals a new class of pharmacological tools with which to probe the role of NR2C- and NR2D-containing NMDA receptors in brain function and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtyzdcP07UmufW6udTcc2eY2r9hYTv9_tLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D&md5=8cde7c73dc6bf72ea3050c21db4f5ad4</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fncomms1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1085%26sid%3Dliteratum%253Aachs%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DVance%26aufirst%3DK.%26aulast%3DOgden%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DKurtkaya%26aufirst%3DN.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DOrr%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DTraynelis%26aufirst%3DS.%26atitle%3DA%2520subunit-selective%2520potentiator%2520of%2520NR2C-%2520and%2520NR2D-containing%2520NMDA%2520receptors%26jtitle%3DNature%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mosley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellano, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bräuner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5476</span><span class="NLM_x">–</span> <span class="NLM_lpage">5490</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100027p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5476-5490&author=C.+A.+Mosleyauthor=T.+M.+Ackerauthor=K.+B.+Hansenauthor=P.+Mullasserilauthor=K.+T.+Andersenauthor=P.+Leauthor=K.+M.+Vellanoauthor=H.+Br%C3%A4uner-Osborneauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=Quinazolin-4-one+Derivatives%3A+A+Novel+Class+of+Noncompetitive+NR2C%2FD+Subunit-Selective+N-Methyl-d-aspartate+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm100027p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100027p%26sid%3Dliteratum%253Aachs%26aulast%3DMosley%26aufirst%3DC.%2BA.%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DAndersen%26aufirst%3DK.%2BT.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DBr%25C3%25A4uner-Osborne%26aufirst%3DH.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DQuinazolin-4-one%2520Derivatives%253A%2520A%2520Novel%2520Class%2520of%2520Noncompetitive%2520NR2C%252FD%2520Subunit-Selective%2520N-Methyl-d-aspartate%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5476%26epage%3D5490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bettini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffante, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carignani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senar-Sancho, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardullo, F.</span><span> </span><span class="NLM_article-title">Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1124%2Fjpet.110.172544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=20810618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=636-644&author=E.+Bettiniauthor=A.+Savaauthor=C.+Griffanteauthor=C.+Carignaniauthor=A.+Busonauthor=A.+M.+Capelliauthor=M.+Negriauthor=F.+Andreetaauthor=S.+A.+Senar-Sanchoauthor=L.+Guiralauthor=F.+Cardullo&title=Identification+and+characterization+of+novel+NMDA+receptor+antagonists+selective+for+NR2A-+over+NR2B-containing+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors</span></div><div class="casAuthors">Bettini, Ezio; Sava, Anna; Griffante, Cristiana; Carignani, Corrado; Buson, Alberto; Capelli, Anna Maria; Negri, Michele; Andreetta, Filippo; Senar-Sancho, Sergio A.; Guiral, Lorena; Cardullo, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-644</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NR1/NR2A is a subtype of N-methyl-D-aspartate receptors (NMDARs), which are glutamate and glycine-gated Ca2+-permeable channels highly expressed in the central nervous system.  A high-throughput screening (HTS) campaign using human osteosarcoma (U-2 OS) cells transiently transduced with NR1/NR2A NMDAR subunits, tested in a specifically designed fluorometric imaging plate reader (FLIPR)/Ca2+ assay, identified sulfonamide deriv. series, exemplified by 3-chloro-4-fluoro-N-[(4-{[2-(phenylcarbonyl)hydrazino]carbonyl}phenyl)methyl]benzenesulfonamide (compd. 1) and thiodiazole deriv. N-(cyclohexylmethyl)-2-({5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio)acetamide (compd. 13) as novel NR1/NR2A receptor antagonists.  Compds. 1 and 13 displayed submicromolar and micromolar potency at NR1/NR2A receptor, resp., although they did not show activity at NR2B-contg. receptor up to 50 μM concn.  Addn. of 1 mM glycine, but not 1 mM L-glutamate, was able to surmount compd. 1 and 13 inhibitory effects in FLIPR NR1/NR2A assay.  However, compds. 1 and 13 displaced a glutamate site antagonist [3H]D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid ([3H]CGP 39653) to a greater extent than the glycine site antagonist [3H]3-[(E)-2-carboxy-2-phenylethenyl]-4,6-dichloro-1H-indole-2-carboxylic acid ([3H]MDL 105,519), in rat brain cortex binding assay.  Results of FLIPR cell-based, electrophysiol., and biochem. binding assays suggest that compds. 1 and 13 are the prototypes of novel classes of NMDAR ligands, which to the best of our knowledge are the first selective antagonists at NR1/NR2A over NR1/NR2B receptor, and might constitute useful tools able to elucidate the relative role of the NR2A subunit in physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFB-QKFiC9sLVg90H21EOLACvtfcHk0liLfRumd0xong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnK&md5=0bffd70be964ba27d17b9fbd877eaef0</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172544%26sid%3Dliteratum%253Aachs%26aulast%3DBettini%26aufirst%3DE.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DCarignani%26aufirst%3DC.%26aulast%3DBuson%26aufirst%3DA.%26aulast%3DCapelli%26aufirst%3DA.%2BM.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAndreeta%26aufirst%3DF.%26aulast%3DSenar-Sancho%26aufirst%3DS.%2BA.%26aulast%3DGuiral%26aufirst%3DL.%26aulast%3DCardullo%26aufirst%3DF.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520novel%2520NMDA%2520receptor%2520antagonists%2520selective%2520for%2520NR2A-%2520over%2520NR2B-containing%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D636%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo-Martin, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skifter, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, D. T.</span><span> </span><span class="NLM_article-title">A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1124%2Fjpet.110.174144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=20858708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=614-621&author=B.+M.+Costaauthor=M.+W.+Irvineauthor=G.+Fangauthor=R.+J.+Eavesauthor=M.+B.+Mayo-Martinauthor=D.+A.+Skifterauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=A+Novel+Family+of+Negative+and+Positive+Allosteric+Modulators+of+NMDA+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of negative and positive allosteric modulators of NMDA receptors</span></div><div class="casAuthors">Costa, Blaise Mathias; Irvine, Mark W.; Fang, Guangyu; Eaves, Richard J.; Mayo-Martin, Marie Belen; Skifter, Donald A.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-621</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor family regulates various central nervous system functions, such as synaptic plasticity.  However, hypo- or hyperactivation of NMDA receptors is critically involved in many neurol. and psychiatric conditions, such as pain, stroke, epilepsy, neurodegeneration, schizophrenia, and depression.  Consequently, subtype-selective pos. and neg. modulators of NMDA receptor function have many potential therapeutic applications not addressed by currently available compds.  We have identified allosteric modulators with several novel patterns of NMDA receptor subtype selectivity that have a novel mechanism of action.  In a series of carboxylated naphthalene and phenanthrene derivs., compds. were identified that selectively potentiate responses at GluN1/GluN2A [e.g., 9-iodophenanthrene-3-carboxylic acid (UBP512)]; GluN1/GluN2A and GluN1/GluN2B [9-cyclopropylphenanthrene-3-carboxylic acid (UBP710)]; GluN1/GluN2D [3,5-dihydroxynaphthalene-2-carboxylic acid (UBP551)]; or GluN1/GluN2C and GluN1/GluN2D receptors [6-, 7-, 8-, and 9-nitro isomers of naphth[1,2-c][1,2,5]oxadiazole-5-sulfonic acid (NSC339614)] and have no effect or inhibit responses at the other NMDA receptors.  Selective inhibition was also obsd.; UBP512 inhibits only GluN1/GluN2C and GluN1/GluN2D receptors, whereas 6-bromo-2-oxo-2H-chromene-3-carboxylic acid (UBP608) inhibits GluN1/GluN2A receptors with a 23-fold selectivity compared with GluN1/GluN2D receptors.  The actions of these compds. were not competitive with the agonists L-glutamate or glycine and were not voltage-dependent.  Whereas the N-terminal regulatory domain was not necessary for activity of either potentiators or inhibitors, segment 2 of the agonist ligand-binding domain was important for potentiating activity, whereas subtype-specific inhibitory activity was dependent upon segment 1.  In terms of chem. structure, activity profile, and mechanism of action, these modulators represent a new class of pharmacol. agents for the study of NMDA receptor subtype function and provide novel lead compds. for a variety of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9F9N6PVoh7Vg90H21EOLACvtfcHk0liLfRumd0xong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI&md5=cefc65523d06856f6dd704274ecb6f22</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174144%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DEaves%26aufirst%3DR.%2BJ.%26aulast%3DMayo-Martin%26aufirst%3DM.%2BB.%26aulast%3DSkifter%26aufirst%3DD.%2BA.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DA%2520Novel%2520Family%2520of%2520Negative%2520and%2520Positive%2520Allosteric%2520Modulators%2520of%2520NMDA%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D614%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Mechanism for Noncompetitive Inhibition by Novel GluN2C/D <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate Receptor Subunit-Selective Modulators</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=782-795&author=T.+M.+Ackerauthor=H.+Yuanauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+S.+Jensenauthor=P.+B.+Burgerauthor=P.+Mullasserilauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=Mechanism+for+Noncompetitive+Inhibition+by+Novel+GluN2C%2FD+N-Methyl-d-aspartate+Receptor+Subunit-Selective+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DMechanism%2520for%2520Noncompetitive%2520Inhibition%2520by%2520Novel%2520GluN2C%252FD%2520N-Methyl-d-aspartate%2520Receptor%2520Subunit-Selective%2520Modulators%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D782%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Santangelo Freel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chepiga, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship of Tetrahydroisoquinoline-Based Potentiators of GluN2C and GluN2D Containing <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5351</span><span class="NLM_x">–</span> <span class="NLM_lpage">5381</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400177t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5351-5381&author=R.+M.+Santangelo+Freelauthor=K.+K.+Ogdenauthor=K.+L.+Strongauthor=A.+Khatriauthor=K.+M.+Chepigaauthor=H.+S.+Jensenauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+of+Tetrahydroisoquinoline-Based+Potentiators+of+GluN2C+and+GluN2D+Containing+N-Methyl-d-aspartate+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1021%2Fjm400177t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400177t%26sid%3Dliteratum%253Aachs%26aulast%3DSantangelo%2BFreel%26aufirst%3DR.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DStrong%26aufirst%3DK.%2BL.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DChepiga%26aufirst%3DK.%2BM.%26aulast%3DJensen%26aufirst%3DH.%2BS.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Tetrahydroisoquinoline-Based%2520Potentiators%2520of%2520GluN2C%2520and%2520GluN2D%2520Containing%2520N-Methyl-d-aspartate%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5351%26epage%3D5381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Acker, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slabber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacsa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships and Pharmacophore Model of a Noncompetitive Pyrazoline Containing Class of GluN2C/GluN2D Selective Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6434</span><span class="NLM_x">–</span> <span class="NLM_lpage">6456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400652r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6434-6456&author=T.+M.+Ackerauthor=A.+Khatriauthor=K.+M.+Vanceauthor=C.+Slabberauthor=J.+Bacsaauthor=J.+P.+Snyderauthor=S.+F.+Traynelisauthor=D.+C.+Liotta&title=Structure%E2%80%93Activity+Relationships+and+Pharmacophore+Model+of+a+Noncompetitive+Pyrazoline+Containing+Class+of+GluN2C%2FGluN2D+Selective+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1021%2Fjm400652r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400652r%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DT.%2BM.%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DSlabber%26aufirst%3DC.%26aulast%3DBacsa%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520and%2520Pharmacophore%2520Model%2520of%2520a%2520Noncompetitive%2520Pyrazoline%2520Containing%2520Class%2520of%2520GluN2C%252FGluN2D%2520Selective%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6434%26epage%3D6456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Hansen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Subunit-selective allosteric inhibition of glycine binding to NMDA receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">6197</span><span class="NLM_x">–</span> <span class="NLM_lpage">6208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1523%2FJNEUROSCI.5757-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=22553026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFeit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=6197-6208&author=B.+K.+Hansenauthor=K.+K.+Ogdenauthor=S.+F.+Traynelis&title=Subunit-selective+allosteric+inhibition+of+glycine+binding+to+NMDA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11hR"><div class="casContent"><span class="casTitleNuber">11h</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit-selective allosteric inhibition of glycine binding to NMDA receptors</span></div><div class="casAuthors">Hansen, Kasper B.; Ogden, Kevin K.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6197-6208</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">NMDA receptors are ligand-gated ion channels that mediate excitatory neurotransmission in the brain and are involved in numerous neuropathol. conditions.  NMDA receptors are activated upon simultaneous binding of coagonists glycine and glutamate to the GluN1 and GluN2 subunits, resp.  Subunit-selective modulation of NMDA receptor function by ligand binding to modulatory sites distinct from the agonist binding sites could allow pharmacol. intervention with therapeutically beneficial mechanisms.  Here, we show the mechanism of action for 3-chloro-4-fluoro-N-[(4-[(2-(phenylcarbonyl)hydrazino)carbonyl]phenyl)methyl]-benzenesulfonamide (TCN-201), a new GluN1/GluN2A-selective NMDA receptor antagonist whose inhibition can be surmounted by glycine.  Electrophysiol. recordings from chimeric and mutant rat NMDA receptors suggest that TCN-201 binds to a novel allosteric site located at the dimer interface between the GluN1 and GluN2 agonist binding domains.  Furthermore, we demonstrate that occupancy of this site by TCN-201 inhibits NMDA receptor function by reducing glycine potency.  TCN-201 is therefore a neg. allosteric modulator of glycine binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_V305_Cww-rVg90H21EOLACvtfcHk0lgK3Rt10-UMug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFeit7g%253D&md5=ce1b6e1eb6403591bf460fda8a6550b1</span></div><a href="/servlet/linkout?suffix=cit11h&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5757-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5757-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DB.%2BK.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DSubunit-selective%2520allosteric%2520inhibition%2520of%2520glycine%2520binding%2520to%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D6197%26epage%3D6208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gauuan, P. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trova, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor-Boros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocckino, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crapo, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, B. J.</span><span> </span><span class="NLM_article-title">Superoxide dismutase mimetics: synthesis and structure–activity relationship study of MnTBAP analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3013</span><span class="NLM_x">–</span> <span class="NLM_lpage">3021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=3013-3021&author=P.+J.+F.+Gauuanauthor=M.+P.+Trovaauthor=L.+Gregor-Borosauthor=S.+B.+Bocckinoauthor=J.+D.+Crapoauthor=B.+J.+Day&title=Superoxide+dismutase+mimetics%3A+synthesis+and+structure%E2%80%93activity+relationship+study+of+MnTBAP+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGauuan%26aufirst%3DP.%2BJ.%2BF.%26aulast%3DTrova%26aufirst%3DM.%2BP.%26aulast%3DGregor-Boros%26aufirst%3DL.%26aulast%3DBocckino%26aufirst%3DS.%2BB.%26aulast%3DCrapo%26aufirst%3DJ.%2BD.%26aulast%3DDay%26aufirst%3DB.%2BJ.%26atitle%3DSuperoxide%2520dismutase%2520mimetics%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520MnTBAP%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D3013%26epage%3D3021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kelly, M. G.; Kincaid, J.; Duncton, M.; Sahasrabudhe, K.; Janagani, S.; Upasani, R. B.; Wu, G.; Fang, Y.; Weig, Z.-L.</span><span> </span><span class="NLM_article-title">Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using same</span>. US 2006/0194801,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+G.+Kelly&author=J.+Kincaid&author=M.+Duncton&author=K.+Sahasrabudhe&author=S.+Janagani&author=R.+B.+Upasani&author=G.+Wu&author=Y.+Fang&author=Z.-L.+Weig&title=Amide+derivatives+as+ion-channel+ligands+and+pharmaceutical+compositions+and+methods+of+using+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BG.%26atitle%3DAmide%2520derivatives%2520as%2520ion-channel%2520ligands%2520and%2520pharmaceutical%2520compositions%2520and%2520methods%2520of%2520using%2520same%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Widmer, U.</span><span> </span><span class="NLM_article-title">A convenient preparation of <i>t</i>-butyl esters</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1055%2Fs-1983-30253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADyaL3sXhsVamtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1983&pages=135-136&author=U.+Widmer&title=A+convenient+preparation+of+t-butyl+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient preparation of tert-butyl esters</span></div><div class="casAuthors">Widmer, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-6</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Heating carboxylic acids RCO2H (R = aryl, 1-pentenyl, 1-heptynyl, 3-oxobutyl, protected prolyl residue) with 4 equiv (Me3CO)2CHNMe2 (I) in benzene or toluene at 80° gave RCO2CMe3 in 55-83% yields.  Diesters (CH2)n(CO2CMe3)2 (n = 2, 3) were obtained similarly using 8 equiv I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4MbvHNZLT5bVg90H21EOLACvtfcHk0lilpMflVi4_Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhsVamtbk%253D&md5=f3dbb22aef634cfaacd5f9df144fa782</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-1983-30253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1983-30253%26sid%3Dliteratum%253Aachs%26aulast%3DWidmer%26aufirst%3DU.%26atitle%3DA%2520convenient%2520preparation%2520of%2520t-butyl%2520esters%26jtitle%3DSynthesis%26date%3D1983%26spage%3D135%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risgaard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perszyk, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Structural determinants of agonist efficacy at the glutamate binding site of <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=114-127&author=K.+B.+Hansenauthor=N.+Tajimaauthor=R.+Risgaardauthor=R.+E.+Perszykauthor=L.+J%C3%B8rgensenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=R.+P.+Clausenauthor=H.+Furukawaauthor=S.+F.+Traynelis&title=Structural+determinants+of+agonist+efficacy+at+the+glutamate+binding+site+of+N-methyl-d-aspartate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DTajima%26aufirst%3DN.%26aulast%3DRisgaard%26aufirst%3DR.%26aulast%3DPerszyk%26aufirst%3DR.%2BE.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DL.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DClausen%26aufirst%3DR.%2BP.%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520determinants%2520of%2520agonist%2520efficacy%2520at%2520the%2520glutamate%2520binding%2520site%2520of%2520N-methyl-d-aspartate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26spage%3D114%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.2174%2F138620708784246040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=18473740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslCisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=304-315&author=K.+B.+Hansenauthor=H.+Brauner-Osborneauthor=J.+Egebjerg&title=Pharmacological+characterization+of+ligands+at+recombinant+NMDA+receptor+subtypes+by+electrophysiological+recordings+and+intracellular+calcium+measurements"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements</span></div><div class="casAuthors">Hansen, Kasper B.; Brauner-Osborne, Hans; Egebjerg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">304-315</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Generation of in vitro cellular assays using fluorescence measurements at heterologously expressed NMDA receptors would speed up the process of ligand characterization and enable high-throughput screening.  The major drawback to the development of such assays is the cytotoxicity caused by Ca2+-flux into the cell via NMDA receptors upon prolonged activation by agonists present in the culture medium.  In the present study, we established four cell lines with stable expression of NMDA receptor subtypes NR1/NR2A, NR1/NR2B, NR1/NR2C, or NR1/NR2D in BHK-21 cells.  To assess the usefulness of the stable cell lines in conjunction with intracellular calcium ([Ca2+]i) measurements for evaluation of NMDA receptor pharmacol., several ligands were characterized using this method.  The results were compared to parallel data obtained by electrophysiol. recordings at NMDA receptors expressed in Xenopus oocytes.  This comparison showed that agonist potencies detd. by [Ca2+]i measurements and electrophysiol. recordings correlated well, meaning that the stable cell lines in conjunction with [Ca2+]i measurements provide a useful tool for characterization of NMDA receptor ligands.  The agonist series of conformationally constrained glutamate analogs (2S,3R,4S)-α-(carboxycyclopropyl)glycine (CCG), 1-aminocyclobutane-r-1,cis-3-dicarboxylic acid (trans-ACBD), and (±)-1-aminocyclopentane-r-1,cis-3-dicarboxylic acid (cis-ACPD), as well as the highly potent agonist tetrazolylglycine were among the characterized ligands that were assessed with respect to subtype selectivity at NMDA receptors.  However, none of the characterized agonists displays more than 2-3 fold selectivity toward a specific NMDA receptor subtype.  Thus, the present study provides a broad pharmacol. characterization of structurally diverse ligands at recombinant NMDA receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYuZIWYgVeGbVg90H21EOLACvtfcHk0lilpMflVi4_Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslCisb4%253D&md5=4e07adfe9e1d8d9e4a0dd9f69ca15eeb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F138620708784246040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620708784246040%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DEgebjerg%26aufirst%3DJ.%26atitle%3DPharmacological%2520characterization%2520of%2520ligands%2520at%2520recombinant%2520NMDA%2520receptor%2520subtypes%2520by%2520electrophysiological%2520recordings%2520and%2520intracellular%2520calcium%2520measurements%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2008%26volume%3D11%26spage%3D304%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullasseril, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvist, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P.</span><span> </span><span class="NLM_article-title">Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401695d&amp;key=10.1124%2Fjpet.110.166256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401695d&amp;key=20197375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401695d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFCls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=650-662&author=K.+B.+Hansenauthor=P.+Mullasserilauthor=S.+Dawitauthor=N.+Kurtkayaauthor=H.+Yuanauthor=K.+Vanceauthor=A.+Orrauthor=T.+Kvistauthor=K.+Ogdenauthor=P.+Le&title=Implementation+of+a+fluorescence-based+screening+assay+identifies+histamine+H3+receptor+antagonists+clobenpropit+and+iodophenpropit+as+subunit-selective+N-methyl-d-aspartate+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists</span></div><div class="casAuthors">Hansen, Kasper B.; Mullasseril, Praseeda; Dawit, Sara; Kurtkaya, Natalie L.; Yuan, Hongjie; Vance, Katie M.; Orr, Anna G.; Kvist, Trine; Ogden, Kevin K.; Le, Phuong; Vellano, Kimberly M.; Lewis, Iestyn; Kurtkaya, Serdar; Du, Yuhong; Qui, Min; Murphy, T. J.; Snyder, James P.; Brauner-Osborne, Hans; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">650-662</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-Methyl-D-aspartate (NMDA) receptors are ligand-gated ion channels that mediate a slow, Ca2+-permeable component of excitatory synaptic transmission in the central nervous system and play a pivotal role in synaptic plasticity, neuronal development, and several neurol. diseases.  The authors describe a fluorescence-based assay that measures NMDA receptor-mediated changes in intracellular calcium in a BHK-21 cell line stably expressing NMDA receptor NR2D with NR1 under the control of a tetracycline-inducible promoter (Tet-On).  The assay selectively identifies allosteric modulators by using supramaximal concns. of glutamate and glycine to minimize detection of competitive antagonists.  The assay is validated by successfully identifying known noncompetitive, but not competitive NMDA receptor antagonists among 1800 screened compds. from two small focused libraries, including the com. available library of pharmacol. active compds.  Hits from the primary screen are validated through a secondary screen that used two-electrode voltage-clamp recordings on recombinant NMDA receptors expressed in Xenopus laevis oocytes.  This strategy identified several novel modulators of NMDA receptor function, including the histamine H3 receptor antagonists clobenpropit and iodophenpropit, as well as the vanilloid receptor transient receptor potential cation channel, subfamily V, member 1 (TRPV1) antagonist capsazepine.  These compds. are noncompetitive antagonists and the histamine H3 receptor ligand showed submicromolar potency at NR1/NR2B NMDA receptors, which raises the possibility that compds. can be developed that act with high potency on both glutamate and histamine receptor systems simultaneously.  Furthermore, it is possible that some actions attributed to histamine H3 receptor inhibition in vivo may also involve NMDA receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3wxHd8lp7dLVg90H21EOLACvtfcHk0lj5EMIEOItkcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFCls78%253D&md5=b11728641a7d25df2e021fb5d53eb2e9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.166256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.166256%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DDawit%26aufirst%3DS.%26aulast%3DKurtkaya%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DVance%26aufirst%3DK.%26aulast%3DOrr%26aufirst%3DA.%26aulast%3DKvist%26aufirst%3DT.%26aulast%3DOgden%26aufirst%3DK.%26aulast%3DLe%26aufirst%3DP.%26atitle%3DImplementation%2520of%2520a%2520fluorescence-based%2520screening%2520assay%2520identifies%2520histamine%2520H3%2520receptor%2520antagonists%2520clobenpropit%2520and%2520iodophenpropit%2520as%2520subunit-selective%2520N-methyl-d-aspartate%2520receptor%2520antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D650%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=U11418" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=U11418','Genbank','U11418'); return false;">Genbank: U11418</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=U08261" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=U08261','Genbank','U08261'); return false;">Genbank: U08261</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=D13211" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=D13211','Genbank','D13211'); return false;">Genbank: D13211</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=U11419" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=U11419','Genbank','U11419'); return false;">Genbank: U11419</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=M91563" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=M91563','Genbank','M91563'); return false;">Genbank: M91563</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=L31611" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=L31611','Genbank','L31611'); return false;">Genbank: L31611</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=X17184" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=X17184','Genbank','X17184'); return false;">Genbank: X17184</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=Z11548" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=Z11548','Genbank','Z11548'); return false;">Genbank: Z11548</a></li><li><a href="http://www.ncbi.nlm.nih.gov/gquery?Term=D13212" onclick="trackOutboundLink('http://www.ncbi.nlm.nih.gov/gquery?Term=D13212','Genbank','D13212'); return false;">Genbank: D13212</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i121"><a href="/doi/suppl/10.1021/jm401695d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21241"></div></div></div></div></div><hr /></hr><p class="last">Experimental information and the generic formula for experimental test compounds described in Tables <a class="ref showTableEvent internalNav" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" href="#tbl8">8</a>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401695d/suppl_file/jm401695d_si_001.pdf">jm401695d_si_001.pdf (299.26 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401695d&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm401695d%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-6%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401695d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799daa56faf2440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
